var title_f26_0_26624="Muscle innervation part A";
var content_f26_0_26624=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F73819%7EPC%2F50878%7EPC%2F62629&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F73819%7EPC%2F50878%7EPC%2F62629&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Function and peripheral and segmental innervation of muscles: part A",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Function",
"       </td>",
"       <td class=\"subtitle1\">",
"        Muscle",
"       </td>",
"       <td class=\"subtitle1\">",
"        Nerve",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\" rowspan=\"1\">",
"        Plexus cervicalis: C1-C4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\" rowspan=\"1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle2_left\">",
"        Cervical nerves",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Flexion, extension, rotation and lateral bending of the back",
"       </td>",
"       <td>",
"        Colli profundi (+ sternocleidomastoideus + trapezius)",
"       </td>",
"       <td>",
"        C1-C4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Lifting of upper thorax; inspiration",
"       </td>",
"       <td>",
"        Scaleni",
"       </td>",
"       <td>",
"        C3-C5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\" rowspan=\"1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle2_left\">",
"        Phrenic nerve",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Inspiration",
"       </td>",
"       <td>",
"        Diaphragm",
"       </td>",
"       <td>",
"        C3-C5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\" rowspan=\"1\">",
"        Plexus brachialis: C5-T1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\" rowspan=\"1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle2_left\">",
"        Anterior thoracic nerve",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Adduction and internal rotation of arm and dorsoventral lowering of shoulder",
"       </td>",
"       <td>",
"        Pectoralis major and minor",
"       </td>",
"       <td>",
"        C5-T1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\" rowspan=\"1\">",
"        &nbsp;&nbsp;",
"       </td>",
"       <td class=\"subtitle2_left\">",
"        Long thoracic nerve",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Fixation of scapula during lifting of arm (anterior movement of shoulder)",
"       </td>",
"       <td>",
"        Serratus anterior",
"       </td>",
"       <td>",
"        C5-C7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\" rowspan=\"1\">",
"        &nbsp;&nbsp;",
"       </td>",
"       <td class=\"subtitle2_left\">",
"        Dorsal scapular nerve",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Elevation and adduction of scapula toward spinal column",
"       </td>",
"       <td>",
"        <p>",
"         Levator scapulae",
"        </p>",
"        <p>",
"         Rhomboidei",
"        </p>",
"       </td>",
"       <td>",
"        C4-C5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\" rowspan=\"1\">",
"        &nbsp;&nbsp;",
"       </td>",
"       <td class=\"subtitle2_left\">",
"        Suprascapular nerve",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Lifting and outward rotation of arm",
"       </td>",
"       <td>",
"        Supraspinatus",
"       </td>",
"       <td>",
"        C4-C6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Outward rotation of arm in shoulder joint",
"       </td>",
"       <td>",
"        Infraspinatus",
"       </td>",
"       <td>",
"        C4-C6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\" rowspan=\"1\">",
"        &nbsp;&nbsp;",
"       </td>",
"       <td class=\"subtitle2_left\">",
"        Dorsal thoracic nerve",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Inward rotation of shoulder joint; adduction from ventral to dorsal; lowering of elevated arm",
"       </td>",
"       <td>",
"        <p>",
"         Latissimus dorsi",
"        </p>",
"        <p>",
"         Teres major",
"        </p>",
"        <p>",
"         Subscapularis",
"        </p>",
"       </td>",
"       <td>",
"        C5-C8 (from dorsal portion of plexus)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\" rowspan=\"1\">",
"        &nbsp;&nbsp;",
"       </td>",
"       <td class=\"subtitle2_left\">",
"        Axillary nerve",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Lateral lifting (abduction) of arm up to the horizontal line",
"       </td>",
"       <td>",
"        Deltoideus",
"       </td>",
"       <td>",
"        C5-C6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Outward rotation of arm",
"       </td>",
"       <td>",
"        Teres minor",
"       </td>",
"       <td>",
"        C4-C5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\" rowspan=\"1\">",
"        &nbsp;&nbsp;",
"       </td>",
"       <td class=\"subtitle2_left\">",
"        Musculocutaneous nerve",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Flexion of upper and lower arm and supination of lower arm",
"       </td>",
"       <td>",
"        Biceps brachii",
"       </td>",
"       <td>",
"        C5-C6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Elevation and adduction of arm",
"       </td>",
"       <td>",
"        Coracobrachialis",
"       </td>",
"       <td>",
"        C5-C7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Flexion of lower arm",
"       </td>",
"       <td>",
"        Brachialis",
"       </td>",
"       <td>",
"        C5-C6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\" rowspan=\"1\">",
"        &nbsp;&nbsp;",
"       </td>",
"       <td class=\"subtitle2_left\">",
"        Median nerve",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Flexion and radial deviation of hand",
"       </td>",
"       <td>",
"        Flexor carpi radialis",
"       </td>",
"       <td>",
"        C6-C7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Pronation of lower arm",
"       </td>",
"       <td>",
"        Pronator teres",
"       </td>",
"       <td>",
"        C6-C7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Flexion of hand",
"       </td>",
"       <td>",
"        Palmaris longus",
"       </td>",
"       <td>",
"        C7-T1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Flexion of fingers II-V in middle phalanges",
"       </td>",
"       <td>",
"        Flexor digitorum superficialis",
"       </td>",
"       <td>",
"        C7-T1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Flexion of end phalanx of the thumb",
"       </td>",
"       <td>",
"        Flexor pollicis longus",
"       </td>",
"       <td>",
"        C6-C8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Flexion of end phalanges of index and middle finger",
"       </td>",
"       <td>",
"        Flexor digitorum profundus (radial portion)",
"       </td>",
"       <td>",
"        C7-T1",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Duus, P. Topical Diagnosis in Neurology, 2nd ed. Thieme Medical Publishers,&nbsp;New York, 1989.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Function and peripheral and segmental innervation of muscles: part B",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Function",
"       </td>",
"       <td class=\"subtitle1\">",
"        Muscle",
"       </td>",
"       <td class=\"subtitle1\">",
"        Nerve",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\" rowspan=\"1\">",
"        Plexus brachialis: C5-T1 (cont'd)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Abduction of metacarpal I",
"       </td>",
"       <td>",
"        Abductor pollicis brevis",
"       </td>",
"       <td>",
"        C7-T1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Flexion of proximal phalanx of thumb",
"       </td>",
"       <td>",
"        Flexor pollicis brevis",
"       </td>",
"       <td>",
"        C7-T1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Opposition of metacarpal I",
"       </td>",
"       <td>",
"        Opponens pollicis brevis",
"       </td>",
"       <td>",
"        C6-C7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\" rowspan=\"1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle2_left\">",
"        Median nerve",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Flexion of proximal phalanges and extension of other joints",
"       </td>",
"       <td>",
"        Lumbricales: Index and middle fingers",
"       </td>",
"       <td class=\"\">",
"        C8-T1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\" rowspan=\"1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle2_left\">",
"        Ulnar nerve",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" rowspan=\"1\">",
"        Flexion of proximal phalanges and extension of other joints",
"       </td>",
"       <td>",
"        Lumbricales: Fourth and little fingers",
"       </td>",
"       <td>",
"        C8-T1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\" rowspan=\"1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle2_left\">",
"        Ulnar nerve",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Flexion and ulnar bending of hand",
"       </td>",
"       <td>",
"        Flexor carpi ulnaris",
"       </td>",
"       <td>",
"        C7-T1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Flexion of proximal phalanges of fourth and little fingers",
"       </td>",
"       <td>",
"        Flexor digitorum profundus (ulnar portion)",
"       </td>",
"       <td>",
"        C7-T1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Adduction of metacarpal I",
"       </td>",
"       <td>",
"        Adductor pollicis",
"       </td>",
"       <td>",
"        C8-T1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Abduction of middle finger",
"       </td>",
"       <td>",
"        Abductor digiti V",
"       </td>",
"       <td>",
"        C8-T1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Opposition of little finger",
"       </td>",
"       <td>",
"        Opponens digiti V",
"       </td>",
"       <td>",
"        C7-T1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\" rowspan=\"1\">",
"        &nbsp;&nbsp;",
"       </td>",
"       <td class=\"subtitle2_left\">",
"        Ulnar nerve",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Flexion of little finger in metacarpo- phalangeal joint",
"       </td>",
"       <td>",
"        Flexor digiti brevis V",
"       </td>",
"       <td>",
"        C7-T1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Bending of proximal phalanges; stretching of fingers III, IV,",
"and V in middle and distal joints as well as spreading and closing of",
"these fingers",
"       </td>",
"       <td>",
"        <p>",
"         Interossei palmares and dorsales",
"        </p>",
"        <p>",
"         Lumbricales 3 and 4",
"        </p>",
"       </td>",
"       <td>",
"        C8-T1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\" rowspan=\"1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle2_left\">",
"        Radial nerve",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Extension of elbow",
"       </td>",
"       <td>",
"        Triceps brachii and M. anconeus",
"       </td>",
"       <td>",
"        C6-C8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Flexion of elbow",
"       </td>",
"       <td>",
"        Brachioradialis",
"       </td>",
"       <td>",
"        C5-C6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Extension and radial abduction of hand",
"       </td>",
"       <td>",
"        Extensor carpi radialis",
"       </td>",
"       <td>",
"        C6-C8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <p>",
"         Extension of proximal phalanges II-V",
"        </p>",
"        <p>",
"         Extension and dorsoflexion of hand; stretching and spreading of fingers",
"        </p>",
"       </td>",
"       <td>",
"        Extensor digitorum",
"       </td>",
"       <td>",
"        C6-C8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Extension of proximal phalanx of little finger",
"       </td>",
"       <td>",
"        Extensor digiti V",
"       </td>",
"       <td>",
"        C6-C8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Extension and ulnar deviation of hand",
"       </td>",
"       <td>",
"        Extensor carpi ulnaris",
"       </td>",
"       <td>",
"        C6-C8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Supination of forearm",
"       </td>",
"       <td>",
"        Supinator",
"       </td>",
"       <td>",
"        C5-C7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Abduction of metacarpal I; radial extension of hand",
"       </td>",
"       <td>",
"        Abductor pollicis longus",
"       </td>",
"       <td>",
"        C6-C7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Extension of thumb in proximal phalanx",
"       </td>",
"       <td>",
"        Extensor pollicis brevis",
"       </td>",
"       <td>",
"        C7-C8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Extension of distal phalanges of thumb",
"       </td>",
"       <td>",
"        Extensor pollicis longus",
"       </td>",
"       <td>",
"        C7-C8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Extension of proximal phalanx of index finger",
"       </td>",
"       <td>",
"        Extensor indicis proprius",
"       </td>",
"       <td>",
"        C6-C8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\" rowspan=\"1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle2_left\">",
"        Thoracic nerves",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Elevation of ribs; expiration; abdominal compression; anteroflexion and lateroflexion of trunk",
"       </td>",
"       <td>",
"        Thoracis and abdominalis",
"       </td>",
"       <td>",
"        T1-L1",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Duus, P. Topical Diagnosis in Neurology, 2nd ed. Thieme Medical Publishers, New York, 1989.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Function and peripheral and segmental innervation of muscles: part C",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Function",
"       </td>",
"       <td class=\"subtitle1\">",
"        Muscle",
"       </td>",
"       <td class=\"subtitle1\">",
"        Nerve",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\" rowspan=\"1\">",
"        Plexus lumbalis: T12-L4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\" rowspan=\"1\">",
"        &nbsp;&nbsp;",
"       </td>",
"       <td class=\"subtitle2_left\">",
"        Femoral nerve",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Flexion and outward rotation of hip",
"       </td>",
"       <td>",
"        Iliopsoas",
"       </td>",
"       <td>",
"        L1-L3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Flexion and inward rotation of lower leg",
"       </td>",
"       <td>",
"        Sartorius",
"       </td>",
"       <td>",
"        L2-L3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Extension of lower leg in knee joint",
"       </td>",
"       <td>",
"        Quadriceps femoris",
"       </td>",
"       <td>",
"        L2-L4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\" rowspan=\"1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle2_left\">",
"        Obturator nerve",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"1\" rowspan=\"5\">",
"        Adduction of thigh",
"       </td>",
"       <td>",
"        Pectineus",
"       </td>",
"       <td>",
"        L2-L3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Adductor longus",
"       </td>",
"       <td>",
"        L2-L3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Adductor brevis",
"       </td>",
"       <td>",
"        L2-L4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Adductor magnus",
"       </td>",
"       <td>",
"        L3-L4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gracilis",
"       </td>",
"       <td>",
"        L2-L4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Adduction and outward rotation of thigh",
"       </td>",
"       <td>",
"        Obturatorius externus",
"       </td>",
"       <td>",
"        L3-L4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\" rowspan=\"1\">",
"        Plexus sacralis: L5-S1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\" rowspan=\"1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle2_left\">",
"        Superior gluteal nerve",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"1\" rowspan=\"2\">",
"        Abduction and inward rotation of thigh",
"       </td>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        Gluteus medius and minimus",
"       </td>",
"       <td>",
"        L4-S1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        L4-L5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Flexion of upper leg in hip; abduction and inward rotation",
"       </td>",
"       <td>",
"        Tensor fasciae latae",
"       </td>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        L5-S1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Outward rotation of thigh and abduction",
"       </td>",
"       <td>",
"        Piriformis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\" rowspan=\"1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle2_left\">",
"        Inferior gluteal nerve",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Extension of thigh in hip",
"       </td>",
"       <td>",
"        Gluteus maximus",
"       </td>",
"       <td>",
"        L4-S2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"1\" rowspan=\"3\">",
"        Outward rotation of thigh",
"       </td>",
"       <td>",
"        Obturatorius internus",
"       </td>",
"       <td>",
"        L5-S1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gemelli",
"       </td>",
"       <td>",
"        L4-S1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Quadratus",
"       </td>",
"       <td>",
"        L4-S1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\" rowspan=\"1\">",
"        &nbsp;&nbsp;",
"       </td>",
"       <td class=\"subtitle2_left\">",
"        Sciatic nerve",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"1\" rowspan=\"3\">",
"        Flexion of lower leg",
"       </td>",
"       <td>",
"        Biceps femoris",
"       </td>",
"       <td>",
"        L4-S2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Semitendinosus",
"       </td>",
"       <td>",
"        L4-S2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Semimembranosus",
"       </td>",
"       <td>",
"        L4-S1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\" rowspan=\"1\">",
"        &nbsp;&nbsp;",
"       </td>",
"       <td class=\"subtitle2_left\">",
"        Deep peroneal nerve",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Dorsiflexion and supination of foot",
"       </td>",
"       <td>",
"        Tibialis anterior",
"       </td>",
"       <td>",
"        L4-L5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Extension of toes and foot",
"       </td>",
"       <td>",
"        Extensor digitorum longus",
"       </td>",
"       <td>",
"        L4-S1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Extension of toes II-V",
"       </td>",
"       <td>",
"        Extensor digitorum brevis",
"       </td>",
"       <td>",
"        L4-S1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Extension of large toe",
"       </td>",
"       <td>",
"        Extensor hallucis longus",
"       </td>",
"       <td>",
"        L4-S1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Extension of large toe",
"       </td>",
"       <td>",
"        Extensor hallucis brevis",
"       </td>",
"       <td>",
"        L4-S1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\" rowspan=\"1\">",
"        &nbsp;&nbsp;",
"       </td>",
"       <td class=\"subtitle2_left\">",
"        Superficial peronealnerve",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Lifting and pronation of outer portion of foot",
"       </td>",
"       <td>",
"        Peronei",
"       </td>",
"       <td>",
"        L5-S1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\" rowspan=\"1\">",
"        &nbsp;&nbsp;",
"       </td>",
"       <td class=\"subtitle2_left\">",
"        Tibial nerve",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Plantar flexion of foot in supination",
"       </td>",
"       <td>",
"        <p>",
"         Gastrocnemius",
"        </p>",
"        <p>",
"         Triceps surae",
"        </p>",
"        <p>",
"         Soleus",
"        </p>",
"       </td>",
"       <td>",
"        L5-S2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Supination and plantar flexion of foot",
"       </td>",
"       <td>",
"        Tibialis posterior",
"       </td>",
"       <td>",
"        L4-L5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Flexion of distal phalanges of toes II-V (plantar flexion of foot in supination)",
"       </td>",
"       <td>",
"        Flexor digitorum longus",
"       </td>",
"       <td>",
"        L5-S2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Flexion of distal phalanx of big toe",
"       </td>",
"       <td>",
"        Flexor hallucis longus",
"       </td>",
"       <td>",
"        L5-S2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Flexion of middle phalanges of toes II-V",
"       </td>",
"       <td>",
"        Flexor digitorum brevis",
"       </td>",
"       <td>",
"        S1-S3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Spreading, closing, and flexing of proximal phalanges of toes",
"       </td>",
"       <td>",
"        Plantaris pedis",
"       </td>",
"       <td>",
"        S1-S3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\" rowspan=\"1\">",
"        &nbsp;&nbsp;",
"       </td>",
"       <td class=\"subtitle2_left\">",
"        Pudendal nerve",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Closing of sphincters of bladder and rectum",
"       </td>",
"       <td>",
"        Perineal and sphincter musculature",
"       </td>",
"       <td>",
"        S2-S4",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Duus, P. Topical Diagnosis in Neurology, 2nd ed. Thieme Medical Publishers, New York, 1989.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_0_26624=[""].join("\n");
var outline_f26_0_26624=null;
var title_f26_0_26625="Osteochondroma humerus";
var content_f26_0_26625=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F67448&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F67448&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Osteochondroma of the humerus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 265px; height: 540px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A radiograph of an osteochondroma of the humerus shows a lesion that is directly contiguous with the marrow space.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Rubin R, Strayer DS. Rubin's Pathology: Clinicopathologic Foundations of Medicine, Fifth Edition. Philadelphia: Lippincott Williams &amp; Wilkins, 2008. Copyright &copy; 2008 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_0_26625=[""].join("\n");
var outline_f26_0_26625=null;
var title_f26_0_26626="Meibomian gland dysfunction";
var content_f26_0_26626=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F78680&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F78680&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Meibomian gland dysfunction",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 283px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Lower eyelid with inflammation of the tarsal conjunctiva and cloudy oil and plugging at the meibomian gland orifices.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_0_26626=[""].join("\n");
var outline_f26_0_26626=null;
var title_f26_0_26627="Normal hip rotation";
var content_f26_0_26627=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F71765&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F71765&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Normal hip rotation according to age (years)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 420px; height: 604px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Hip rotation is assessed with the child prone. The mean and normal range (two standard deviations) for internal rotation (upper panel) and external rotation (lower panel) are depicted above.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Staheli LT. Lower limb. In: Fundamentals of Pediatric Orthopedics, 4th ed, Lippincott Williams &amp; Wilkins, Philadelphia 2008. Copyright &copy; 2008 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_0_26627=[""].join("\n");
var outline_f26_0_26627=null;
var title_f26_0_26628="Desirudin: Patient drug information";
var content_f26_0_26628=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Desirudin: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/60/25541?source=see_link\">",
"     see \"Desirudin: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F9590966\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Iprivask&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10081845\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700437",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       People who have had recent spinal anesthesia, epidurals, or spinal taps are more likely to have bleeding problems when started on this drug. This bleeding rarely happens, but can be very bad. Tell your doctor if you have had any spinal care. Do not take any other blood-thinner drugs including nonsteroidal anti-inflammatory drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705929",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor you use this drug before you get spinal anesthesia or a spinal treatment.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10081885\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691655",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to thin the blood so that clots will not form.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10081884\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2716040",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to desirudin or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703718",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have bleeding problems.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10081889\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697622",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before using products that have aspirin, blood thinners, garlic, ginseng, ginkgo, ibuprofen or like products, pain drugs, or vitamin E.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697633",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell dentists, surgeons, and other doctors that you use this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697795",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may bleed more easily. Be careful and avoid injury. Use a soft toothbrush and an electric razor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697760",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use care to stop injury and avoid falls or crashes.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10081924\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697901",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Bleeding problems.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698189",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Irritation where the shot is given.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10081926\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698653",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A fall or crash when you hit your head. Talk with your doctor even if you feel fine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699031",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699095",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swelling, warmth, or pain in the leg or arm.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10081887\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2722759",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into the fatty part of the skin on the right or left side of the belly or thigh.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696360",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Your doctor may teach you how to give the shot.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696257",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wash your hands before and after use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Move the site where you give the shot with each shot.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696118",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Throw away needles in a needle/sharp disposal box and take the box back to your doctor when it is full.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10081888\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696583",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696485",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use 2 doses or extra doses.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10081927\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from light.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10081928\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11649 Version 31.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-118.195.65.248-D487AFE9F4-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_0_26628=[""].join("\n");
var outline_f26_0_26628=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9590966\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10081845\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10081885\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10081884\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10081889\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10081924\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10081926\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10081887\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10081888\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10081927\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10081928\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?24/60/25541?source=related_link\">",
"      Desirudin: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f26_0_26629="Danazol: Drug information";
var content_f26_0_26629=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Danazol: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?31/54/32613?source=see_link\">",
"    see \"Danazol: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?5/11/5301?source=see_link\">",
"    see \"Danazol: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F5708691\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F156636\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Cyclomen&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F156678\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Androgen",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F156640\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Endometriosis (females):",
"     </b>",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Mild disease: Initial: 200-400 mg/day in 2 divided doses",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Moderate-to-severe disease: Initial: 800 mg/day in 2 divided doses",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Maintenance: Mild-severe disease: Dosage should be individualized. Continue therapy uninterrupted for 3-6 months (up to 9 months).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Fibrocystic breast disease (females):",
"     </b>",
"     Oral: Range: 100-400 mg/day in 2 divided doses. Pain and tenderness may be eliminated in 2-3 months; elimination of nodularity may require therapy for 4-6 months.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Hereditary angioedema (males/females):",
"     </b>",
"     Oral: Initial: 200 mg 2-3 times/day; after favorable response, decrease the dosage by 50% or less at intervals of 1-3 months or longer if the frequency of attacks dictates. If an attack occurs, increase the dosage by up to 200 mg/day.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F156641\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F15795958\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use is contraindicated in patients with markedly impaired renal function.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F15795959\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use is contraindicated in patients with markedly impaired hepatic function.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F156615\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule, oral: 50 mg, 100 mg, 200 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F156600\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F14259298\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Endometriosis, fibrocystic breast disease: Initiate therapy during menstruation or ensure patient is not pregnant while on therapy. Symptoms may recur following discontinuation of therapy and treatment may need reinstated.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F156616\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of endometriosis, fibrocystic breast disease, and hereditary angioedema",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F156684\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Danazol may be confused with Dantrium&reg;",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F156676\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Benign intracranial hypertension (rare), edema, flushing, hypertension, MI, palpitation, tachycardia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Anxiety (rare), chills (rare), convulsions (rare), depression, dizziness, emotional lability, fainting, fatigue, fever (rare), Guillain-Barr&eacute; syndrome (rare), headache, nervousness, sleep disorders",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Acne, alopecia, erythema multiforme (rare), mild hirsutism, maculopapular rash, papular rash, petechial rash, pruritus, purpuric rash, seborrhea, Stevens-Johnson syndrome (rare), photosensitivity (rare), urticaria, vesicular rash",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Amenorrhea (which may continue post therapy), breast size reduction, clitoris hypertrophy (rare), glucose intolerance/glucagon changes, HDL decreased, LDL increased, libido changes, nipple discharge (rare), menstrual disturbances (spotting, altered timing of cycle), semen abnormalities (changes in volume, viscosity, sperm count/motility), sex hormone-binding globulin changes, spermatogenesis reduction, thyroid binding globulin changes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Appetite changes (rare), bleeding gums (rare), constipation, gastroenteritis, nausea, pancreatitis (rare), splenic peliosis (rare), vomiting, weight gain",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Genitourinary: Vaginal dryness, vaginal irritation, pelvic pain (rare)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hematologic: Eosinophilia, erythrocytosis (reversible), leukocytosis, leukopenia, platelet count increased, polycythemia, RBC increased, thrombocytopenia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hepatic: Cholestatic jaundice, hepatic adenoma, jaundice, liver enzymes increased, malignant tumors (after prolonged use), peliosis hepatis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Back pain, carpal tunnel syndrome (rare), CPK changes, extremity pain, joint lockup, joint pain, joint swelling, muscle cramps, neck pain, paresthesia, spasms, tremor, weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular: Cataracts (rare), visual disturbances",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Renal: Hematuria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Interstitial pneumonitis, nasal congestion (rare)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Diaphoresis, voice change (hoarseness, sore throat, instability, deepening of pitch)",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F156619\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to danazol or any component of the formulation; undiagnosed genital bleeding; pregnancy; breast-feeding; porphyria; markedly impaired hepatic, renal, or cardiac function; androgen-dependent tumor; active or history of thrombosis or thromboembolic disease",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F156604\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Androgenic effects: May cause nonreversible androgenic effects.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Blood lipid changes: Anabolic steroids may cause blood lipid changes with increased risk of arteriosclerosis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic effects:",
"     <b>",
"      [U.S. Boxed Warning]: Peliosis hepatis and benign hepatic adenoma have been reported with long-term use",
"     </b>",
"     (may be complicated by acute intra-abdominal hemorrhage). Monitor closely for potential hepatotoxicity during therapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Intracranial hypertension:",
"     <b>",
"      [U.S. Boxed Warning]: May cause benign intracranial hypertension (pseudotumor cerebri);",
"     </b>",
"     monitor for headache, nausea/vomiting, visual disturbances and/or papilledema.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Thromboembolic events:",
"     <b>",
"      [U.S. Boxed Warning]: Thromboembolism, thrombotic, and thrombophlebitic events have been reported (including life-threatening or fatal strokes).",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Diabetes: Use with caution in patients with diabetes mellitus; insulin requirements may be increased; monitor carefully.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Edematous conditions: Use with caution in patients with conditions influenced by edema (eg, cardiovascular disease, migraine, seizure disorder, renal impairment); may cause fluid retention.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Fibrocystic disease: Breast cancer should be ruled out prior to treatment for fibrocystic breast disease. Symptoms of pain and tenderness may recur following discontinuation of therapy. Ovulation may not be suppressed at doses used for fibrocystic disease therefore nonhormonal contraception is recommended.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Use with caution in patients with hepatic impairment; use is contraindicated with marked impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Porphyria: May cause exacerbations of acute intermittent porphyria; use is contraindicated in patients with porphyria.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pregnancy:",
"     <b>",
"      [U.S. Boxed Warning]: Pregnancy must be ruled out prior to treatment;",
"     </b>",
"     a nonhormonal method of contraception should be used during therapy.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F156674\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Inhibits",
"     </b>",
"     CYP3A4 (weak)",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F156608\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP3A4 Inhibitors (Weak) may increase the serum concentration of ARIPiprazole.  Management: Monitor for increased aripiprazole pharmacologic effects. Aripiprazole dose adjustments may or may not be required based on concomitant therapy and/or indication. Consult full interaction monograph for specific recommendations.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CarBAMazepine: Danazol may decrease the metabolism of CarBAMazepine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CycloSPORINE (Systemic): Androgens may enhance the hepatotoxic effect of CycloSPORINE (Systemic). Androgens may increase the serum concentration of CycloSPORINE (Systemic).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HMG-CoA Reductase Inhibitors: Danazol may increase the serum concentration of HMG-CoA Reductase Inhibitors.  Management: Concurrent use of simvastatin with danazol is contraindicated.  Initiate lovastatin at an adult maximum dose of 10 mg/day, and do not exceed 20 mg/day, when danazol is given concomitantly.  Fluvastatin, pravastatin and rosuvastatin may pose lower risk.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Fluvastatin; Pravastatin; Rosuvastatin.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lomitapide: CYP3A4 Inhibitors (Weak) may increase the serum concentration of Lomitapide.  Management: Limit the maximum adult dose of lomitapide to 30 mg daily when used in combination with any weak CYP3A4 inhibitor.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pimozide: CYP3A4 Inhibitors (Weak) may increase the serum concentration of Pimozide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tacrolimus (Systemic): Danazol may increase the serum concentration of Tacrolimus (Systemic).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tacrolimus (Topical): Danazol may increase the serum concentration of Tacrolimus (Topical).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin D Analogs: Danazol may enhance the hypercalcemic effect of Vitamin D Analogs.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin K Antagonists (eg, warfarin): Androgens may enhance the anticoagulant effect of Vitamin K Antagonists.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F156630\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Food: Delays time to peak; high-fat meal increases plasma concentration and extent of availability.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F156611\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     X (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F156622\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      [U.S. Boxed Warning]: Pregnancy should be ruled out prior to treatment",
"     </b>",
"     using a sensitive test (beta subunit test, if available). Nonhormonal contraception should be used during therapy. May cause androgenic effects to the female fetus; clitoral hypertrophy, labial fusion, urogenital sinus defect, vaginal atresia, and ambiguous genitalia have been reported. Therapy should be discontinued for 2 months prior to attempting pregnancy (Caballero, 2012).",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F156644\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Contraindicated",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F156621\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsules",
"     </b>",
"     (Danazol Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     50 mg (100): $190.91",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     100 mg (100): $286.45",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     200 mg (60): $324.86",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F156613\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Liver and renal function tests (periodically). Signs and symptoms of intracranial hypertension (papilledema, headache, nausea, vomiting), lipoproteins, androgenic changes",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F156623\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Anargil (MY, TH);",
"     </li>",
"     <li>",
"      Azol (AU, ID, TW);",
"     </li>",
"     <li>",
"      Cipladanogen (CO);",
"     </li>",
"     <li>",
"      Cyclolady (TW);",
"     </li>",
"     <li>",
"      D-Zol (NZ);",
"     </li>",
"     <li>",
"      Danasin (TR);",
"     </li>",
"     <li>",
"      Danatrol (BE, CH, ES, FR, GR, IT, LU, NL, PT);",
"     </li>",
"     <li>",
"      Danazol (KP, PL);",
"     </li>",
"     <li>",
"      Danazol Jean Marie (HK);",
"     </li>",
"     <li>",
"      Danazol-ratiopharm (DE);",
"     </li>",
"     <li>",
"      Danocil (KP);",
"     </li>",
"     <li>",
"      Danocrine (BB, BM, BS, BZ, DK, FI, GY, HK, JM, NO, PK, SE, SR, TT);",
"     </li>",
"     <li>",
"      Danodiol (AE, BB, BH, BM, BS, BZ, CY, EC, EG, GH, GY, IL, JM, JO, KE, LB, LY, MU, OM, PR, QA, SA, SR, SY, TT, TZ, YE);",
"     </li>",
"     <li>",
"      Danogar (CN);",
"     </li>",
"     <li>",
"      Danogen (HN, IN);",
"     </li>",
"     <li>",
"      Danokrin (AT);",
"     </li>",
"     <li>",
"      Danol (AE, BH, CY, EE, EG, GB, HN, IE, IL, IQ, IR, JO, KW, LB, LY, OM, QA, SA, SY, YE);",
"     </li>",
"     <li>",
"      Danoval (BG, CZ, HN, HR, HU, PL, RU);",
"     </li>",
"     <li>",
"      Dorink (TW);",
"     </li>",
"     <li>",
"      Ectopal (TH);",
"     </li>",
"     <li>",
"      Gonablok (IN);",
"     </li>",
"     <li>",
"      Ladazol (ZA);",
"     </li>",
"     <li>",
"      Ladogal (AR, BR, MX, MY, PE, PH, TH, TW, UY, VE);",
"     </li>",
"     <li>",
"      Mastodanatrol (PT);",
"     </li>",
"     <li>",
"      Nazol (MY, SG);",
"     </li>",
"     <li>",
"      Novaprin (MX);",
"     </li>",
"     <li>",
"      Vabon (TH);",
"     </li>",
"     <li>",
"      Winobanin (DE);",
"     </li>",
"     <li>",
"      Zendol (IN)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F156603\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Suppresses pituitary output of follicle-stimulating hormone and luteinizing hormone that causes regression and atrophy of normal and ectopic endometrial tissue; decreases rate of growth of abnormal breast tissue; reduces attacks associated with hereditary angioedema by increasing levels of C4 component of complement",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F156618\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: Therapeutic: ~4 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Extensively hepatic, primarily to 2-hydroxymethyl danazol and ethisterone",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: ~10 hours (variable; up to 24 hours following long-term use for endometriosis)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak, serum: Within 2-8 hours (median 4 hours)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine and feces",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Caballero T, Farkas H, Bouillet L, et al, \"International Consensus and Practical Guidelines on the Gynecologic and Obstetric Management of Female Patients With Hereditary Angioedema Caused by C1 Inhibitor Deficiency,\"",
"      <i>",
"       J Allergy Clin Immunol",
"      </i>",
"      , 2012, 129(2):308-20.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?26/0/26629/abstract-text/22197274/pubmed\" id=\"22197274\" target=\"_blank\">",
"        22197274",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gately LE 3d and Andes WA, &ldquo;Danazol and Erythema Multiforme,&rdquo;",
"      <i>",
"       Ann Intern Med",
"      </i>",
"      , 1988, 109(1):85.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?26/0/26629/abstract-text/2967661/pubmed\" id=\"2967661\" target=\"_blank\">",
"        2967661",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kishino Y, Tanaka Y, Naitoh S, et al, \"Danazol Falsely Increased Values in Estradiol Immunoassays,\"",
"      <i>",
"       Clin Chim Acta",
"      </i>",
"      , 2010, 411(17-18):1380-1.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?26/0/26629/abstract-text/20478287/pubmed\" id=\"20478287\" target=\"_blank\">",
"        20478287",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Makdisi WJ, Cherian R, Vanveldhuizen PJ, et al, &ldquo;Fatal Peliosis of the Liver and Spleen in a Patient With Agnogenic Myeloid Metaplasia Treated With Danazol,&rdquo;",
"      <i>",
"       Am J Gastroenterol",
"      </i>",
"      , 1995, 90(2):317-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?26/0/26629/abstract-text/7847311/pubmed\" id=\"7847311\" target=\"_blank\">",
"        7847311",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Weinblatt ME, Kochen J, and Ortega J, &ldquo;Danazol for Children With Immune Thrombocytopenic Purpura,&rdquo;",
"      <i>",
"       Am J Dis Child",
"      </i>",
"      , 1988, 142(12):1317-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?26/0/26629/abstract-text/3195531/pubmed\" id=\"3195531\" target=\"_blank\">",
"        3195531",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9321 Version 41.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-83.177.194.223-2AD339225F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_0_26629=[""].join("\n");
var outline_f26_0_26629=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5708691\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F156636\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F156678\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F156640\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F156641\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15795958\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15795959\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F156615\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F156600\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14259298\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F156616\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F156684\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F156676\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F156619\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F156604\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F156674\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F156608\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F156630\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F156611\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F156622\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F156644\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F156621\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F156613\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F156623\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F156603\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F156618\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9321\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9321|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?31/54/32613?source=related_link\">",
"      Danazol: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?5/11/5301?source=related_link\">",
"      Danazol: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f26_0_26630="Glenohumeral osteoarthritis";
var content_f26_0_26630=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Glenohumeral osteoarthritis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/0/26630/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/0/26630/contributors\">",
"     Bruce C Anderson, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/0/26630/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/0/26630/contributors\">",
"     Peter Tugwell, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/0/26630/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/0/26630/contributors\">",
"     Paul L Romain, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?26/0/26630/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 19, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Osteoarthritis of the glenohumeral joint, a wear-and-tear of the articular cartilage of the glenoid labrum and humeral head, is a relatively uncommon cause of shoulder complaints [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26630/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Trauma precedes the condition in most cases, although the injury may have occurred years earlier. Injuries that are associated with the development of osteoarthritis include previous dislocation, humeral head or neck fracture, and large rotator cuff tendon tears (cuff tear arthropathy) and may also include detachments of the superior glenoid labrum from anterior to posterior (SLAP lesions) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26630/abstract/3\">",
"     3",
"    </a>",
"    ]. Primary glenohumeral osteoarthritis is more common in women and in patients over the age of 60.",
"   </p>",
"   <p>",
"    Glenohumeral osteoarthritis must be distinguished from rheumatoid arthritis (RA) affecting the glenohumeral joint. Shoulder involvement is common in RA, although typically fairly late in the course of disease. In one study, 55 percent of 74 patients with RA had developed radiographic evidence of erosive glenohumeral joint disease at 15 years [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26630/abstract/4\">",
"     4",
"    </a>",
"    ]. The symptoms of glenohumeral osteoarthritis and RA affecting the glenohumeral joint are identical; single joint involvement in an older patient suggests the former, while multiple joint involvement tends to occur in the latter. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/46/13033?source=see_link\">",
"     \"Clinical features of rheumatoid arthritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The clinical examination in patients with glenohumeral osteoarthritis is identical to that of patients with frozen shoulder, and presenting symptoms may be similar. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/7/33912?source=see_link\">",
"     \"Frozen shoulder (adhesive capsulitis)\"",
"    </a>",
"    .) X-rays are diagnostic in the former.",
"   </p>",
"   <p>",
"    The clinical presentation, evaluation, diagnosis, and treatment of glenohumeral osteoarthritis are reviewed here. The clinical evaluation and use of imaging in patients with shoulder complaints are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/7/35961?source=see_link\">",
"     \"Evaluation of the patient with shoulder complaints\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/11/27834?source=see_link\">",
"     \"Physical examination of the shoulder\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/36/36425?source=see_link\">",
"     \"Radiologic evaluation of the painful shoulder\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PRESENTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with glenohumeral osteoarthritis complain of the gradual development of anterior shoulder pain and stiffness over a period of months to years. The patient may rub the front of the shoulder while describing the symptoms. The pain generally is aggravated by activity and is relieved by rest, although patients may complain of night pain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;As mentioned above, patients with frozen shoulder may present with symptoms similar to those of patients with glenohumeral osteoarthritis, and the physical examinations in both cases are nearly identical. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/7/33912?source=see_link\">",
"     \"Frozen shoulder (adhesive capsulitis)\"",
"    </a>",
"    .) Thus, plain x-rays are necessary to confirm the diagnosis. Occasionally, in early cases of osteoarthritis, more specialized radiographic studies are necessary to identify thinning of the glenoid articular cartilage. Patients with multiple affected joints should be screened for other arthritides such as rheumatoid arthritis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following physical examination findings are typically present in patients with glenohumeral osteoarthritis:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Local glenohumeral joint line tenderness and swelling anteriorly",
"     </li>",
"     <li>",
"      Loss of range of motion of external rotation and abduction",
"     </li>",
"     <li>",
"      Crepitation",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    While osteoarthritis also is frequently associated with effusion, this may be difficult to detect on physical examination since the glenohumeral joint lies deep within the soft tissues. Large effusions may present with infraclavicular swelling or general shoulder fullness, assessed best by looking down on the joint from above and by comparing the",
"    <span class=\"nowrap\">",
"     posterior/anterior",
"    </span>",
"    (PA) dimension with the healthy side.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Joint line tenderness",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tenderness is located along the anterior joint line just under the thumb-shaped projection of the coracoid process (",
"    <a class=\"graphic graphic_figure graphicRef81764 graphicRef54102 graphicRef69995 \" href=\"UTD.htm?33/63/34810\">",
"     figure 1A-C",
"    </a>",
"    ). Firm outward and slightly upward pressure is necessary to elicit pain along the joint line.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Restricted range of motion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endpoint stiffness and restricted external rotation and abduction are the hallmark physical signs of glenohumeral arthritis.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The &ldquo;NFL touchdown&rdquo; sign is an active maneuver used to assess the range of motion of the shoulder joint and the strength of abduction (",
"      <a class=\"graphic graphic_picture graphicRef65710 \" href=\"UTD.htm?26/14/26849\">",
"       picture 1",
"      </a>",
"      ). Full abduction requires a normal glenohumeral joint, intact rotator cuff tendons, a functional AC joint, and reasonably well-developed deltoid and rotator cuff muscles. Patients with glenohumeral osteoarthritis will have stiffness and pain with this maneuver.",
"     </li>",
"     <li>",
"      The Apley scratch test is used to assess rotation of the shoulder joint (",
"      <a class=\"graphic graphic_picture graphicRef50093 \" href=\"UTD.htm?18/63/19442\">",
"       picture 2",
"      </a>",
"      ). Patients with normal glenohumeral motion should be able to scratch the midback at the T8 to T10 level. Patients with glenohumeral osteoarthritis (or frozen shoulder and possibly acute rotator cuff tendinitis) have limited range of motion when compared with the healthy arm; the impairment of rotation correlates well with the severity of these conditions.",
"     </li>",
"     <li>",
"      Passive movement of the arm in abduction and external rotation also is measured. The normal glenohumeral joint rotates externally to 90 degrees and abducts to 90 to 110 degrees.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Crepitation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Crepitation with movement of the joint often can be palpated anteriorly in patients with glenohumeral osteoarthritis; it may be audible in moderate to severe cases. Crepitation is best elicited by resisting abduction in midarc and by feeling for the crepitation as tension is released (as the humeral head moves rapidly across the irregular glenoid cartilage).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Radiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Plain radiographs of the shoulder (including PA, external rotation, Y-outlet, and axillary views) are recommended in patients with suspected glenohumeral osteoarthritis to differentiate this condition from frozen shoulder. Plain films are normal in patients with pure frozen shoulder, while cartilaginous wear, osteophytes on the inferior portion of the humeral head, sclerosis of the humeral head, and narrowing of the inferior portion of the glenohumeral articular cartilage (normal 3 to 4 mm) are characteristic of osteoarthritis (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef59306 \" href=\"UTD.htm?23/46/24302\">",
"     image 1",
"    </a>",
"    ). The earliest changes of osteoarthritis include narrowing of the articular cartilage and irregularities at the inferior glenoid fossa. The distance between the inferior glenoid and the humeral head gradually decreases as the disease progresses, and spurring of the inferior portion of the humeral head increases. A large spur may be evident in patients with advanced disease, along with flattening of the humeral head and obliteration of the articular cartilage at the inferior glenoid.",
"   </p>",
"   <p>",
"    Specialized radiographic testing is not necessary in most patients with glenohumeral osteoarthritis who have moderate to advanced disease and well-defined changes on plain film. CT arthrography can be useful to detect earlier disease, particularly in young patients who have had trauma to the shoulder [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26630/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Glenohumeral osteoarthritis is a slowly progressive disorder that is usually effectively controlled with physical therapy and occasionally with intraarticular injection. Maintenance toning exercises limit recurrences. Shoulder replacement surgery is indicated for patients who have impairment of overall shoulder function that has a significant impact on daily activities or that is associated with intractable pain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Acute period",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute therapy of glenohumeral osteoarthritis consists of activity restrictions, heat followed by stretching exercises, and antiinflammatory therapy. (See",
"    <a class=\"medical medical_patient\" href=\"UTD.htm?3/17/3345?source=see_link\">",
"     \"Patient information: Shoulder osteoarthritis treatment (Beyond the Basics)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients should be advised to eliminate heavy work, overhead reaching, and forceful pushing and pulling.",
"     </li>",
"     <li>",
"      Nonsteroidal antiinflammatory drugs (NSAIDs) can be prescribed for three to four weeks, followed by",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"       acetaminophen",
"      </a>",
"      (1000 mg twice a day).",
"     </li>",
"     <li>",
"      The anterior shoulder should be heated for 10 to 15 minutes with moist heat or in a bathtub or shower.",
"     </li>",
"     <li>",
"      The weighted pendulum stretch exercise is performed for five minutes daily following the heat application (",
"      <a class=\"graphic graphic_picture graphicRef75504 \" href=\"UTD.htm?1/21/1366\">",
"       picture 3",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Passive stretching exercises are performed after the pendulum stretch exercise daily, emphasizing exercises that provide stretch in the direction in which the patient has experienced the greatest loss of function (usually abduction and external rotation) (",
"      <a class=\"graphic graphic_picture graphicRef76033 graphicRef55131 graphicRef67887 \" href=\"UTD.htm?36/34/37413\">",
"       picture 4A-C",
"      </a>",
"      ). Abduction stretch should be limited to no higher than shoulder level, and patients should be advised to stretch to the point of tension but not pain.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    After the acute pain has resolved, patients should be instructed in general rotator cuff toning exercises (",
"    <a class=\"graphic graphic_figure graphicRef59996 \" href=\"UTD.htm?27/31/28144\">",
"     figure 2",
"    </a>",
"    ). Patients can resume their usual daily activities once tone in internal and external rotation has been restored.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Persistent symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients should be seen in follow-up at six to eight weeks to reevaluate range of motion, to reinforce passive stretching exercises, and to encourage use of isometric toning exercises if they are not yet being done. Patients with persistent symptoms despite these measures are candidates for intraarticular injection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Intraarticular injections",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intraarticular injection with glucocorticoids or a series of injections of a high molecular weight preparation of sodium hyaluronate may provide some relief from shoulder pain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29161401\">",
"    <span class=\"h4\">",
"     Glucocorticoid injections",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intraarticular glucocorticoid injection may be performed in the office, or patients can be referred to a radiologist for injection under fluoroscopic guidance. Fluoroscopy is strongly recommended for obese patients. The injection is performed as follows (",
"    <a class=\"graphic graphic_picture graphicRef67940 \" href=\"UTD.htm?4/22/4449\">",
"     picture 5",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The patient assumes a sitting position with the shoulder relaxed.",
"     </li>",
"     <li>",
"      The humeral head, coracoid process, and acromioclavicular (AC) joint are located and marked. The point of entry is 0.5 inches below the coracoid process. The angle of entry is 10 to 20 degrees up and out, aligned with the AC joint. A 3.5-inch, 22-gauge needle is necessary in the obese or muscular patient since the depth of the joint can be 2 to 2.5 inches.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/2/14370?source=see_link\">",
"       Ethyl chloride",
"      </a>",
"      is sprayed on the skin. Local anesthetic is placed at the pectoralis fascia (1 mL), at the subscapularis fascia (1 mL), and intra-articularly (1 to 2 mL). One mL of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/38/39520?source=see_link\">",
"       triamcinolone",
"      </a>",
"      acetonide (40",
"      <span class=\"nowrap\">",
"       mg/mL)",
"      </span>",
"      is then injected intra-articularly.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Injection aftercare is",
"    <strong>",
"     critical",
"    </strong>",
"    to the success of glucocorticoid injection. The patient should be advised to:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Protect the injection by resting for three days and by avoiding reaching, overhead positioning, lifting, pushing, and pulling. Restrictions should be continued for one month.",
"     </li>",
"     <li>",
"      If the injection causes soreness or irritation, apply ice for 15 minutes every four to six hours and take",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"       acetaminophen",
"      </a>",
"      , 1000 mg twice a day",
"     </li>",
"     <li>",
"      Begin the pendulum stretching exercise on day four (",
"      <a class=\"graphic graphic_figure graphicRef81764 graphicRef54102 graphicRef69995 \" href=\"UTD.htm?33/63/34810\">",
"       figure 1A-C",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Perform passive stretching exercises following the pendulum exercise daily (",
"      <a class=\"graphic graphic_picture graphicRef76033 graphicRef55131 graphicRef67887 \" href=\"UTD.htm?36/34/37413\">",
"       picture 4A-C",
"      </a>",
"      ). It is crucial that the muscles of the shoulder are totally relaxed. Sets of 20 to 25 stretches in each direction are performed.",
"     </li>",
"     <li>",
"      Begin the isometric toning exercises of lifting and rotation once the range of motion has begun to improve (",
"      <a class=\"graphic graphic_picture graphicRef75504 \" href=\"UTD.htm?1/21/1366\">",
"       picture 3",
"      </a>",
"      ). These exercises are necessary to restore any lost muscle strength. Mild muscle soreness in the back of the shoulder is expected. The exercise must be stopped if dramatic pain develops.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The injection may be repeated at six weeks if overall improvement is less than 50 percent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29161415\">",
"    <span class=\"h4\">",
"     Intraarticular sodium hyaluronate injections",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are limited data on the efficacy and safety of intraarticular glenohumeral joint injections for patients with persistent shoulder pain due to OA. A study that showed statistically significant but clinically very modest benefit included 660 patients with shoulder pain of various etiologies; patients were randomly assigned to receive five weekly glenohumeral joint injections with sodium hyaluronate or buffered saline solution [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26630/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A statistically significant difference in shoulder pain favored the groups receiving either three or five hyaluronate injections versus those who received saline (placebo) injections. However, the predetermined primary end points of the study were not achieved, and the degree of benefit was small and of uncertain clinical significance. An improvement from baseline of at least 20 percent was statistically significantly more common in patients receiving five sodium hyaluronate injections compared with control injections (85 versus 77 percent). A subgroup analysis noted a statistically significant difference between those with glenohumeral OA who received a series of three injections of hyaluronate and two saline injections versus those who received only saline injections.",
"   </p>",
"   <p>",
"    The injection technique and aftercare instructions for sodium hyaluronate injections are similar to those described above for glucocorticoids. (See",
"    <a class=\"local\" href=\"#H29161401\">",
"     'Glucocorticoid injections'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Referral and surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Repeat x-rays should be performed at three months to look for disease progression if the patient has lost significant range of motion",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    if symptoms have been progressive despite the above measures. Surgical consultation can be considered if symptoms fail to improve significantly with two injections, stretching exercises, and time (6 to 12 months).",
"   </p>",
"   <p>",
"    The primary indication for surgery is pain that is unresponsive to medical management. The established surgical treatment for shoulder osteoarthritis is prosthetic replacement, except in very young patients in whom arthroscopic debridement and removal of osteophytes might be attempted to delay the need for prosthetic replacement. The outcomes of this procedure, however, are unpredictable and should be seen as a measure of last resort in patients otherwise unsuitable for replacement due to age or to functional requirements [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26630/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A secondary, relative indication specifically for reverse shoulder replacement has been developed for the treatment of pseudoparalysis, the severe functional limitation associated with massive, irreparable rotator cuff tears, even in the setting of milder degrees of arthritis and pain. This very specific indication is the exception to the general rule that prosthetic replacement is performed primarily for pain relief rather than function.",
"   </p>",
"   <p>",
"    Either hemiarthroplasty or total shoulder replacement (a more complicated and technically more difficult procedure) is performed, depending upon the condition of the glenoid [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26630/abstract/8\">",
"     8",
"    </a>",
"    ]. Both are associated with high degrees of success in the appropriate patients (&gt;72 to 90 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26630/abstract/8-10\">",
"     8-10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Hemiarthroplasty results in less improvement in function compared with total shoulder arthroplasty but does not differ with respect to benefit for pain, range of motion, quality of life, or strength [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26630/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. Arthritis of the glenoid is responsible for continued pain and for the need for revision arthroplasty in some patients who undergo initial hemiarthroplasty [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26630/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Reverse (or also inverse) shoulder replacement is a further modification of traditional total shoulder replacement. By switching the position of the ball and socket components, a lever arm is created that can effectively substitute deltoid function for a deficient rotator cuff and that can provide improved function. It, therefore, provides an alternative to hemiarthroplasty for the treatment of osteoarthritis with associated irreparable rotator cuff deficiency [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26630/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Contraindications to surgical intervention include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Neurologic injury leading to an insufficient deltoid",
"     </li>",
"     <li>",
"      Insufficient general health and fitness to undergo postprocedure physical therapy",
"     </li>",
"     <li>",
"      Severely reduced bone mineral density that increases risk of humeral fracture (a relative contraindication)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Several factors affect the choice of procedure, including the preferences and personal experience of the surgeon. The following characteristics identify patients who may be better candidates for the more limited procedure of hemiarthroplasty:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Patients with irreparable severe rotator cuff insufficiency from tears and disuse",
"     </li>",
"     <li>",
"      Patients with concentric loss of glenoid cartilage, who generally do well with hemiarthroplasty and who do not require total shoulder replacement",
"     </li>",
"     <li>",
"      Patients who have significant comorbidities, including cardiovascular or metabolic disease, and who are, therefore, felt to benefit from the less invasive and faster procedure",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?3/17/3345?source=see_link\">",
"       \"Patient information: Shoulder osteoarthritis treatment (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H501233\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Osteoarthritis of the glenohumeral joint, a wear-and-tear of the articular cartilage of the glenoid labrum and humeral head, is a relatively uncommon cause of shoulder complaints. Trauma precedes the condition in most cases, although the injury may have occurred years earlier. Patients with glenohumeral osteoarthritis complain of the gradual development of anterior shoulder pain and stiffness over a period of months to years. The pain generally is aggravated by activity and is relieved by rest, although patients may complain of night pain. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H2\">",
"       'Presentation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The symptoms and physical examination resemble those of frozen shoulder, with findings of glenohumeral joint line tenderness, anterior swelling, diminished external rotation and abduction, and crepitation. The diagnosis is confirmed by plain radiography. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Diagnosis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H4\">",
"       'Physical examination'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H8\">",
"       'Radiography'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Acute therapy of glenohumeral osteoarthritis consists of activity restrictions, heat followed by stretching exercises, and antiinflammatory therapy. After the acute pain has resolved, patients should be instructed in general rotator cuff toning exercises and can resume their usual daily activities once tone in internal and external rotation has been restored. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Acute period'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Intraarticular injection with glucocorticoids or a series of injections of a high molecular weight preparation of sodium hyaluronate may provide some relief from shoulder pain in patients in whom persistent symptoms at six to eight weeks follow-up do not respond to reinforcement of continuing passive stretching exercises and to use of isometric toning exercises, if they are not yet being done. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Persistent symptoms'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H12\">",
"       'Intraarticular injections'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Repeat x-rays should be performed at three months to look for disease progression if the patient has lost significant range of motion",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      if symptoms have been progressive despite the above measures. Surgical consultation can be considered if symptoms fail to improve significantly with two injections, stretching exercises, and time (6 to 12 months). The primary indication for surgery is pain that is unresponsive to medical management. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Referral and surgery'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26630/abstract/1\">",
"      Nakagawa Y, Hyakuna K, Otani S, et al. Epidemiologic study of glenohumeral osteoarthritis with plain radiography. J Shoulder Elbow Surg 1999; 8:580.",
"     </a>",
"    </li>",
"    <li>",
"     Anderson BC. Office Orthopedics for Primary Care: Diagnosis, Third Edition, Elsevier Saunders Company, Philadelphia 2006.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26630/abstract/3\">",
"      Patzer T, Lichtenberg S, Kircher J, et al. Influence of SLAP lesions on chondral lesions of the glenohumeral joint. Knee Surg Sports Traumatol Arthrosc 2010; 18:982.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26630/abstract/4\">",
"      Lehtinen JT, Kaarela K, Belt EA, et al. Incidence of glenohumeral joint involvement in seropositive rheumatoid arthritis. A 15 year endpoint study. J Rheumatol 2000; 27:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26630/abstract/5\">",
"      Green A, Norris TR. Imaging techniques for glenohumeral arthritis and glenohumeral arthroplasty. Clin Orthop Relat Res 1994; :7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26630/abstract/6\">",
"      Blaine T, Moskowitz R, Udell J, et al. Treatment of persistent shoulder pain with sodium hyaluronate: a randomized, controlled trial. A multicenter study. J Bone Joint Surg Am 2008; 90:970.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26630/abstract/7\">",
"      Cole BJ, Yanke A, Provencher MT. Nonarthroplasty alternatives for the treatment of glenohumeral arthritis. J Shoulder Elbow Surg 2007; 16:S231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26630/abstract/8\">",
"      Boyd AD Jr, Thornhill TS. Surgical treatment of osteoarthritis of the shoulder. Rheum Dis Clin North Am 1988; 14:591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26630/abstract/9\">",
"      Gartsman GM, Roddey TS, Hammerman SM. Shoulder arthroplasty with or without resurfacing of the glenoid in patients who have osteoarthritis. J Bone Joint Surg Am 2000; 82:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26630/abstract/10\">",
"      Rispoli DM, Sperling JW, Athwal GS, et al. Humeral head replacement for the treatment of osteoarthritis. J Bone Joint Surg Am 2006; 88:2637.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26630/abstract/11\">",
"      Bryant D, Litchfield R, Sandow M, et al. A comparison of pain, strength, range of motion, and functional outcomes after hemiarthroplasty and total shoulder arthroplasty in patients with osteoarthritis of the shoulder. A systematic review and meta-analysis. J Bone Joint Surg Am 2005; 87:1947.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26630/abstract/12\">",
"      Singh JA, Sperling J, Buchbinder R, McMaken K. Surgery for shoulder osteoarthritis. Cochrane Database Syst Rev 2010; :CD008089.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26630/abstract/13\">",
"      Frankle M, Siegal S, Pupello D, et al. The Reverse Shoulder Prosthesis for glenohumeral arthritis associated with severe rotator cuff deficiency. A minimum two-year follow-up study of sixty patients. J Bone Joint Surg Am 2005; 87:1697.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5503 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-183.166.191.243-0970125B04-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_0_26630=[""].join("\n");
var outline_f26_0_26630=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H501233\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PRESENTATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Joint line tenderness",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Restricted range of motion",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Crepitation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Radiography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Acute period",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Persistent symptoms",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Intraarticular injections",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H29161401\">",
"      Glucocorticoid injections",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H29161415\">",
"      Intraarticular sodium hyaluronate injections",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Referral and surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H501233\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"RHEUM/5503\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"RHEUM/5503|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?23/46/24302\" title=\"diagnostic image 1\">",
"      Glenohumeral osteoarthritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"RHEUM/5503|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?32/20/33093\" title=\"figure 1A\">",
"      Shoulder anatomy anterior",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?27/60/28613\" title=\"figure 1B\">",
"      Basic shoulder anatomy lateral view",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?27/6/27748\" title=\"figure 1C\">",
"      Basic shoulder anatomy posterior view",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?27/31/28144\" title=\"figure 2\">",
"      Shoulder strength exercises",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"RHEUM/5503|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?26/14/26849\" title=\"picture 1\">",
"      NFL touchdown sign",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?18/63/19442\" title=\"picture 2\">",
"      Apley scratch sign",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?1/21/1366\" title=\"picture 3\">",
"      Weighted pendulum PI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?7/55/8063\" title=\"picture 4A\">",
"      Armpit stretch",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?11/56/12175\" title=\"picture 4B\">",
"      Walk up wall stretch",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?20/10/20655\" title=\"picture 4C\">",
"      Towel stretch",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?4/22/4449\" title=\"picture 5\">",
"      Intraarticular injection",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/46/13033?source=related_link\">",
"      Clinical features of rheumatoid arthritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/7/35961?source=related_link\">",
"      Evaluation of the patient with shoulder complaints",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/7/33912?source=related_link\">",
"      Frozen shoulder (adhesive capsulitis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?3/17/3345?source=related_link\">",
"      Patient information: Shoulder osteoarthritis treatment (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/11/27834?source=related_link\">",
"      Physical examination of the shoulder",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/36/36425?source=related_link\">",
"      Radiologic evaluation of the painful shoulder",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f26_0_26631="Treatment of fibromuscular dysplasia of the renal arteries";
var content_f26_0_26631=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Treatment of fibromuscular dysplasia of the renal arteries",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/0/26631/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/0/26631/contributors\">",
"     David P Slovut, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/0/26631/contributors\">",
"     Jeffrey W Olin, DO",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/0/26631/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/0/26631/contributors\">",
"     George L Bakris, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/0/26631/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/0/26631/contributors\">",
"     John P Forman, MD, MSc",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?26/0/26631/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 26, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fibromuscular dysplasia (FMD) is a noninflammatory, nonatherosclerotic disorder that leads to arterial stenosis, aneurysm, and dissection. It has been observed in nearly every arterial bed. The most often involved arteries are the renal and internal carotid arteries, and less often the vertebral, iliac, subclavian, and visceral arteries. FMD may rarely occur in the coronary arteries.",
"   </p>",
"   <p>",
"    Disease presentation may vary widely, depending upon the arterial segment involved and the severity of disease. The most common manifestations are hypertension, transient ischemic attack, and stroke.",
"   </p>",
"   <p>",
"    Treatment options for patients with renal artery FMD include medical therapy alone, or revascularization by either percutaneous transluminal angioplasty (PTA) or surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26631/abstract/1\">",
"     1",
"    </a>",
"    ]. However, independent of angioplasty, hypertension should be treated [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26631/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The treatment of renal fibromuscular dysplasia will be reviewed here. The clinical manifestations and diagnosis of this disorder and the management of atherosclerotic renovascular disease and chronic kidney disease due to renal ischemia are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/42/34471?source=see_link\">",
"     \"Clinical manifestations and diagnosis of fibromuscular dysplasia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/43/29369?source=see_link\">",
"     \"Treatment of unilateral atherosclerotic renal artery stenosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/54/8040?source=see_link\">",
"     \"Treatment of bilateral atherosclerotic renal artery stenosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/41/33433?source=see_link\">",
"     \"Chronic kidney disease associated with atherosclerotic renovascular disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     MEDICAL THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Independent of the decision to undertake angioplasty, blood pressure should be controlled according to the recommendations of the Joint National Committee on the Prevention, Detection and Treatment of High Blood Pressure 7 (JNC 7) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26631/abstract/2\">",
"     2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/36/32330?source=see_link\">",
"     \"Overview of hypertension in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/40/33417?source=see_link\">",
"     \"What is goal blood pressure in the treatment of hypertension?\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/54/8040?source=see_link&amp;anchor=H6#H6\">",
"     \"Treatment of bilateral atherosclerotic renal artery stenosis\", section on 'Medical therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Since the underlying pathogenesis of the hypertension includes activation of the renin-angiotensin-aldosterone system and sodium retention (among patients with bilateral disease or disease to a single functioning kidney), the initial drug class of choice in FMD is an angiotensin-converting enzyme inhibitor (ACE inhibitor) or angiotensin-receptor blocker (ARB) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26631/abstract/3\">",
"     3",
"    </a>",
"    ]. We prefer adding a thiazide diuretic if goal blood pressure is not obtained with monotherapy [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26631/abstract/3\">",
"     3",
"    </a>",
"    ]. If blood pressure control remains suboptimal, other agents should be added.",
"   </p>",
"   <p>",
"    This approach is in agreement with the 2005 American College of",
"    <span class=\"nowrap\">",
"     Cardiology/American",
"    </span>",
"    Heart Association guidelines on Peripheral Artery Disease, which also acknowledged the effectiveness of calcium channel blockers and beta blockers [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26631/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The major potential complication of this regimen is a hemodynamically mediated decline in glomerular filtration rate (GFR), especially if the stenotic lesions are severe and bilateral. The normal autoregulatory response to maintain GFR in the setting of reduced renal perfusion involves an angiotensin II-mediated preferential increase in resistance at the efferent (postcapillary) arteriole. This is blunted by blocking angiotensin II formation with an ACE inhibitor or an angiotensin receptor blocking agent, and the effect is more pronounced with diuretic-induced volume depletion [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26631/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. When it occurs, the rise in the plasma creatinine concentration is usually mild (less than 0.5 to 1",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    or 44 to 88",
"    <span class=\"nowrap\">",
"     &micro;mol/L)",
"    </span>",
"    and acceptable. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/60/19398?source=see_link\">",
"     \"Renal effects of ACE inhibitors in hypertension\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    ACE inhibitors and ARBs also increase the plasma potassium concentration in patients with decreased GFR, an effect that may be countered by the concomitant use of a thiazide diuretic. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/2/18473?source=see_link\">",
"     \"Major side effects of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    These observations, however, do not mean that ACE inhibitors or ARBs are contraindicated in this disorder as long as the patient is carefully monitored, since the decline in GFR or rise in plasma potassium is small in most patients. Termination of the ACE inhibitor or ARB should be considered if hyperkalemia cannot be controlled or the plasma creatinine concentration increases substantially above the baseline value. These abnormalities are usually reversible.",
"   </p>",
"   <p>",
"    An important limitation of pursuing medical therapy alone is that renal artery stenosis and kidney dysfunction may progress despite good blood pressure control. This most often occurs in patients with intimal or perimedial fibroplasia. As a result, every patient with FMD should have periodic measurement of serum creatinine along with imaging studies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     RENAL ARTERY REVASCULARIZATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The principal rationale for renal artery revascularization, either by surgery or PTA, is control of hypertension. There is also the possibility of delaying or preventing loss of renal mass, particularly in patients with intimal or perimedial disease, although this is not well established. The consequences of uncontrolled hypertension, and ischemic nephropathy are extensively discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/36/32330?source=see_link&amp;anchor=H10#H10\">",
"     \"Overview of hypertension in adults\", section on 'Complications'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/41/33433?source=see_link\">",
"     \"Chronic kidney disease associated with atherosclerotic renovascular disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Hypertension is cured or improved (better blood pressure control on fewer antihypertensive agents) following renal artery revascularization (either PTA or surgery) in a large proportion of patients with fibromuscular dysplasia. The reported hypertension cure rate ranges from 20 to 85 percent, and most remaining patients are improved [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26631/abstract/1,7,8\">",
"     1,7,8",
"    </a>",
"    ]. The rate of cure of hypertension may be lower if FMD affects multiple vascular beds, or if the intrarenal vessels are involved. In one report, hypertension was cured following angioplasty in 62 versus 28 percent of patients with unilateral, isolated renal FMD versus systemic FMD, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26631/abstract/7\">",
"     7",
"    </a>",
"    ]. In addition, the longer the duration of hypertension, the lesser the likelihood of cure after revascularization [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26631/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Data regarding preservation of kidney function are less clear. Although revascularization does not reverse cortical thinning and lost renal mass, renal function appears to be stabilized [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26631/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Indications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Based upon the above observations, it is generally recommended that the following patients undergo renal artery revascularization:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Those with recent onset hypertension, in particular younger patients who are less likely to have underlying atherosclerotic disease, in whom the goal is to cure hypertension or significantly reduce the number of antihypertensive medications.",
"     </li>",
"     <li>",
"      Patients whose blood pressure cannot be lowered to the desired goal despite compliance with a reasonable medication regimen. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/40/33417?source=see_link\">",
"       \"What is goal blood pressure in the treatment of hypertension?\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Patients who are unable to tolerate antihypertensive medications or are noncompliant with their medication regimen.",
"     </li>",
"     <li>",
"      Patients with loss of parenchymal mass from ischemic nephropathy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In patients with relatively well-controlled hypertension, or with no loss of renal parenchymal mass, the risks of the procedure may outweigh the benefits. In eligible patients who choose not to undergo revascularization, it is useful to periodically evaluate renal parenchymal mass.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Percutaneous transluminal angioplasty",
"    </span>",
"    &nbsp;&mdash;&nbsp;PTA has largely supplanted surgery for managing significant renal artery stenosis in FMD, primarily related to similar technical success rates and lower risk of the procedure. The reported technical (angiographic) success rates for PTA, defined in some studies as visually estimated angiographic residual stenosis less than 50 percent, range from 83 to nearly 100 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26631/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. Procedural success rates for angioplasty alone in non-medial FMD is lower [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26631/abstract/13\">",
"     13",
"    </a>",
"    ]. Hypertension is usually cured (22 to 59 percent) or improved (22 to 74 percent), but a significant proportion fail to improve (2 to 30 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26631/abstract/8,11,12,14-18\">",
"     8,11,12,14-18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For patients who undergo PTA or stent implantation for atherosclerotic renal artery stenosis, the rate of restenosis ranges from 12 to 34 percent over follow-up intervals of six months to two years [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26631/abstract/4,11,19-21\">",
"     4,11,19-21",
"    </a>",
"    ]. However, it is difficult to determine if patients with FMD develop restenosis, or if the lesion was not completely treated correctly the first time [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26631/abstract/9,22\">",
"     9,22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition, restenosis is not necessarily associated with recurrent hypertension. Over long-term follow-up (mean 7.0 + 4.7 years), FMD patients who underwent successful PTA showed significant and sustained reductions in systolic blood pressure, diastolic blood pressure, serum creatinine, and number of anti-hypertensive agents. Systolic blood pressure response was better in patients with FMD affecting the main renal artery than in patients with branch vessel involvement [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26631/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Advances in guidewires, catheters, and balloons, as well as an improvement in operator skill have made it possible to perform PTA for even the most complex renal artery lesions. Cutting balloon angioplasty may be used to dilate lesions that fail to yield with balloon dilatation [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26631/abstract/23\">",
"     23",
"    </a>",
"    ]. The 2006",
"    <span class=\"nowrap\">",
"     ACC/AHA",
"    </span>",
"    guidelines on the management of peripheral artery disease recommended balloon angioplasty alone, with bailout stent placement if necessary, for lesions due to fibromuscular dysplasia [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26631/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Stenting in the renal artery is associated with a restenosis rate of up to 10 to 20 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26631/abstract/24\">",
"     24",
"    </a>",
"    ]. Should surgical revascularization become necessary (eg, for in-stent restenosis that has recurred despite repeat stenting), patients may require more complex branch repair to bypass the occluded stent since the stent often covers the renal artery up to the point of the first intrarenal branch. While drug-eluting stent implantation has been rarely used in patients with atherosclerotic renal artery stenosis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26631/abstract/25\">",
"     25",
"    </a>",
"    ], it has not been used in patients with RAS secondary to FMD.",
"   </p>",
"   <p>",
"    While many clinicians use visual inspection to determine if the angioplasty was adequate, it is becoming apparent visual inspection alone is not accurate. Therefore other methods are important to assure that the stenosis has been adequately treated [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26631/abstract/9,26\">",
"     9,26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Physiologic assessment may be performed using a pressure guidewire, with a mean gradient of &lt;5 mmHg across the treated segment suggesting a satisfactory result [",
"      <a class=\"abstract\" href=\"UTD.htm?26/0/26631/abstract/27\">",
"       27",
"      </a>",
"      ]. It is important to measure pressure gradients both before and after angioplasty to be certain that all of the intraluminal fibrous webs have been adequately disrupted.",
"     </li>",
"     <li>",
"      Intravascular ultrasound can be used to evaluate the elimination or reduction of various endoluminal defects [",
"      <a class=\"abstract\" href=\"UTD.htm?26/0/26631/abstract/28\">",
"       28",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Post-procedure renal duplex scanning has also been used to assess the adequacy of intervention. In successfully treated patients, the ratio of renal artery peak systolic velocity to aortic peak systolic velocity (ie, renal-aortic ratio, RAR) decreases to less than 3.5, a value which classifies the diameter stenosis as &lt;60 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?26/0/26631/abstract/29\">",
"       29",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    If the patient either has no improvement in blood pressure or an initial improvement followed by recurrence of hypertension a few weeks after PTA, we recommend a repeat angiogram and PTA. In this case, \"restenosis\" may actually represent inadequate angioplasty during the first procedure [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26631/abstract/20\">",
"     20",
"    </a>",
"    ]. Hypertension that persists despite technically successful PTA, particularly if confirmed using intravascular ultrasound or a pressure guidewire, suggests that the cause of hypertension is unrelated to fibromuscular disease.",
"   </p>",
"   <p>",
"    Complications of PTA are mostly related to vascular access. In rare cases, renal artery perforation, dissection, or segmental renal infarction may occur [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26631/abstract/8\">",
"     8",
"    </a>",
"    ]. The rate of complications has decreased, a trend attributed in part to use of more flexible guiding catheters and lower",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    doses. In a series of 268 patients who underwent 320 procedures, the complication rate decreased from 16 percent in 1998 to 3 percent in 2001 [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26631/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients who undergo percutaneous revascularization should undergo periodic duplex ultrasound examinations to detect disease progression, restenosis, or loss of kidney volume [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26631/abstract/31,32\">",
"     31,32",
"    </a>",
"    ]. We suggest imaging soon after renal artery angioplasty, and repeating this at six months, 12 months and yearly thereafter, or whenever there is recurrence or worsening of hypertension, or unexplained increase in the serum creatinine.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Before the advent of PTA, surgical revascularization was the primary therapeutic alternative for patients with refractory hypertension. In contemporary surgical series, technical success rates are greater than 88 percent, long-term blood pressure was cured in 33 to 63 percent, and improved in 24 to 57 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26631/abstract/18,33,34\">",
"     18,33,34",
"    </a>",
"    ]. Improvement or stabilization of renal function was seen in up to 92 percent of patients. Surgical cure rates are lower in older patients, those with hypertension of longer duration, a greater degree of concomitant atherosclerotic disease, and more complex disease necessitating branch vessel repair [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26631/abstract/35,36\">",
"     35,36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In rare cases, renal artery aneurysms may be identified in patients with FMD. The aneurysms may rupture or lead to infarction from macroscopic embolization. Renal artery aneurysms may be treated percutaneously using a covered stent graft or repaired surgically with minimal morbidity or mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26631/abstract/37-39\">",
"     37-39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although both surgery and PTA lead to similar technical success rates, surgery is associated with markedly higher morbidity [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26631/abstract/40\">",
"     40",
"    </a>",
"    ]. Perioperative mortality appears to be very low (no deaths in 105 procedures from 2000 to 2004 in the United States) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26631/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Given the lower morbidity with PTA, surgical revascularization is usually reserved for patients with FMD who fulfill the following criteria: medical therapy alone is not sufficient to control the hypertension or there is evidence of significant loss of renal parenchymal mass; and failed PTA or arterial anatomy that is not amenable to PTA [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26631/abstract/4\">",
"     4",
"    </a>",
"    ]. As an example, patients who have disease in secondary branch vessels, a long stenotic segment, or aneurysms, may need complex, sometimes ex-vivo, reconstructions [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26631/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Given that surgical revascularization is usually limited to complex cases, reported success and complication rates are probably higher than if simpler cases were included. In one series of 26 patients, six of whom had failed PTA and 20 who were unsuitable for PTA, there were two bypass occlusions resulting in renal loss, and five significant non-renal complications during a median follow-up of 2.4 years [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26631/abstract/21\">",
"     21",
"    </a>",
"    ]. Cumulative patency at one and three years was 89 and 82 percent, respectively.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1362742\">",
"    <span class=\"h1\">",
"     MONITORING AND TREATMENT OF NONRENAL LESIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fibromuscular dysplasia (FMD) of the internal carotid and vertebral arteries occurs with a similar frequency as renal artery FMD [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26631/abstract/43,44\">",
"     43,44",
"    </a>",
"    ]. Fibromuscular dysplasia in the extracranial cerebrovasculature may be associated with dissection, stenosis, intracranial aneurysm, TIA and stroke, or may be entirely asymptomatic.",
"   </p>",
"   <p>",
"    Imaging of the carotid arteries should be obtained in patients with renal artery FMD even if the patient is asymptomatic. Duplex ultrasound of the carotid and vertebral arteries is the most cost effective method of screening. It is important for the ultrasonographer to image as far distally as possible and for the physician interpreting the ultrasound to be familiar with the ultrasound findings of carotid and vertebral FMD.&nbsp;If the ultrasound is normal, no further imaging is necessary. If the test is suggestive of FMD, magnetic resonance angiography (MRA) or CT angiography (CTA) of the neck and intracranial vessels should be obtained to exclude the presence of aneurysm(s).",
"   </p>",
"   <p>",
"    There is no evidence to support serial carotid duplex ultrasound to monitor disease progression as is done for patients with atherosclerotic carotid artery disease. In addition, there is no role for repeat MRA or CTA once an aneurysm has been excluded. If there is an intracranial aneurysm present, then serial imaging (every 6 to 12 months) with MRA or CTA should be performed so that the aneurysm can be treated once it reaches a prespecified size.",
"   </p>",
"   <p>",
"    The treatment depends in part upon the absence or presence of symptoms. Antiplatelet therapy with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    is reasonable in patients with asymptomatic carotid or vertebral artery FMD. Percutaneous balloon angioplasty is recommended for patients with TIA or stroke. Stenting is reserved for patients with suboptimal angioplasty results or for patients with a dissection who fail anticoagulation therapy. To date, no randomized trials have been conducted to evaluate the efficacy of this treatment strategy. &nbsp;",
"   </p>",
"   <p>",
"    The treatment of FMD in other arterial beds with percutaneous balloon angioplasty should be reserved for patients with symptoms (ie, claudication, intestinal ischemia, coronary ischemia). Aneurysms can be treated with covered stents, coil embolization or surgical resection when the size warrants such treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    In all patients, we recommend blood pressure control according to the guidelines of the Joint National Committee on the Prevention, Detection and Treatment of High Blood Pressure 7 (JNC 7). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/40/33417?source=see_link\">",
"     \"What is goal blood pressure in the treatment of hypertension?\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Given that renal artery stenosis results in activation of the renin-angiotensin-aldosterone system and sodium retention, we recommend treating hypertension with an ACE inhibitor or ARB, adding a thiazide diuretic if blood pressure remains suboptimal (",
"    <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"     Grade 1B",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/54/8040?source=see_link&amp;anchor=H6#H6\">",
"     \"Treatment of bilateral atherosclerotic renal artery stenosis\", section on 'Medical therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    We recommend monitoring the plasma creatinine and potassium concentrations within one week of initiating the ACE inhibitor or ARB, and periodically thereafter. We recommend discontinuing the ACE inhibitor or ARB if hyperkalemia cannot be controlled, or if there is progressive increase in the plasma creatinine concentration. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Medical therapy'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    We suggest revascularization for the following patients (",
"    <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"     Grade 2B",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Those with recent onset hypertension, in particular younger patients who are less likely to have concomitant atherosclerotic disease.",
"     </li>",
"     <li>",
"      Patients whose blood pressure cannot be lowered to desired ranges despite compliance with a comprehensive medication regimen.",
"     </li>",
"     <li>",
"      Those who are unable to tolerate antihypertensive medications or are noncompliant with their medication regimen.",
"     </li>",
"     <li>",
"      Patients with loss of parenchymal mass from ischemic nephropathy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    For most patients, we recommend revascularization using percutaneous angioplasty (PTA) rather than open surgery, based on similar technical success rates and lower associated morbidity (",
"    <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"     Grade 1B",
"    </a>",
"    ). If the patient either has no improvement in blood pressure or an initial improvement followed by recurrence of hypertension a few weeks after PTA, we usually repeat the angiogram, and perform repeat PTA if restenosis has occurred. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Percutaneous transluminal angioplasty'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    For patients whose arterial anatomy is not amenable to PTA, or who have failed PTA, we suggest surgical revascularization (",
"    <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"     Grade 2B",
"    </a>",
"    ). Given the morbidity associated with surgery, this modality is usually considered only in patients in whom medical therapy alone is insufficient to control blood pressure",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    there is evidence of significant loss of renal parenchymal mass. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Surgery'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    For patients who have undergone percutaneous revascularization, we recommend duplex ultrasound examinations to detect disease progression, restenosis, or loss of kidney volume, after six months, 12 months and yearly thereafter, or whenever there is recurrence or worsening of hypertension or unexplained increase in the serum creatinine.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26631/abstract/1\">",
"      Slovut DP, Olin JW. Fibromuscular dysplasia. N Engl J Med 2004; 350:1862.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26631/abstract/2\">",
"      Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289:2560.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26631/abstract/3\">",
"      Tullis MJ, Caps MT, Zierler RE, et al. Blood pressure, antihypertensive medication, and atherosclerotic renal artery stenosis. Am J Kidney Dis 1999; 33:675.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26631/abstract/4\">",
"      Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 2006; 113:e463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26631/abstract/5\">",
"      Hall JE, Guyton AC, Jackson TE, et al. Control of glomerular filtration rate by renin-angiotensin system. Am J Physiol 1977; 233:F366.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26631/abstract/6\">",
"      Hricik DE, Dunn MJ. Angiotensin-converting enzyme inhibitor-induced renal failure: causes, consequences, and diagnostic uses. J Am Soc Nephrol 1990; 1:845.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26631/abstract/7\">",
"      L&uuml;scher TF, Keller HM, Imhof HG, et al. Fibromuscular hyperplasia: extension of the disease and therapeutic outcome. Results of the University Hospital Zurich Cooperative Study on Fibromuscular Hyperplasia. Nephron 1986; 44 Suppl 1:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26631/abstract/8\">",
"      Bonelli FS, McKusick MA, Textor SC, et al. Renal artery angioplasty: technical results and clinical outcome in 320 patients. Mayo Clin Proc 1995; 70:1041.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26631/abstract/9\">",
"      Olin JW, Pierce M. Contemporary management of fibromuscular dysplasia. Curr Opin Cardiol 2008; 23:527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26631/abstract/10\">",
"      Mounier-V&eacute;hier C, Haulon S, Devos P, et al. Renal atrophy outcome after revascularization in fibromuscular dysplasia disease. J Endovasc Ther 2002; 9:605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26631/abstract/11\">",
"      Kl&oslash;w NE, Paulsen D, Vatne K, et al. Percutaneous transluminal renal artery angioplasty using the coaxial technique. Ten years of experience from 591 procedures in 419 patients. Acta Radiol 1998; 39:594.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26631/abstract/12\">",
"      Birrer M, Do DD, Mahler F, et al. Treatment of renal artery fibromuscular dysplasia with balloon angioplasty: a prospective follow-up study. Eur J Vasc Endovasc Surg 2002; 23:146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26631/abstract/13\">",
"      Barrier P, Julien A, Guillaume C, et al. Technical and clinical results after percutaneous angioplasty in nonmedial fibromuscular dysplasia: outcome after endovascular management of unifocal renal artery stenoses in 30 patients. Cardiovasc Intervent Radiol 2010; 33:270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26631/abstract/14\">",
"      Surowiec SM, Sivamurthy N, Rhodes JM, et al. Percutaneous therapy for renal artery fibromuscular dysplasia. Ann Vasc Surg 2003; 17:650.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26631/abstract/15\">",
"      Jensen G, Zachrisson BF, Delin K, et al. Treatment of renovascular hypertension: one year results of renal angioplasty. Kidney Int 1995; 48:1936.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26631/abstract/16\">",
"      Davidson RA, Barri Y, Wilcox CS. Predictors of cure of hypertension in fibromuscular renovascular disease. Am J Kidney Dis 1996; 28:334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26631/abstract/17\">",
"      de Fraissinette B, Garcier JM, Dieu V, et al. Percutaneous transluminal angioplasty of dysplastic stenoses of the renal artery: results on 70 adults. Cardiovasc Intervent Radiol 2003; 26:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26631/abstract/18\">",
"      Trinquart L, Mounier-Vehier C, Sapoval M, et al. Efficacy of revascularization for renal artery stenosis caused by fibromuscular dysplasia: a systematic review and meta-analysis. Hypertension 2010; 56:525.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26631/abstract/19\">",
"      Oertle M, Do DD, Baumgartner I, et al. Discrepancy of clinical and angiographic results in the follow-up of percutaneous transluminal renal angioplasty (PTRA). Vasa 1998; 27:154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26631/abstract/20\">",
"      Alhadad A, Mattiasson I, Ivancev K, et al. Revascularisation of renal artery stenosis caused by fibromuscular dysplasia: effects on blood pressure during 7-year follow-up are influenced by duration of hypertension and branch artery stenosis. J Hum Hypertens 2005; 19:761.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26631/abstract/21\">",
"      Carmo M, Bower TC, Mozes G, et al. Surgical management of renal fibromuscular dysplasia: challenges in the endovascular era. Ann Vasc Surg 2005; 19:208.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26631/abstract/22\">",
"      Olin JW. Misconceptions about the diagnosis and treatment of fibromuscular dysplasia. Catheter Cardiovasc Interv 2009; 74:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26631/abstract/23\">",
"      Tanaka R, Higashi M, Naito H. Angioplasty for non-arteriosclerotic renal artery stenosis: the efficacy of cutting balloon angioplasty versus conventional angioplasty. Cardiovasc Intervent Radiol 2007; 30:601.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26631/abstract/24\">",
"      White, CJ, Olin, JW. Renal artery revascularization in patients with atherosclerotic renal artery stenosis:Improving patient selection and outcomes. Nature Clin Practice 2009; 6:1763.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26631/abstract/25\">",
"      Lookstein RA, Talenfeld AD, Raju R, et al. Sirolimus-eluting stent placement for refractory renal artery in-stent restenosis: sustained patency and clinical benefit at 24 months. Vasc Med 2009; 14:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26631/abstract/26\">",
"      Prasad A, Zafar N, Mahmud E. Assessment of renal artery fibromuscular dysplasia: angiography, intravascular ultrasound (with virtual histology), and pressure wire measurements. Catheter Cardiovasc Interv 2009; 74:260.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26631/abstract/27\">",
"      Gross CM, Kr&auml;mer J, Weing&auml;rtner O, et al. Determination of renal arterial stenosis severity: comparison of pressure gradient and vessel diameter. Radiology 2001; 220:751.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26631/abstract/28\">",
"      Gowda MS, Loeb AL, Crouse LJ, Kramer PH. Complementary roles of color-flow duplex imaging and intravascular ultrasound in the diagnosis of renal artery fibromuscular dysplasia: should renal arteriography serve as the \"gold standard\"? J Am Coll Cardiol 2003; 41:1305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26631/abstract/29\">",
"      Edwards JM, Zaccardi MJ, Strandness DE Jr. A preliminary study of the role of duplex scanning in defining the adequacy of treatment of patients with renal artery fibromuscular dysplasia. J Vasc Surg 1992; 15:604.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26631/abstract/30\">",
"      Zeller T, Frank U, M&uuml;ller C, et al. Technological advances in the design of catheters and devices used in renal artery interventions: impact on complications. J Endovasc Ther 2003; 10:1006.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26631/abstract/31\">",
"      Carman TL, Olin JW, Czum J. Noninvasive imaging of the renal arteries. Urol Clin North Am 2001; 28:815.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26631/abstract/32\">",
"      Olin JW. Atherosclerotic renal artery disease. Cardiol Clin 2002; 20:547.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26631/abstract/33\">",
"      Reiher L, Pfeiffer T, Sandmann W. Long-term results after surgical reconstruction for renal artery fibromuscular dysplasia. Eur J Vasc Endovasc Surg 2000; 20:556.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26631/abstract/34\">",
"      Marekovic Z, Mokos I, Krhen I, et al. Long-term outcome after surgical kidney revascularization for fibromuscular dysplasia and atherosclerotic renal artery stenosis. J Urol 2004; 171:1043.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26631/abstract/35\">",
"      L&uuml;scher TF, Lie JT, Stanson AW, et al. Arterial fibromuscular dysplasia. Mayo Clin Proc 1987; 62:931.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26631/abstract/36\">",
"      Novick AC, Ziegelbaum M, Vidt DG, et al. Trends in surgical revascularization for renal artery disease. Ten years' experience. JAMA 1987; 257:498.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26631/abstract/37\">",
"      Bisschops RH, Popma JJ, Meyerovitz MF. Treatment of fibromuscular dysplasia and renal artery aneurysm with use of a stent-graft. J Vasc Interv Radiol 2001; 12:757.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26631/abstract/38\">",
"      English WP, Pearce JD, Craven TE, et al. Surgical management of renal artery aneurysms. J Vasc Surg 2004; 40:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26631/abstract/39\">",
"      Pfeiffer T, Reiher L, Grabitz K, et al. Reconstruction for renal artery aneurysm: operative techniques and long-term results. J Vasc Surg 2003; 37:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26631/abstract/40\">",
"      Mackrell PJ, Langan EM 3rd, Sullivan TM, et al. Management of renal artery stenosis: effects of a shift from surgical to percutaneous therapy on indications and outcomes. Ann Vasc Surg 2003; 17:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26631/abstract/41\">",
"      Modrall JG, Rosero EB, Smith ST, et al. Operative mortality for renal artery bypass in the United States: Results from the National Inpatient Sample. J Vasc Surg 2008; 48:317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26631/abstract/42\">",
"      Crutchley TA, Pearce JD, Craven TE, et al. Branch renal artery repair with cold perfusion protection. J Vasc Surg 2007; 46:405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26631/abstract/43\">",
"      Olin JW, Sealove BA. Diagnosis, management, and future developments of fibromuscular dysplasia. J Vasc Surg 2011; 53:826.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26631/abstract/44\">",
"      Olin JW, Froehlich J, Gu X, et al. The United States Registry for Fibromuscular Dysplasia: results in the first 447 patients. Circulation 2012; 125:3182.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3826 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-91.202.164.29-18C9BB78CB-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_0_26631=[""].join("\n");
var outline_f26_0_26631=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H7\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      MEDICAL THERAPY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      RENAL ARTERY REVASCULARIZATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Indications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Percutaneous transluminal angioplasty",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1362742\">",
"      MONITORING AND TREATMENT OF NONRENAL LESIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/41/33433?source=related_link\">",
"      Chronic kidney disease associated with atherosclerotic renovascular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/42/34471?source=related_link\">",
"      Clinical manifestations and diagnosis of fibromuscular dysplasia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/2/18473?source=related_link\">",
"      Major side effects of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/36/32330?source=related_link\">",
"      Overview of hypertension in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/60/19398?source=related_link\">",
"      Renal effects of ACE inhibitors in hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/54/8040?source=related_link\">",
"      Treatment of bilateral atherosclerotic renal artery stenosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/43/29369?source=related_link\">",
"      Treatment of unilateral atherosclerotic renal artery stenosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/40/33417?source=related_link\">",
"      What is goal blood pressure in the treatment of hypertension?",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f26_0_26632="Treatment for specific phobias of medical and dental procedures";
var content_f26_0_26632=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Treatment for specific phobias of medical and dental procedures",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/0/26632/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/0/26632/contributors\">",
"     Yujuan Choy, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/0/26632/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/0/26632/contributors\">",
"     Murray B Stein, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/0/26632/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/0/26632/contributors\">",
"     Richard Hermann, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?26/0/26632/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 27, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H607336119\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute procedural anxiety is an excessive fear of medical, dental, or surgical procedures that results in acute distress or interference with completing necessary procedures. Patients may experience anxiety in anticipation of or during procedures used for screening (eg, mammography), diagnosis (eg, amniocentesis or endoscopy), and treatment (eg, angioplasty or major surgery). Avoidance of clinical procedures due to acute procedural anxiety can have negative health consequences [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26632/abstract/1-7\">",
"     1-7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Specific phobias are a subset of the varied manifestations of acute procedural anxiety, diagnosed under DSM-IV-TR criteria only when the patient&rsquo;s fears are specific to the procedure and its immediate effects (eg, fear of suffocation during an MRI) rather than fears not specific to the procedure itself (eg, a fear of the underlying illness that might be diagnosed). Specific phobias related to clinical procedures include: blood-injection-injury phobia, dental phobia, and MRI claustrophobia.",
"   </p>",
"   <p>",
"    This topic addresses the treatment for specific phobias of clinical procedures. Treatment of acute procedural anxiety in adults that does not constitute a specific phobia is discussed separately. The epidemiology, clinical manifestations, course, screening, assessment, and differential diagnosis of acute procedural anxiety are also discussed separately. The epidemiology, clinical manifestations, course, diagnosis, and treatment of other specific phobias are also discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/18/9512?source=see_link\">",
"     \"Treatment of acute procedure anxiety in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/39/9849?source=see_link\">",
"     \"Acute procedure anxiety in adults: Epidemiology and clinical presentation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/32/11782?source=see_link\">",
"     \"Acute procedure anxiety in adults: Course, screening, assessment, and differential diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/24/22921?source=see_link\">",
"     \"Specific phobia in adults: Epidemiology, clinical manifestations, course and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/59/25527?source=see_link\">",
"     \"Psychotherapy for specific phobia in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/41/6806?source=see_link\">",
"     \"Pharmacotherapy for specific phobia in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3468418\">",
"    <span class=\"h1\">",
"     SPECIFIC PHOBIAS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Presentations of acute procedural anxiety are diagnosed as a specific phobia, under DSM-IV-TR criteria, only when the focus of the patient&rsquo;s fears are specific to the procedure or its immediate effects (eg, fear of suffocating during an MRI scan) rather than a focus that is not specific to the procedure itself (eg, a fear of the underlying illness that might be diagnosed). Interventions for three specific phobias of clinical procedures are discussed below:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Blood-injection-injury phobia",
"     </li>",
"     <li>",
"      Dental phobia",
"     </li>",
"     <li>",
"      MRI claustrophobia",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H607336126\">",
"    <span class=\"h1\">",
"     GENERAL TREATMENT PRINCIPLES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several general principles, used in the management of acute procedural anxiety, can also be helpful in the management of specific phobias related to clinical procedures. &nbsp;(See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/18/9512?source=see_link&amp;anchor=H1821648#H1821648\">",
"     \"Treatment of acute procedure anxiety in adults\", section on 'General treatment principles'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H607337094\">",
"    <span class=\"h1\">",
"     INTERVENTIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H607337101\">",
"    <span class=\"h2\">",
"     Blood-injection-injury phobia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Blood-injection-injury phobia is characterized by the fear of seeing blood, receiving an injection, or of other invasive medical procedures [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26632/abstract/8\">",
"     8",
"    </a>",
"    ]. We suggest applied tension, a combination of muscle tensing and exposure therapy, as first-line treatment for blood-injection-injury phobia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H607337108\">",
"    <span class=\"h3\">",
"     Applied tension",
"    </span>",
"    &nbsp;&mdash;&nbsp;Applied tension is used to counteract the vasovagal fainting response associated with blood phobia [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26632/abstract/9-11\">",
"     9-11",
"    </a>",
"    ]. Applied tension involves repeatedly tensing body muscles to increase blood pressure and prevent fainting when in the presence of the phobic stimulus (ie, with in-vivo exposure).",
"   </p>",
"   <p>",
"    In treatment with applied tension, the patient is instructed to tense the muscles in their arms, torso and legs and hold the tension until a warm feeling is experienced in the head, typically 10 to 15 seconds. The patient then releases the tension and waits for 20 to 30 seconds for the body to return to normal. The patient then practices this tension-release cycle repeatedly until he or she becomes skilled in the technique. Once the technique is mastered, the patient is instructed to use the technique in response to the early signs of a drop in blood pressure (eg, lightheadedness) during exposure practice to feared situations.",
"   </p>",
"   <p>",
"    A review of five randomized trials found that applied tension was more effective in blood-injection-injury type phobia than exposure alone or muscle tension alone, leading to reduced anxiety, avoidance, and fainting; however, the trials were limited by small sample sizes and yielded variable results [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26632/abstract/11,12\">",
"     11,12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As an example, 30 patients with blood-injection-injury phobia were randomly assigned to five sessions of applied tension, in-vivo exposure alone, or muscle tension alone [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26632/abstract/13\">",
"     13",
"    </a>",
"    ]. Greater rates of response were seen for applied tension and tension alone compared to in-vivo exposure alone (90 and 80 versus 40 percent, respectively). Results were sustained on assessment one year later.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H607337115\">",
"    <span class=\"h3\">",
"     Other interventions",
"    </span>",
"    &nbsp;&mdash;&nbsp;When there is a known history of fainting and the patient has not learned the applied tension technique, the patient should lie down during a procedure (eg, venipuncture), look away from the site of blood draw, and sit up slowly only after sensations of dizziness and fainting resolve.",
"   </p>",
"   <p>",
"    There are no clinical trials of medication for blood phobia, and in our clinical experience, medication is not useful for the phobia. Commonly used anxiolytics, such as benzodiazepines, have no effect on the vasovagal phenomenon in our clinical experience.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H607337122\">",
"    <span class=\"h2\">",
"     Dental phobia",
"    </span>",
"    &nbsp;&mdash;&nbsp;We suggest first-line treatment for most cases of dental phobia with in-vivo exposure therapy. However, treatment with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/29/11732?source=see_link\">",
"     nitrous oxide",
"    </a>",
"    is a reasonable choice in some patients. Clinical trials comparing psychotherapy to medication in dental phobia are described below. Selecting between these modalities in dental phobia follows the principles outlined for other manifestations of acute procedural anxiety. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/18/9512?source=see_link&amp;anchor=H876428#H876428\">",
"     \"Treatment of acute procedure anxiety in adults\", section on 'Treatment selection'",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H607337192\">",
"     'Duration of treatment effects'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H607337129\">",
"    <span class=\"h3\">",
"     Psychotherapies",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the absence of rigorous comparative trials, and based on the trials described below, in-vivo exposure therapy is the psychotherapy of choice in the treatment of dental phobia. Trials of psychotherapy for dental phobia are limited by variations in the definition of dental phobia and in other inclusion criteria, assessment methods, and treatment components. Further information on these psychotherapies for specific phobias is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/59/25527?source=see_link\">",
"     \"Psychotherapy for specific phobia in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H607337136\">",
"    <span class=\"h4\">",
"     In vivo exposure therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;A single trial of 40 patients with dental phobia found that treatment with in-vivo exposure therapy resulted in decreased anxiety, increased positive thinking and decreased negative thinking about dental treatment, and decreased avoidance of dental treatment compared with a waitlist control [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26632/abstract/14\">",
"     14",
"    </a>",
"    ]. Mean absence of dental care before treatment was 11.4 years. In the year following treatment with exposure therapy, a total of 77 percent of patients sought dental care. Individuals assigned to receive five sessions of exposure therapy experienced greater reduction of dental anxiety compared to patients treated with a single session, but avoidance behavior post-treatment did not differ between the two groups. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/18/9512?source=see_link&amp;anchor=H393630#H393630\">",
"     \"Treatment of acute procedure anxiety in adults\", section on 'Exposure therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H607337143\">",
"    <span class=\"h4\">",
"     Cognitive restructuring",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cognitive restructuring involves the identification and modification of overly negative cognitions regarding the feared stimulus. Evidence from a single clinical trial does not support cognitive restructuring as monotherapy for dental phobia [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26632/abstract/15\">",
"     15",
"    </a>",
"    ]. The trial randomly assigned 52 patients with dental phobia to receive a one-hour session of cognitive restructuring, provision of information about dental",
"    <span class=\"nowrap\">",
"     health/treatment,",
"    </span>",
"    or a wait-list control condition. The cognitive intervention was more effective than the control conditions in reducing dental anxiety and decreasing the frequency and believability of negative thoughts about dental treatment. However, patients receiving cognitive therapy still had moderate anxiety post-treatment and only 33 percent were considered to be clinically improved",
"    <strong>",
"     .",
"    </strong>",
"    After one year, there was no difference in dental anxiety between patients who did or did not receive the cognitive intervention.",
"   </p>",
"   <p>",
"    The augmentation of exposure therapy with cognitive treatment, which is an effective strategy for some anxiety disorders, has not been tested in acute procedural anxiety, and has led to mixed results in specific phobias unrelated to clinical procedures. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/59/25527?source=see_link&amp;anchor=H1203604#H1203604\">",
"     \"Psychotherapy for specific phobia in adults\", section on 'Cognitive therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H607337150\">",
"    <span class=\"h4\">",
"     Systematic desensitization",
"    </span>",
"    &nbsp;&mdash;&nbsp;Systematic desensitization involves imaginal exposure to the feared stimulus coupled with muscle relaxation to cope with the anxiety. Clinical trials suggest that systematic desensitization is more efficacious than a control condition, but less efficacious than in-vivo exposure in specific phobia [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26632/abstract/12,16,17\">",
"     12,16,17",
"    </a>",
"    ]; the intervention has largely been supplanted by exposure therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26632/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/59/25527?source=see_link&amp;anchor=H1203625#H1203625\">",
"     \"Psychotherapy for specific phobia in adults\", section on 'Systematic desensitization'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H607337157\">",
"    <span class=\"h4\">",
"     Coping strategies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Coping strategies used to treat dental anxiety include relaxation and applied relaxation. The most common form of relaxation technique is progressive muscle relaxation in which patients are instructed to practice tensing (5 seconds) and relaxing (10 seconds) different muscle groups starting from top of the head down to the toes [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26632/abstract/20\">",
"     20",
"    </a>",
"    ]. This exercise takes about 15 minutes and is practiced twice a day for 1-2 weeks until proficient. Then the tension part is eliminated and release-only relaxation of different muscle groups is practiced, which takes 5-7 minutes. This is then followed by conditioned relaxation in which the patients learn to relax the whole body at once on cue using the self-instruction &ldquo;relax,&rdquo; which further reduces relaxation to 30 seconds.",
"   </p>",
"   <p>",
"    In applied relaxation, patients are taught to apply the skills of relaxation to anxiety provoking situations as a coping strategy to counteract the physiological arousal experienced when anxious [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26632/abstract/20\">",
"     20",
"    </a>",
"    ]. Patients are instructed first to relax on cue many times a day (15 to 20 times) to daily non-stressful situations. Then, they practice in anxiety-provoking situations. Patients are taught to recognize early signs of anxiety and apply relaxation even before entering an anxious situation. In contrast to in vivo exposure therapy in which patients remain in the anxiety provoking situation for a prolonged period of times (up to one to two hours) with the goal of",
"    <span class=\"nowrap\">",
"     habituation/extinction",
"    </span>",
"    of the physiological arousal elicited, exposure in applied relaxation is much briefer (10 to 15 minutes) with the goal of coping with anxiety encountered in natural situations.",
"   </p>",
"   <p>",
"    In a single randomized trial of 112 adults with dental phobia, relaxation therapy (a variation of applied relaxation) was more efficacious in reducing dental and overall anxiety than cognitive therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26632/abstract/21\">",
"     21",
"    </a>",
"    ]. In the relaxation therapy condition, patients were trained in progressive muscle relaxation with the aid of electromyographic (EMG) biofeedback to increase the patient&rsquo;s ability to relax. Once proficiency in muscle relaxation was achieved, patients were trained to maintain relaxation during exposure to successively more anxiety provoking dental situations (first video scenes, then progress to handling dental instruments). Although relaxation treatment was more effective, treatment completion rate was higher in the cognitive group compared to the relaxation group (74 percent versus 59 percent).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H607337164\">",
"    <span class=\"h4\">",
"     Hypnotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypnotherapy for dental anxiety includes the following components [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26632/abstract/22\">",
"     22",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Progressive relaxation",
"     </li>",
"     <li>",
"      Suggestions for deepening the hypnotic state, relaxation, and comfort",
"     </li>",
"     <li>",
"      Instructions to the patient to imagine dental scenes and procedures in a successively more anxiety-provoking hierarchy",
"     </li>",
"     <li>",
"      Suggestions to the patient, when in a stage of hypnosis, that he or she would no longer be afraid of the imagined dental situations",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Clinical trials of hypnotherapy for dental anxiety do not show evidence of efficacy:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A clinical trial of 174 patients with dental phobia compared hypnotherapy to systematic desensitization, group therapy, or a waiting list control, finding that all three treatments led to similar reductions of anxiety compared to the control group [",
"      <a class=\"abstract\" href=\"UTD.htm?26/0/26632/abstract/23\">",
"       23",
"      </a>",
"      ]. Avoidance of dental treatment remained high among patients in all three groups",
"      <strong>",
"       .",
"      </strong>",
"      More than 50 percent of the sample dropped out of the study or did not follow through with dental treatment in the community within one year.",
"     </li>",
"     <li>",
"      A trial randomly assigned 22 female patients with dental phobia to hypnotherapy or to a behavioral intervention involving exposure [",
"      <a class=\"abstract\" href=\"UTD.htm?26/0/26632/abstract/22\">",
"       22",
"      </a>",
"      ]. Exposure therapy resulted in a reduction in dental anxiety, while hypnotherapy did not. The small sample size and a drop-out rate of 44 percent limit the conclusions that can be drawn",
"      <strong>",
"       .",
"      </strong>",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H607337171\">",
"    <span class=\"h3\">",
"     Medication",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients with dental phobia in which medication treatment is indicated, we suggest the use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/29/11732?source=see_link\">",
"     nitrous oxide",
"    </a>",
"    sedation over general anesthesia or benzodiazepines. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/18/9512?source=see_link&amp;anchor=H876428#H876428\">",
"     \"Treatment of acute procedure anxiety in adults\", section on 'Treatment selection'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H607337178\">",
"    <span class=\"h4\">",
"     Nitrous oxide",
"    </span>",
"    &nbsp;&mdash;&nbsp;Despite the paucity of efficacy data,",
"    <span class=\"nowrap\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?11/29/11732?source=see_link\">",
"      nitrous oxide",
"     </a>",
"     /oxygen",
"    </span>",
"    is the sedation method of choice in dental practice [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26632/abstract/24\">",
"     24",
"    </a>",
"    ]",
"    <strong>",
"     .",
"    </strong>",
"    Administration of nitrous oxide has been associated with reduced anxiety and avoidance in patients with dental phobia in clinical trials, but has not been compared to placebo in this population [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26632/abstract/25-27\">",
"     25-27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other advantages of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/29/11732?source=see_link\">",
"     nitrous oxide",
"    </a>",
"    sedation include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pain relief",
"     </li>",
"     <li>",
"      Inhalation method of delivery, eliminating the need for intravenous administration (particularly helpful in patients with injection phobia)",
"     </li>",
"     <li>",
"      Rapid induction of sedation",
"     </li>",
"     <li>",
"      Ability to titrate the level of sedation",
"     </li>",
"     <li>",
"      Rapid elimination from the body such that patients are fully recovered within minutes after discontinuation",
"     </li>",
"     <li>",
"      Relatively safe for use in all ages with minimal side effects.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Contraindications of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/29/11732?source=see_link\">",
"     nitrous oxide",
"    </a>",
"    sedation include early pregnancy, chronic respiratory conditions (eg, chronic pulmonary disease and cystic fibrosis), certain illnesses (eg, upper respiratory tract infections, pneumothorax) and following certain surgical procedures (eg, eye surgeries or tympanic membrane repair with graft). Sedation with nitrous oxide is discussed in more detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/51/34618?source=see_link\">",
"     \"Procedural sedation in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H607337185\">",
"    <span class=\"h4\">",
"     Other medications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Empirical support for the use of general anesthesia [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26632/abstract/28\">",
"     28",
"    </a>",
"    ] and benzodiazepines in dental phobia [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26632/abstract/29\">",
"     29",
"    </a>",
"    ] is more limited",
"    <strong>",
"     .",
"    </strong>",
"   </p>",
"   <p>",
"    General anesthesia is usually reserved for the most severe cases of dental fear, and has the advantage of allowing major dental work to be completed in a single treatment. A clinical trial of 99 patients compared general anesthesia to behavioral therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26632/abstract/28\">",
"     28",
"    </a>",
"    ]. After receiving these interventions, followed by dental test treatment, 69 and 92 percent of patients, respectively, completed subsequent dental treatment at a community dental clinic specializing in dental phobia. Although these results lacked a placebo group for comparison, the patients had previously avoided treatment for an average of 15 years.",
"   </p>",
"   <p>",
"    Benzodiazepines are used for sedation and anxiolytic effects during dental treatment, but have disadvantages compared to other treatments. Benzodiazepines cause sedating and psychomotor impairment that can last for hours, in contrast to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/29/11732?source=see_link\">",
"     nitrous oxide",
"    </a>",
"    , the effects of which wear off in minutes (",
"    <a class=\"graphic graphic_table graphicRef71754 \" href=\"UTD.htm?23/28/24012\">",
"     table 1",
"    </a>",
"    ). The clinical effects of benzodiazepines last only for that treatment episode, while the effects of exposure therapy can last for months or years. Administration of benzodiazepines for acute procedural anxiety is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/18/9512?source=see_link&amp;anchor=H876469#H876469\">",
"     \"Treatment of acute procedure anxiety in adults\", section on 'Benzodiazepines'",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H607337178\">",
"     'Nitrous oxide'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H607337192\">",
"     'Duration of treatment effects'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Clinical experience and limited evidence support the effectiveness of benzodiazepines for dental phobia. A clinical trial of 91 patients randomly assigned patients to receive",
"    <a class=\"drug drug_general\" href=\"UTD.htm?3/60/4042?source=see_link\">",
"     midazolam",
"    </a>",
"    , psychological treatment (consisting of information, cognitive restructuring, relaxation, and applied relaxation) or no treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26632/abstract/29\">",
"     29",
"    </a>",
"    ]. Fifty patients completed the trial, which found both interventions to decrease dental anxiety compared to no treatment. At two-month and one-year follow up, decreased anxiety was only seen in patients who received psychological treatment, compared to patients who received no treatment. Clinical trials have found benzodiazepines to be effective in other specific phobias. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/41/6806?source=see_link\">",
"     \"Pharmacotherapy for specific phobia in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/41/6806?source=see_link&amp;anchor=H576036#H576036\">",
"     \"Pharmacotherapy for specific phobia in adults\", section on 'Benzodiazepines'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H607337192\">",
"    <span class=\"h3\">",
"     Duration of treatment effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Limited evidence from clinical trials suggests that the duration of effectiveness may be greater for psychotherapy than for medication in dental anxiety [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26632/abstract/29,30\">",
"     29,30",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A trial of pretreatment prior to oral surgery in 91 patients with dental anxiety compared psychotherapy (consisting of information, cognitive restructuring, relaxation, and applied relaxation) to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?3/60/4042?source=see_link\">",
"       midazolam",
"      </a>",
"      , or to a control no-treatment condition [",
"      <a class=\"abstract\" href=\"UTD.htm?26/0/26632/abstract/29\">",
"       29",
"      </a>",
"      ]. Patients receiving either psychotherapy or midazolam experienced reduced anxiety prior to surgery compared to the control group. At follow-up two months after the surgery, patients treated with psychotherapy were more likely to have received continued dental treatment compared to patients treated with midazolam (70 versus 20 percent). On assessment one year after the surgery, only the group that received psychotherapy maintained benefit from treatment.",
"     </li>",
"     <li>",
"      A follow-up study of 29 patients 10 years after treatment for dental anxiety found that patients who received systematic desensitization and biofeedback were more likely to report regular dental care during the follow up period compared to patients who received",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/46/16105?source=see_link\">",
"       diazepam",
"      </a>",
"      or general anesthesia (92 versus 63 or 33 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?26/0/26632/abstract/30\">",
"       30",
"      </a>",
"      ]",
"      <strong>",
"       .",
"      </strong>",
"      There was no difference in self-reported anxiety between the psychotherapy and diazepam-treated groups at the 10 year follow-up examination, but anxiety was higher in the group who received general anesthesia. Patients who received general anesthesia had poorer dental health status compared to those in the other two groups.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Drop-out rates in clinical trials of psychotherapies and medications in dental phobia are among the highest among the subtypes of specific phobia [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26632/abstract/12\">",
"     12",
"    </a>",
"    ]",
"    <strong>",
"     ,",
"    </strong>",
"    ranging from 44 to 59 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26632/abstract/21-23,29\">",
"     21-23,29",
"    </a>",
"    ]",
"    <strong>",
"     .",
"    </strong>",
"    This finding highlights the severe level of avoidance in dental phobia and the need to develop treatments that are more acceptable and tolerable as well as interventions to enhance patient motivation to seek and stay in treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3468846\">",
"    <span class=\"h3\">",
"     Treatment selection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Due to the repeated need for dental care and the evidence of a longer-term benefit from exposure therapy in specific phobias and other anxiety disorders, we suggest first-line treatment for most cases of dental phobia with in-vivo exposure therapy over other treatments. However, treatment with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/29/11732?source=see_link\">",
"     nitrous oxide",
"    </a>",
"    is a reasonable alternative, particularly when:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?11/29/11732?source=see_link\">",
"       Nitrous oxide",
"      </a>",
"      is preferred by the patient",
"     </li>",
"     <li>",
"      Exposure therapy is unavailable",
"     </li>",
"     <li>",
"      Dental treatment is needed on an emergent basis",
"     </li>",
"     <li>",
"      The patient&rsquo;s anxiety is too severe to tolerate exposure therapy",
"     </li>",
"     <li>",
"      The patient has previously failed an adequate trial of exposure therapy",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There are no clinical trials comparing exposure therapy to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/29/11732?source=see_link\">",
"     nitrous oxide",
"    </a>",
"    in dental phobia. A single trial, described above, comparing",
"    <a class=\"drug drug_general\" href=\"UTD.htm?3/60/4042?source=see_link\">",
"     midazolam",
"    </a>",
"    to psychotherapy (consisting of information, cognitive restructuring, relaxation, and applied relaxation) in dental phobia found both interventions to be efficacious in the acute treatment of dental phobia compared to no treatment, but no difference in efficacy between them [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26632/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although there is a lack of supporting evidence from clinical trials, in our clinical experience, it may be useful to augment exposure therapy with cognitive restructuring or relaxation training, with their selection, based on the patient&rsquo;s clinical presentation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H607337199\">",
"    <span class=\"h2\">",
"     MRI claustrophobia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adjustment of the patient&rsquo;s position in the MRI scanner can relieve MRI claustrophobia in some patients. In patients where that approach is not effective, we suggest treatment with benzodiazepines over psychotherapy in most cases. Selection between benzodiazepines and psychotherapy for MRI claustrophobia can be made on the basis of principles described for other manifestations of acute procedural anxiety. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/18/9512?source=see_link&amp;anchor=H876428#H876428\">",
"     \"Treatment of acute procedure anxiety in adults\", section on 'Treatment selection'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H607337206\">",
"    <span class=\"h3\">",
"     Positional adjustment",
"    </span>",
"    &nbsp;&mdash;&nbsp;A simple strategy for managing MRI claustrophobia is to change the patient&rsquo;s positioning in the scanner. This approach is feasible only for MRI scans where specific positioning is not critical.",
"   </p>",
"   <p>",
"    The patient should be positioned feet first in the scanner. Feet-first exams are less likely to be associated with a claustrophobic reaction compared to head-first exams [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26632/abstract/31\">",
"     31",
"    </a>",
"    ]",
"    <strong>",
"     .",
"    </strong>",
"    Placing the patient in prone position can also be helpful. Prone positioning compared to supine positioning in the scanner is associated with a lower incidence of premature termination [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26632/abstract/32\">",
"     32",
"    </a>",
"    ]",
"    <strong>",
"    </strong>",
"    and is less likely to result in a claustrophobic reaction [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26632/abstract/31\">",
"     31",
"    </a>",
"    ]",
"    <strong>",
"     .",
"    </strong>",
"    Based on the clinical experience of 1160 patients undergoing MRI scans, an MRI center reported that 19 patients who were initially unable to complete an MRI scan because of claustrophobia; they reported that all 19 were able to complete the scan when turned prone [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26632/abstract/33\">",
"     33",
"    </a>",
"    ]",
"    <strong>",
"     .",
"    </strong>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H607337213\">",
"    <span class=\"h3\">",
"     Benzodiazepines",
"    </span>",
"    &nbsp;&mdash;&nbsp;If positional adjustment is not possible or ineffective, we suggest treatment of most patients with MRI claustrophobia with a benzodiazepine over other treatments. There are no controlled trials comparing a benzodiazepine to placebo in MRI claustrophobia. In an observational study of 1,133 patients treated with a benzodiazepine prior to an MRI scan, sedation was achieved 89 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26632/abstract/34\">",
"     34",
"    </a>",
"    ]. Sedation for MRI claustrophobia is generally safe. A study of 4,761 patients had a complication rate of 0.4 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26632/abstract/34\">",
"     34",
"    </a>",
"    ]. The most common complication was oxygen desaturation; there were no fatalities.",
"   </p>",
"   <p>",
"    To achieve sedation in a patient with (or likely to experience) MRI claustrophobia, a benzodiazepine is typically administered intravenously 15 minutes prior to the procedure or 30 minutes for oral formulations.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/46/16105?source=see_link\">",
"     Diazepam",
"    </a>",
"    has a more rapid onset than",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/8/8329?source=see_link\">",
"     lorazepam",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?30/31/31224?source=see_link\">",
"     alprazolam",
"    </a>",
"    . As an example, 10 mg of oral diazepam is recommended for healthy adults [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26632/abstract/34\">",
"     34",
"    </a>",
"    ]. A table provides dosing of oral and intravenous benzodiazepines commonly used in procedural sedation (",
"    <a class=\"graphic graphic_table graphicRef71754 \" href=\"UTD.htm?23/28/24012\">",
"     table 1",
"    </a>",
"    ). Further details about the use of benzodiazepines for procedural anxiety, including MRI claustrophobia, are discussed separately, including dose adjustments for clinical subgroups, repeat dosing, and patient education about side effects and driving. Adverse effects of benzodiazepines are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/18/9512?source=see_link&amp;anchor=H876469#H876469\">",
"     \"Treatment of acute procedure anxiety in adults\", section on 'Benzodiazepines'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/62/13290?source=see_link&amp;anchor=H21#H21\">",
"     \"Treatment of insomnia\", section on 'Adverse effects'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/53/38745?source=see_link\">",
"     \"Use of psychotropic medications in breastfeeding women\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/0/28682?source=see_link&amp;anchor=H31#H31\">",
"     \"Depression in pregnant women: Management\", section on 'Benzodiazepines'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H607337220\">",
"    <span class=\"h3\">",
"     Psychotherapies",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients with claustrophobia not limited to MRI, or who require repeated MRIs and prefer psychotherapy, or have medical contraindications to benzodiazepines, we suggest treatment with in-vivo exposure therapy over other treatments. If in-vivo exposure is used for MRI claustrophobia, the therapy should ideally be conducted in an environment similar to that of an MRI suite. Two trials have found cognitive therapy and in-vivo exposure therapy to be equally effective in the treatment of claustrophobia compared to placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26632/abstract/35,36\">",
"     35,36",
"    </a>",
"    ]. As an example, in a trial of 46 patients with claustrophobia, symptomatic improvement was maintained for one year in 81 to 100 percent of patients receiving exposure therapy, and 93 percent of patients receiving cognitive therapy, but only 17 percent of patients assigned to a waiting list control [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26632/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In cognitive therapy, distorted and negative beliefs about the MRI scanner, such as fear of suffocation, fear of machine causing harm, and fear of losing control in the scanner, should be identified and challenged [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26632/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An alternative psychotherapy for claustrophobia is interoceptive exposure in which patients are exposed to the physical sensations of anxiety that are reproduced in a controlled setting. In a trial of 48 patients, interoceptive exposure was shown to have modest effects in decreasing the frequency of negative cognitions and physical sensations of claustrophobia in comparison to modification of negative cognitions, or a control condition [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26632/abstract/35\">",
"     35",
"    </a>",
"    ].",
"    <strong>",
"    </strong>",
"   </p>",
"   <p>",
"    Further study is needed to test whether these findings in claustrophobia can be generalized to MRI claustrophobia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H607338248\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Presentations of acute procedural anxiety are diagnosed as a specific phobia only when the focus of the patient&rsquo;s fear is specific to the procedure or its immediate effects (eg, fears of seeing blood during venipuncture, experiencing pain or being restrained during dental treatment, or suffocating during an MRI scan). (See",
"      <a class=\"local\" href=\"#H3468418\">",
"       'Specific phobias'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Acute procedural anxiety that is not specific to the procedure itself (eg, fear that a diagnostic test will reveal a serious illness) is not considered specific phobia and is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/18/9512?source=see_link\">",
"       \"Treatment of acute procedure anxiety in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For individuals with",
"      <strong>",
"       blood-injection-injury phobia",
"      </strong>",
"      , we suggest treatment with applied tension (muscle tension in combination with exposure treatment) over other treatments (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). Commonly used anxiolytics, such as benzodiazepines, have no effect on the vasovagal phenomenon. (See",
"      <a class=\"local\" href=\"#H607337101\">",
"       'Blood-injection-injury phobia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      If a patient has a history of fainting at the sight of blood during an injection, but has not learned the applied tension technique, he or she should lie down during the procedure, look away from the site of the blood draw, and sit up slowly only after sensations of dizziness and fainting resolve. (See",
"      <a class=\"local\" href=\"#H607337115\">",
"       'Other interventions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Due to the usual repeated need for dental care and the evidence of a longer-term benefit from exposure therapy, we suggest first-line treatment for most cases of",
"      <strong>",
"       dental phobia",
"      </strong>",
"      with in-vivo exposure therapy over other treatments (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). However, treatment of dental phobia with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?11/29/11732?source=see_link\">",
"       nitrous oxide",
"      </a>",
"      is a reasonable alternative, particularly when:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?11/29/11732?source=see_link\">",
"       Nitrous oxide",
"      </a>",
"      is preferred by the patient",
"     </li>",
"     <li>",
"      Exposure therapy is unavailable",
"     </li>",
"     <li>",
"      Dental treatment is needed on an emergent basis",
"     </li>",
"     <li>",
"      The patient&rsquo;s anxiety is too severe to tolerate exposure therapy",
"     </li>",
"     <li>",
"      The patient has previously failed an adequate trial of exposure therapy",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"local\" href=\"#H3468846\">",
"       'Treatment selection'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H607337136\">",
"       'In vivo exposure therapy'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H607337178\">",
"       'Nitrous oxide'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For",
"      <strong>",
"       MRI claustrophobia",
"      </strong>",
"      , positional adjustment, ie, placing the patient in a prone, feet-first position in the scanner, is sufficient to relieve anxiety in some patients. (See",
"      <a class=\"local\" href=\"#H607337206\">",
"       'Positional adjustment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In most patients where positional readjustment is ineffective or not feasible, we suggest treatment with a benzodiazepine over psychotherapy (",
"      <a class=\"graphic graphic_table graphicRef71754 \" href=\"UTD.htm?23/28/24012\">",
"       table 1",
"      </a>",
"      ) (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). As an example,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/46/16105?source=see_link\">",
"       diazepam",
"      </a>",
"      10 mg can be given intravenously approximately 15 minutes before the procedure, or orally approximately 25 minutes before the procedure, and repeated if needed after 30 to 60 minutes. (See",
"      <a class=\"local\" href=\"#H607337213\">",
"       'Benzodiazepines'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with claustrophobia not limited to MRI, or who require repeated MRIs and prefer psychotherapy, or have medical contraindications to benzodiazepines, we suggest treatment with in-vivo exposure therapy over other treatments (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). If in-vivo exposure is used for MRI claustrophobia, the therapy should ideally be conducted in an environment similar to that of an MRI suite. (See",
"      <a class=\"local\" href=\"#H607337136\">",
"       'In vivo exposure therapy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26632/abstract/1\">",
"      Page AC. Blood-injury-injection fears in medical practice. Med J Aust 1996; 164:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26632/abstract/2\">",
"      Lilliecreutz C, Sydsj&ouml; G, Josefsson A. Obstetric and perinatal outcomes among women with blood- and injection phobia during pregnancy. J Affect Disord 2011; 129:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26632/abstract/3\">",
"      Doerr PA, Lang WP, Nyquist LV, Ronis DL. Factors associated with dental anxiety. J Am Dent Assoc 1998; 129:1111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26632/abstract/4\">",
"      Poulton R, Thomson WM, Brown RH, Silva PA. Dental fear with and without blood-injection fear: implications for dental health and clinical practice. Behav Res Ther 1998; 36:591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26632/abstract/5\">",
"      Elter JR, Strauss RP, Beck JD. Assessing dental anxiety, dental care use and oral status in older adults. J Am Dent Assoc 1997; 128:591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26632/abstract/6\">",
"      Zambanini A, Newson RB, Maisey M, Feher MD. Injection related anxiety in insulin-treated diabetes. Diabetes Res Clin Pract 1999; 46:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26632/abstract/7\">",
"      Bienvenu OJ, Eaton WW. The epidemiology of blood-injection-injury phobia. Psychol Med 1998; 28:1129.",
"     </a>",
"    </li>",
"    <li>",
"     American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed, American Psychiatric Association, Washington, DC 2000.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26632/abstract/9\">",
"      Ost LG, Sterner U. Applied tension. A specific behavioral method for treatment of blood phobia. Behav Res Ther 1987; 25:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26632/abstract/10\">",
"      Hellstr&ouml;m K, Fellenius J, Ost LG. One versus five sessions of applied tension in the treatment of blood phobia. Behav Res Ther 1996; 34:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26632/abstract/11\">",
"      Ayala ES, Meuret AE, Ritz T. Treatments for blood-injury-injection phobia: a critical review of current evidence. J Psychiatr Res 2009; 43:1235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26632/abstract/12\">",
"      Choy Y, Fyer AJ, Lipsitz JD. Treatment of specific phobia in adults. Clin Psychol Rev 2007; 27:266.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26632/abstract/13\">",
"      Ost LG, Fellenius J, Sterner U. Applied tension, exposure in vivo, and tension-only in the treatment of blood phobia. Behav Res Ther 1991; 29:561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26632/abstract/14\">",
"      Haukeb&oslash; K, Skaret E, Ost LG, et al. One- vs. five-session treatment of dental phobia: a randomized controlled study. J Behav Ther Exp Psychiatry 2008; 39:381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26632/abstract/15\">",
"      de Jongh A, Muris P, ter Horst G, et al. One-session cognitive treatment of dental phobia: preparing dental phobics for treatment by restructuring negative cognitions. Behav Res Ther 1995; 33:947.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26632/abstract/16\">",
"      Bandura A, Blahard EB, Ritter B. Relative efficacy of desensitization and modeling approaches for inducing behavioral, affective, and attitudinal changes. J Pers Soc Psychol 1969; 13:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26632/abstract/17\">",
"      Egan S. Reduction of anxiety in aquaphobics. Can J Appl Sport Sci 1981; 6:68.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26632/abstract/18\">",
"      Wolpe J. Psychotherapy by reciprocal inhibition. Cond Reflex 1968; 3:234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26632/abstract/19\">",
"      Coldwell SE, Wilhelm FH, Milgrom P, et al. Combining alprazolam with systematic desensitization therapy for dental injection phobia. J Anxiety Disord 2007; 21:871.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26632/abstract/20\">",
"      Ost LG. Applied relaxation: description of a coping technique and review of controlled studies. Behav Res Ther 1987; 25:397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26632/abstract/21\">",
"      Berggren U, Hakeberg M, Carlsson SG. Relaxation vs. cognitively oriented therapies for dental fear. J Dent Res 2000; 79:1645.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26632/abstract/22\">",
"      Hammarstrand G, Berggren U, Hakeberg M. Psychophysiological therapy vs. hypnotherapy in the treatment of patients with dental phobia. Eur J Oral Sci 1995; 103:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26632/abstract/23\">",
"      Moore R, Abrahamsen R, Br&oslash;dsgaard I. Hypnosis compared with group therapy and individual desensitization for dental anxiety. Eur J Oral Sci 1996; 104:612.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26632/abstract/24\">",
"      Brunick A, Clark M. Nitrous oxide and oxygen sedation: an update. Dent Assist 2010; 79:22.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26632/abstract/25\">",
"      Willumsen T, Vassend O, Hoffart A. A comparison of cognitive therapy, applied relaxation, and nitrous oxide sedation in the treatment of dental fear. Acta Odontol Scand 2001; 59:290.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26632/abstract/26\">",
"      Folayan MO, Faponle A, Lamikanra A. Seminars on controversial issues. A review of the pharmacological approach to the management of dental anxiety in children. Int J Paediatr Dent 2002; 12:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26632/abstract/27\">",
"      Nathan JE, Venham LL, West MS, Werboff J. The effects of nitrous oxide on anxious young pediatric patients across sequential visits: a double-blind study. ASDC J Dent Child 1988; 55:220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26632/abstract/28\">",
"      Berggren U, Linde A. Dental fear and avoidance: a comparison of two modes of treatment. J Dent Res 1984; 63:1223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26632/abstract/29\">",
"      J&ouml;hren P, Jackowski J, G&auml;ngler P, et al. Fear reduction in patients with dental treatment phobia. Br J Oral Maxillofac Surg 2000; 38:612.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26632/abstract/30\">",
"      Hakeberg M, Berggren U, Carlsson SG, Gr&ouml;ndahl HG. Long-term effects on dental care behavior and dental health after treatments for dental fear. Anesth Prog 1993; 40:72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26632/abstract/31\">",
"      Dewey M, Schink T, Dewey CF. Claustrophobia during magnetic resonance imaging: cohort study in over 55,000 patients. J Magn Reson Imaging 2007; 26:1322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26632/abstract/32\">",
"      Eshed I, Althoff CE, Hamm B, Hermann KG. Claustrophobia and premature termination of magnetic resonance imaging examinations. J Magn Reson Imaging 2007; 26:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26632/abstract/33\">",
"      Hricak H, Amparo EG. Body MRI: alleviation of claustrophobia by prone positioning. Radiology 1984; 152:819.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26632/abstract/34\">",
"      Bluemke DA, Breiter SN. Sedation procedures in MR imaging: safety, effectiveness, and nursing effect on examinations. Radiology 2000; 216:645.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26632/abstract/35\">",
"      Booth R, Rachman S. The reduction of claustrophobia--I. Behav Res Ther 1992; 30:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26632/abstract/36\">",
"      Ost LG, Alm T, Brandberg M, Breitholtz E. One vs five sessions of exposure and five sessions of cognitive therapy in the treatment of claustrophobia. Behav Res Ther 2001; 39:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26632/abstract/37\">",
"      Thorpe S, Salkovskis PM, Dittner A. Claustrophobia in MRI: the role of cognitions. Magn Reson Imaging 2008; 26:1081.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 83458 Version 1.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-61.234.146.186-40244E071D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_0_26632=[""].join("\n");
var outline_f26_0_26632=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H607338248\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H607336119\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3468418\">",
"      SPECIFIC PHOBIAS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H607336126\">",
"      GENERAL TREATMENT PRINCIPLES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H607337094\">",
"      INTERVENTIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H607337101\">",
"      Blood-injection-injury phobia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H607337108\">",
"      - Applied tension",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H607337115\">",
"      - Other interventions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H607337122\">",
"      Dental phobia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H607337129\">",
"      - Psychotherapies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H607337136\">",
"      In vivo exposure therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H607337143\">",
"      Cognitive restructuring",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H607337150\">",
"      Systematic desensitization",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H607337157\">",
"      Coping strategies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H607337164\">",
"      Hypnotherapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H607337171\">",
"      - Medication",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H607337178\">",
"      Nitrous oxide",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H607337185\">",
"      Other medications",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H607337192\">",
"      - Duration of treatment effects",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3468846\">",
"      - Treatment selection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H607337199\">",
"      MRI claustrophobia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H607337206\">",
"      - Positional adjustment",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H607337213\">",
"      - Benzodiazepines",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H607337220\">",
"      - Psychotherapies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H607338248\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PSYCH/83458\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PSYCH/83458|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/28/24012\" title=\"table 1\">",
"      Common benzodiazepines for treatment of procedural anxiety",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/32/11782?source=related_link\">",
"      Acute procedure anxiety in adults: Course, screening, assessment, and differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/39/9849?source=related_link\">",
"      Acute procedure anxiety in adults: Epidemiology and clinical presentation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/0/28682?source=related_link\">",
"      Depression in pregnant women: Management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/41/6806?source=related_link\">",
"      Pharmacotherapy for specific phobia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/51/34618?source=related_link\">",
"      Procedural sedation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/59/25527?source=related_link\">",
"      Psychotherapy for specific phobia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/24/22921?source=related_link\">",
"      Specific phobia in adults: Epidemiology, clinical manifestations, course and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/18/9512?source=related_link\">",
"      Treatment of acute procedure anxiety in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/62/13290?source=related_link\">",
"      Treatment of insomnia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/53/38745?source=related_link\">",
"      Use of psychotropic medications in breastfeeding women",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f26_0_26633="Clinical manifestations and diagnosis of congenital anomalies of the uterus";
var content_f26_0_26633=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical manifestations and diagnosis of congenital anomalies of the uterus",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/0/26633/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/0/26633/contributors\">",
"     Ronald E Iverson, Jr, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/0/26633/contributors\">",
"     Alan H DeCherney, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/0/26633/contributors\">",
"     Marc R Laufer, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/0/26633/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/0/26633/contributors\">",
"     Robert L Barbieri, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/0/26633/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/0/26633/contributors\">",
"     Sandy J Falk, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?26/0/26633/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 22, 2011.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Congenital anomalies of the uterus are often asymptomatic and therefore unrecognized. They may affect a young woman due to pain at the time of menarche, or a woman's obstetric",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    gynecologic health.",
"   </p>",
"   <p>",
"    The classification, diagnosis, and clinical manifestations of congenital uterine anomalies will be reviewed here. Treatment of these anomalies and congenital cervical and vaginal abnormalities are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/21/29014?source=see_link\">",
"     \"Surgical management of congenital uterine anomalies\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/32/23048?source=see_link\">",
"     \"Congenital cervical anomalies and benign cervical lesions\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/11/12473?source=see_link\">",
"     \"Diagnosis and management of congenital anomalies of the vagina\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLASSIFICATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A classification system is an attempt to group by symptomatology, treatment, or prognosis. It is through use of standardized nomenclature that physicians can more accurately codify the symptomatology, treatment, and outcome of patients with uterine anomalies. Unfortunately, there is no universally accepted and interpreted classification system for uterine anomalies.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The American Fertility Society in 1988 produced a standard form for classification of m&uuml;llerian defects (",
"      <a class=\"graphic graphic_table graphicRef76124 \" href=\"UTD.htm?2/32/2572\">",
"       table 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_figure graphicRef81036 \" href=\"UTD.htm?33/40/34439\">",
"       figure 1",
"      </a>",
"      )&nbsp;[",
"      <a class=\"abstract\" href=\"UTD.htm?26/0/26633/abstract/1\">",
"       1",
"      </a>",
"      ]. This descriptive form focuses largely on vertical fusion defects and, therefore, on uterine dysgenesis. Associated anomalies in the vagina, cervix, fallopian tubes, and renal system should also be noted.",
"     </li>",
"     <li>",
"      Other classification systems have been described, such as the clinical embryological system shown in the table (",
"      <a class=\"graphic graphic_table graphicRef50939 \" href=\"UTD.htm?1/23/1404\">",
"       table 2",
"      </a>",
"      )&nbsp;[",
"      <a class=\"abstract\" href=\"UTD.htm?26/0/26633/abstract/2\">",
"       2",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     INCIDENCE",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Overview",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of congenital uterine anomalies is difficult to determine since many women with such anomalies are not diagnosed, especially if they are asymptomatic. Uterine anomalies occur in 2 to 4 percent of fertile women with normal reproductive outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26633/abstract/3-9\">",
"     3-9",
"    </a>",
"    ]. In one of the better designed studies, the uteri of 679 women with normal reproductive outcomes were evaluated with laparoscopy or laparotomy prior to tubal ligation, and then by follow-up hysterosalpingogram (HSG) five months after sterilization [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26633/abstract/3\">",
"     3",
"    </a>",
"    ]. The incidence of congenital uterine anomalies was 3.2 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26633/abstract/3\">",
"     3",
"    </a>",
"    ]. The type and frequency of abnormality were septate uteri (90 percent), bicornuate uterus (5 percent), and didelphic uterus (5 percent).",
"   </p>",
"   <p>",
"    The prevalence is higher among women with adverse reproductive outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26633/abstract/5,9\">",
"     5,9",
"    </a>",
"    ]. As an example, the incidence of mullerian anomalies among women with recurrent first trimester miscarriage or late first trimester-second trimester",
"    <span class=\"nowrap\">",
"     miscarriage/preterm",
"    </span>",
"    delivery was 5 to 10 percent and greater than 25 percent, respectively, in another study [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26633/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Women with primary infertility have about the same prevalence of congenital uterine anomalies as fertile women with normal reproductive outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26633/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Frequency of specific anomalies",
"    </span>",
"    &nbsp;&mdash;&nbsp;A review including a combined population of infertile and fertile women, the frequency of anomalies by type was: septate (35 percent), bicornuate (26 percent), arcuate (18 percent), unicornuate (10 percent), didelphys (8 percent), and agenesis (3 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26633/abstract/9\">",
"     9",
"    </a>",
"    ]. However, these proportions can vary substantially depending upon the specific population studied and the methodology used to identify the abnormalities.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     DEVELOPMENTAL DEFECTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The normal embryology of the female genital tract is reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/11/12473?source=see_link&amp;anchor=H2#H2\">",
"     \"Diagnosis and management of congenital anomalies of the vagina\", section on 'Embryology'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are three common developmental defects of the m&uuml;llerian system to consider:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Agenesis",
"     </li>",
"     <li>",
"      Lateral fusion defects",
"     </li>",
"     <li>",
"      Vertical fusion defects",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Agenesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Mayer-Rokitansky-K&uuml;ster-Hauser (MRKH) syndrome refers to congenital absence of the vagina with variable uterine development; it is the result of m&uuml;llerian agenesis. Variable uterine development may result in lateral hemi-uteri or uterine horns, a midline uterus without a cervix, or no uterine structures at all. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/11/12473?source=see_link&amp;anchor=H23#H23\">",
"     \"Diagnosis and management of congenital anomalies of the vagina\", section on 'Vaginal agenesis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Lateral fusion defects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lateral fusion defects are the most common type of m&uuml;llerian defect. The resulting organs are either symmetric or asymmetric, and obstructed or nonobstructed. These fusion defects result from failure of formation of one m&uuml;llerian duct, migration of a duct, fusion of the m&uuml;llerian ducts, or absorption of the intervening septum. Defective resorption of the tissue between the fused m&uuml;llerian ducts results in a uterine septum, which may extend either partially down the uterus or the full length to the cervix. A septum is the most common type of uterine defect.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Septate/arcuate uterus",
"    </span>",
"    &nbsp;&mdash;&nbsp;A septate uterus has a normal external surface but two endometrial cavities (",
"    <a class=\"graphic graphic_figure graphicRef60684 \" href=\"UTD.htm?15/44/16079\">",
"     figure 2",
"    </a>",
"    ), in contrast to a bicornuate uterus (see below) which has an indented fundus and two endometrial cavities (",
"    <a class=\"graphic graphic_figure graphicRef53703 \" href=\"UTD.htm?8/40/8847\">",
"     figure 3",
"    </a>",
"    ). The septate uterus develops from a defect in canalization or resorption of the midline septum between the two m&uuml;llerian ducts. The degree of septation varies from a small midline septum (",
"    <a class=\"graphic graphic_figure graphicRef60684 \" href=\"UTD.htm?15/44/16079\">",
"     figure 2",
"    </a>",
"    ) to total failure in resorption resulting in a septate uterus with longitudinal vaginal septum (",
"    <a class=\"graphic graphic_figure graphicRef63396 graphicRef75163 \" href=\"UTD.htm?13/43/14003\">",
"     figure 4A-B",
"    </a>",
"    ). Partial and complete uterine septa are defined by the proximity of the septum to the internal os; the presence or absence of a complete or partial vaginal septum is not relevant to the classification [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26633/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An arcuate uterus has a slight midline septum with minimal, and often broad, fundal cavity indentation (",
"    <a class=\"graphic graphic_figure graphicRef53338 \" href=\"UTD.htm?13/57/14239\">",
"     figure 5",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef79328 \" href=\"UTD.htm?40/11/41137\">",
"     image 1",
"    </a>",
"    ); it has been variously classified as a septate uterus, bicornuate uterus, or normal variant [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26633/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There appears to be a higher risk of recurrent miscarriage associated with longer septa, but this is controversial and many untreated women have good pregnancy outcomes. Pregnancy outcomes reported in such women revealed spontaneous abortion in 21-44 percent, preterm delivery in 12-33 percent, and live birth in 50-72 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26633/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Surgical repair with resection of the septum hysteroscopically, or hysteroscopic metroplasty, provides excellent posttreatment results [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26633/abstract/12\">",
"     12",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/21/29014?source=see_link\">",
"     \"Surgical management of congenital uterine anomalies\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Unicornuate uterus",
"    </span>",
"    &nbsp;&mdash;&nbsp;The unicornuate uterus is an example of an asymmetric lateral fusion defect (",
"    <a class=\"graphic graphic_figure graphicRef58931 \" href=\"UTD.htm?43/40/44686\">",
"     figure 6",
"    </a>",
"    ). One cavity is usually normal, with a fallopian tube and cervix, while the failed m&uuml;llerian duct has various configurations (",
"    <a class=\"graphic graphic_figure graphicRef78813 graphicRef73807 graphicRef61993 graphicRef73768 graphicRef50733 \" href=\"UTD.htm?19/29/19929\">",
"     figure 7A-E",
"    </a>",
"    ). The affected m&uuml;llerian duct may not develop at all, or it may develop only partially as either a rudimentary horn on the uterus or an anlage (a cluster of embryonic cells). This horn or anlage may or may not communicate with the uterus. Although most rudimentary horns are asymptomatic, others contain functional, but not necessarily normal [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26633/abstract/13\">",
"     13",
"    </a>",
"    ], endometrium that is shed cyclically. If the rudimentary horn is obstructed (without communication to the other uterus or cervix), the women may develop cyclic or chronic abdominopelvic pain and may require surgical excision of the obstructed horn. In a literature review, the mean age of presentation was the mid 20s [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26633/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A review of pregnancy outcomes in unicornuate uteri reported that, although unicornuate uteri occurs in 1:4020 women in the general population, it is more common in infertile women [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26633/abstract/14\">",
"     14",
"    </a>",
"    ]. In addition, women with unicornuate uteri had the following rates of obstetric complications: 2.7 percent ectopic pregnancy, 24.3 percent first trimester abortion, 9.7 percent second trimester abortion, 20.1 percent preterm delivery, 10.5 percent intrauterine fetal demise, and 49.9 percent live births.",
"   </p>",
"   <p>",
"    Unicornuate uterus can be associated with an ectopic ovary, which is of clinical importance in women undergoing ovulation induction or who develop ovarian neoplasms [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26633/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. Ectopic ovaries have been identified using magnetic resonance imaging.",
"   </p>",
"   <p>",
"    The kidneys should be evaluated sonographically if a unicornuate uterus is noted because of the high incidence (40 percent) of associated renal abnormalities [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26633/abstract/17\">",
"     17",
"    </a>",
"    ]. Women with a unicornuate uterus are at higher risk for infertility, endometriosis, premature labor, and breech presentations (see",
"    <a class=\"local\" href=\"#H20\">",
"     'Obstetrical complications'",
"    </a>",
"    below)&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26633/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Bicornuate uterus",
"    </span>",
"    &nbsp;&mdash;&nbsp;A bicornuate uterus refers to a uterus in which the fundus is indented (arbitrarily defined as &ge;1 cm) and the vagina is generally normal [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26633/abstract/19\">",
"     19",
"    </a>",
"    ]. This anomaly results from only partial fusion of the m&uuml;llerian ducts. This leads to a variable degree of separation of the uterine horns that can be complete (",
"    <a class=\"graphic graphic_figure graphicRef53703 \" href=\"UTD.htm?8/40/8847\">",
"     figure 3",
"    </a>",
"    ), partial (",
"    <a class=\"graphic graphic_figure graphicRef82622 \" href=\"UTD.htm?1/45/1759\">",
"     figure 8",
"    </a>",
"    ), or minimal (ie, the arcuate uterus merely has an indentation at the center of the fundus) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26633/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pregnancy outcomes have been reported to be close to those of the general population. However, some women do develop complications, such as pregnancy loss, preterm labor, or malpresentations (see",
"    <a class=\"local\" href=\"#H20\">",
"     'Obstetrical complications'",
"    </a>",
"    below)&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26633/abstract/7\">",
"     7",
"    </a>",
"    ]. Surgical treatment requires uterine reunification through a laparotomy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Uterine didelphys",
"    </span>",
"    &nbsp;&mdash;&nbsp;Uterine didelphys, or double uterus, occurs when the two m&uuml;llerian ducts fail to fuse, thus producing duplication of the reproductive structures (",
"    <a class=\"graphic graphic_figure graphicRef77029 graphicRef55525 \" href=\"UTD.htm?42/19/43314\">",
"     figure 9A-B",
"    </a>",
"    ). Generally the duplication is limited to the uterus and cervix (uterine didelphys and bicollis [two cervices]) (",
"    <a class=\"graphic graphic_picture graphicRef60361 graphicRef76867 graphicRef62754 \" href=\"UTD.htm?28/8/28809\">",
"     picture 1A-C",
"    </a>",
"    ), although duplication of the vulva, bladder, urethra, vagina, and anus may also occur. Fifteen to 20 percent of women with didelphic uterus also have unilateral anomalies, such as an obstructed hemivagina and ipsilateral renal agenesis; the anomalies are on the right in 65 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26633/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Women with a didelphic uterus and bicollis often have good reproductive outcomes. A septated vagina occurs in 75 percent of cases and may cause difficulty with sexual intercourse or vaginal delivery. Affected women may opt for resection of the vaginal septum. Metroplasty should be considered for women with pelvic pain, recurrent miscarriages, or a history of preterm delivery.",
"   </p>",
"   <p>",
"    Women with an obstructed hemivagina and ipsilateral renal",
"    <span class=\"nowrap\">",
"     agenesis/anomaly",
"    </span>",
"    (",
"    <a class=\"graphic graphic_figure graphicRef76524 \" href=\"UTD.htm?36/62/37871\">",
"     figure 10",
"    </a>",
"    ) will have regular menses because menstrual blood from one uterus can egress through its nonobstructed cervix and hemivagina [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26633/abstract/21\">",
"     21",
"    </a>",
"    ]. However, such patients will most likely develop cyclic pain due to build up of blood in the obstructed hemivagina [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26633/abstract/22\">",
"     22",
"    </a>",
"    ]. In addition, there may be a microcommunication between the patent vagina and the obstructed vagina resulting in an infected obstructed hemivagina. Treatment involves resection of the wall of the obstructed vagina followed by creation of a single vaginal vault. Bilateral obstruction is also possible, and presents with primary amenorrhea (",
"    <a class=\"graphic graphic_figure graphicRef65261 \" href=\"UTD.htm?37/8/38030\">",
"     figure 11",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Vertical fusion defects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vertical fusion defects are due to either defective fusion of the caudal end of the m&uuml;llerian duct and urogenital sinus or problems with vaginal canalization. The resulting vaginal septum or cervical agenesis or dysgenesis may be obstructed or nonobstructed. The amount of obstruction will determine symptomatology, including obstetric outcomes. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/11/12473?source=see_link\">",
"     \"Diagnosis and management of congenital anomalies of the vagina\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/32/23048?source=see_link\">",
"     \"Congenital cervical anomalies and benign cervical lesions\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Diethylstilbestrol induced defects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Exposure to diethylstilbestrol (DES), a synthetic estrogen used from 1949 to 1971, is associated with a variety of female genital tract anomalies.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Uterine anomalies (T-shaped uterine cavity, hypoplastic uterus, midfundal constrictions, filling defects, and endometrial cavity adhesions (",
"      <a class=\"graphic graphic_figure graphicRef68607 graphicRef80368 graphicRef62485 \" href=\"UTD.htm?39/29/40405\">",
"       figure 12A-C",
"      </a>",
"      )).",
"     </li>",
"     <li>",
"      Vaginal adenosis, vaginal ridges, transverse septa.",
"     </li>",
"     <li>",
"      Cervical anomalies including hypoplasia, hoods, collars, or pseudopolyps.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/15/3322?source=see_link\">",
"     \"Outcome and follow-up of diethylstilbestrol (DES) exposed individuals\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Associated renal anomalies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Renal anomalies are found in 20 to 30 percent of women with m&uuml;llerian defects [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26633/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. Therefore, all women with m&uuml;llerian defects should undergo a radiologic renal investigation, such as an intravenous pyelogram or renal ultrasound.",
"   </p>",
"   <p>",
"    Ipsilateral renal agenesis is invariably noted with obstructive m&uuml;llerian defects. Obstruction may occur in a unicornuate uterus with a functioning, noncommunicating horn; an obstructed cavity in one of the double uteri; or with a vaginal septum leading to obstruction. Obstructions have only been observed unilaterally; most likely, if bilateral obstruction occurs, bilateral renal agenesis will occur as well, which is a lethal abnormality. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/58/16296?source=see_link\">",
"     \"Prenatal diagnosis of renal agenesis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition, upper urinary tract anomalies such as horseshoe kidney, duplication of the collecting system, pelvic kidney, and ectopically located ureteral orifices have all been noted at increased frequency. In one series, as an example, 37 percent of women with a solitary kidney had genital abnormalities [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26633/abstract/25\">",
"     25",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/52/28487?source=see_link\">",
"     \"Renal ectopic and fusion anomalies\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The underlying etiology of congenital m&uuml;llerian defects is not well understood. The karyotype of women with these anomalies is usually normal (46,XX in 92 percent). Most of the defects are likely to be related to polygenic and multifactorial causes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Congenital anomalies of the uterus are often diagnosed incidentally during the evaluation of common gynecologic and obstetric problems. Adolescents may present with pelvic pain due to an obstruction or associated endometriosis. Many anomalies in adults are discovered after hysterosalpingography during a work-up of infertility or reproductive loss.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Signs and symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;The signs and symptoms associated with m&uuml;llerian anomalies vary greatly, depending upon the defect involved.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Adolescents may have increased pelvic pain (either cyclic or noncyclic), dysmenorrhea, abnormal vaginal bleeding, or vaginal pain. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/25/31125?source=see_link\">",
"       \"Primary dysmenorrhea in adolescents\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Menstrual abnormalities: Hypomenorrhea may occur if there is minimal endometrium; amenorrhea may be a sign of Mayer-Rokitansky-Kuster-Hauser syndrome or a vertical fusion defect.",
"     </li>",
"     <li>",
"      Longitudinal vaginal septum may occur alone, but is usually seen with didelphic or other forms of double uterus. A vaginal septum may lead to dyspareunia or complaints of bleeding despite use of a tampon (these patients need two tampons, one in each vagina), leukorrhea, or dystocia at delivery.",
"     </li>",
"     <li>",
"      If one side of the vagina is obstructed, complications such a hydrocolpos and hematocolpos may occur and a mass may be detected on bimanual examination. In addition, microperforations into the obstructed vagina can lead to infection.",
"     </li>",
"     <li>",
"      The woman may present with endometriosis and its associated symptoms if a noncommunicating functioning horn seeds the peritoneum through retromenstruation. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/48/19210?source=see_link\">",
"       \"Pathogenesis, clinical features, and diagnosis of endometriosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Obstetrical complications are more common in women with uterine anomalies (see below)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There does not appear to be any association between the presence of uterine anomalies and development of ovarian neoplasia [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26633/abstract/10,26\">",
"     10,26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Fertility",
"    </span>",
"    &nbsp;&mdash;&nbsp;Uterine abnormalities typically don't prevent conception and implantation. Women with uterine anomalies undergoing IVF have similar clinical pregnancy rates as women with normal uteri undergoing IVF [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26633/abstract/27,28\">",
"     27,28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     OBSTETRICAL COMPLICATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Overview",
"    </span>",
"    &nbsp;&mdash;&nbsp;Obstetrical complications reported to occur more commonly with uterine anomalies include increased risks of miscarriage, prematurity, intrauterine growth restriction, antepartum and postpartum bleeding, cervical incompetence, abnormal fetal presentation, pregnancy-associated hypertension, and cesarean delivery [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26633/abstract/9,14,29-32\">",
"     9,14,29-32",
"    </a>",
"    ]. The term cornual pregnancy refers to implantation in either the horn of a bicornuate uterus, a rudimentary horn of a unicornuate uterus, or in the lateral half of a septated or partially septated uterus. Alternatively, the term cornual pregnancy is used interchangeably with \"interstitial pregnancy\" to describe an ectopic gestation implanted in the fallopian tube proximal segment that is embodied within the muscular wall of the uterus.",
"   </p>",
"   <p>",
"    Growth restriction may be related to a small uterine cavity or abnormal vascularization of the uterus, with resultant uteroplacental insufficiency. The increased risk of malpresentation and occasional occurrence of anomalies in the vagina are the main reasons for the increased risk of cesarean delivery [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26633/abstract/33\">",
"     33",
"    </a>",
"    ]. Postpartum hemorrhage may result from the placenta becoming partially trapped in an accessory horn. Pregnancy-associated hypertension has been attributed to coexistent congenital renal abnormalities [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26633/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In general, obstetric complications are most common in women with a uterine septum and least common in those with an arcuate uterus [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26633/abstract/19,23\">",
"     19,23",
"    </a>",
"    ]. However, studies attempting to quantitate the risk of adverse obstetrical outcome have shown widely varying results and inconsistencies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Recurrent pregnancy loss",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many women have normal reproductive histories in spite of m&uuml;llerian anomalies; however, there appears to be a high rate of recurrent first and second trimester abortion [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26633/abstract/9,34,35\">",
"     9,34,35",
"    </a>",
"    ]. Because there have been no good prospective studies on women with various uterine anomalies and their reproductive outcome, it is difficult to know what the true risk of spontaneous abortion is for these women. A review including over 4500 women with recurrent pregnancy loss found 13 percent had a uterine anomaly [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26633/abstract/9\">",
"     9",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/6/8298?source=see_link\">",
"     \"Definition and etiology of recurrent pregnancy loss\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Preterm delivery",
"    </span>",
"    &nbsp;&mdash;&nbsp;An increased incidence of premature births may be explained, at least in part, by the decreased size of the uterine cavity, especially in the unicornuate uteri. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/3/35898?source=see_link\">",
"     \"Risk factors for preterm labor and delivery\"",
"    </a>",
"    .) Routine cerclage is not recommended in all women with uterine anomalies; standard indications for cerclage placement are followed. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/22/4457?source=see_link\">",
"     \"Cervical insufficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    One series reported pregnancy outcome in 42 women with uterine anomalies (5 unicornuate, 61 bicornuate, 25 septate, 10 didelphic) and 101 pregnancies managed in high-risk pregnancy clinics [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26633/abstract/31\">",
"     31",
"    </a>",
"    ]. Term pregnancy was achieved in 60 percent of the unicornuate and didelphys groups, 39 percent of the bicornuate group, and 48 percent of the septate group. Preterm labor requiring tocolysis occurred in 21 percent of bicornuate and 15 percent of septate uteri and 5 percent of women with bicornuate uteri required cerclage. Fetal survival in women with bicornuate and septate uteri before and after high-risk pregnancy care was similar, approximately 50 to 60 percent. Therefore, the cure for these poor obstetric outcomes does not seem to lie in more intensive pregnancy management. The efficacy of surgery for lowering the rate of preterm birth has also not been established [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26633/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition, a literature review of pregnancy outcomes in women with untreated uterine anomalies reported the following percentages of pregnancies that resulted in",
"    <span class=\"nowrap\">",
"     abortion/preterm",
"    </span>",
"    <span class=\"nowrap\">",
"     delivery/term",
"    </span>",
"    delivery: unicornuate",
"    <span class=\"nowrap\">",
"     (37/16/45),",
"    </span>",
"    didelphys",
"    <span class=\"nowrap\">",
"     (32/28/36),",
"    </span>",
"    bicornuate",
"    <span class=\"nowrap\">",
"     (36/23/41),",
"    </span>",
"    septate",
"    <span class=\"nowrap\">",
"     (44/22/33),",
"    </span>",
"    and arcuate",
"    <span class=\"nowrap\">",
"     (26/8/63)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26633/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Malpresentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Uterine anomalies are associated with an increased risk of fetal malpresentations, such as breech presentation [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26633/abstract/33\">",
"     33",
"    </a>",
"    ]. However, most breech presenting fetuses occur in women with normal uteri.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Uterine rupture",
"    </span>",
"    &nbsp;&mdash;&nbsp;The estimated incidence of a rudimentary horn pregnancy is 1 in over 100,000 pregnancies [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26633/abstract/37\">",
"     37",
"    </a>",
"    ]. Uterine rupture",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    placental attachment abnormalities (eg, increta, percreta) are associated with pregnancies in an obstructed or rudimentary uterine horn [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26633/abstract/13,18,38-43\">",
"     13,18,38-43",
"    </a>",
"    ]. As an example, a study of 328 pregnancies in obstructed horns found that only 1 percent of such pregnancies were alive at term and 89 percent of the horns ruptured [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26633/abstract/38\">",
"     38",
"    </a>",
"    ]. Both spontaneous rupture and rupture in association with labor or induction have been reported. Thus, such pregnancies should be immediately terminated. One approach is to use both systemic",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    and local injection of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/57/34711?source=see_link\">",
"     potassium chloride",
"    </a>",
"    to stop the growth of the pregnancy. Laparoscopic resection of the rudimentary horn should be performed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Overview",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many anomalies are initially diagnosed or suspected based upon presenting symptoms (pain, pelvic mass, dysmenorrhea, dyspareunia, infertility, or recurrent pregnancy loss) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26633/abstract/44\">",
"     44",
"    </a>",
"    ]. A diagnosis of a structural uterine abnormality may be defined at hysterosalpingography during an infertility evaluation or by ultrasonography for an evaluation of pelvic pain or a mass, additional studies are often required for definitive diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26633/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Ultrasound examination (transabdominal, transvaginal, or transperineal) can be helpful in identifying the anatomic causes of reproductive tract anomalies [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26633/abstract/46-51\">",
"     46-51",
"    </a>",
"    ]. Traditionally, magnetic resonance imaging (MRI) has been considered the \"gold standard\" for diagnosing anomalies of the reproductive tract [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26633/abstract/52-55\">",
"     52-55",
"    </a>",
"    ]. However, a normal unestrogenized prepubertal uterus is small and may be difficult to image even with MRI; this often leads to an inappropriate diagnosis of uterine agenesis. MRI is very useful in determining the presence or absence of a cervix in a complex anomaly, or the presence of functioning endometrium in the case of a noncommunicating obstructed rudimentary uterine horn. MRI may not be able to identify a rudimentary uterine horn if it is located laterally along the psoas muscle and pelvic sidewall [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26633/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although MRI has historically been considered the gold standard for diagnosis of structural abnormalities, other modalities may be useful for evaluation. A hysterosalpingogram, performed on an outpatient basis with the use of fluoroscopy, can be helpful in determining the patency and possible complex communications in cases of genital tract anomalies [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26633/abstract/54\">",
"     54",
"    </a>",
"    ]. Sonohysterography and 3-dimensional (3-D) ultrasound have also been shown to be helpful [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26633/abstract/57,58\">",
"     57,58",
"    </a>",
"    ]. 3-D ultrasound is noninvasive, highly accurate, and able to provide detailed images of uterine anatomy.",
"   </p>",
"   <p>",
"    In cases of complicated m&uuml;llerian anomalies, additional information may also be obtained by examination with the patient under anesthesia, vaginoscopy, laparoscopy,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    hysteroscopy. However, these procedures are required less frequently because of the radiologic advances described above [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26633/abstract/54,59\">",
"     54,59",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The sensitivity, specificity, and positive and negative predictive values of the differing techniques for diagnosis of uterine anomalies have not been determined in large, comparative series.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one small series, 16 women with clinically or hysterosalpingographically suspected congenital mullerian defects underwent sonographic examination, magnetic resonance imaging, diagnostic laparoscopy, and hysteroscopy [",
"      <a class=\"abstract\" href=\"UTD.htm?26/0/26633/abstract/60\">",
"       60",
"      </a>",
"      ]. Abnormalities included unicornuate (n = 2), bicornuate (n = 6), and septate (n = 6) uteri, and normal uteri with septate vagina (n = 2). Sonography and magnetic resonance (MR) imaging had an overall sensitivity of 57 and 77 percent, specificity of 50 and 33 percent, positive predictive value of 89 and 83 percent, and negative predictive value of 14 and 25 percent, respectively, for all anomalies. Sonography and MR imaging correctly diagnosed septate uterus in",
"      <span class=\"nowrap\">",
"       2/6",
"      </span>",
"      and",
"      <span class=\"nowrap\">",
"       3/6",
"      </span>",
"      cases, respectively; bicornuate uterus in",
"      <span class=\"nowrap\">",
"       6/6",
"      </span>",
"      and",
"      <span class=\"nowrap\">",
"       5/6",
"      </span>",
"      cases, respectively; and unicornuate uterus in",
"      <span class=\"nowrap\">",
"       0/2",
"      </span>",
"      and",
"      <span class=\"nowrap\">",
"       2/2",
"      </span>",
"      cases, respectively.",
"     </li>",
"     <li>",
"      In another series; however, MR imaging allowed diagnosis of 24 of 24 cases, and sonography was correct in 11 of 12 cases, while HSG was correct in only four cases [",
"      <a class=\"abstract\" href=\"UTD.htm?26/0/26633/abstract/54\">",
"       54",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Differences in these results relate, in part, to the types of anomalies being investigated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Hysterosalpingogram",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hysterosalpingography (HSG) is an important tool to evaluate uterine and tubal causes of infertility. This procedure entails injecting radiopaque dye slowly through a cannula (eg, Jarcho cannula, HSG catheter) in the cervical canal and taking radiographic films as the dye fills the uterine cavity and fallopian tubes and then spills from the tubes into the peritoneal cavity [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26633/abstract/61\">",
"     61",
"    </a>",
"    ]. The first film should be taken after injection of a small amount of dye (eg, 2 mL) to look for small filling defects, such as polyps and fibroids. In general, hysterosalpingograms are performed after menses in the follicular phase to minimize the possibility of an early pregnancy. The best images are obtained using fluoroscopy with image intensification, by positioning the uterus axially, by withdrawing the speculum so as not to obscure the cervix, and by not injecting too much or too little dye.",
"   </p>",
"   <p>",
"    A nonsteroidal antiinflammatory agent (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/38/15978?source=see_link\">",
"     ibuprofen",
"    </a>",
"    600 to 800 mg) should be taken one hour prior to the procedure to diminish patient discomfort and prophylactic antibiotics are administered (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/41/2714?source=see_link\">",
"     doxycycline",
"    </a>",
"    100 mg BID for three days starting the day prior to the procedure) to reduce the risk of infection.",
"   </p>",
"   <p>",
"    Hysterosalpingography is an excellent method of evaluating the uterine cavity to assist in diagnosis of a uterine anomaly. However, definitive diagnosis often requires the evaluation of the external uterine contour, which is poorly defined by HSG.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Ultrasonography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sonography is useful for evaluating the kidneys, detecting hematometra or hematocolpos, and for confirming the presence of ovaries in women with primary amenorrhea. It also provides information about uterine contour, internal and external. Performing the examination in the secretory phase of the menstrual cycle improves visualization of the endometrium. A uterine anomaly should be suspected if the endometrial echo is separated by a longitudinal division from the fundus towards the cervix or if the interstitial portion of one of the Fallopian tubes cannot be identified. These findings suggest duplication or agenesis, respectively.",
"   </p>",
"   <p>",
"    Saline infusion sonohysterography is particularly effective for delineating the intracavitary space and structures. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/55/40823?source=see_link\">",
"     \"Saline infusion sonohysterography\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h3\">",
"     Three-dimensional ultrasound",
"    </span>",
"    &nbsp;&mdash;&nbsp;Three-dimensional ultrasound examination can visualize the uterine cavity, myometrium, and the external contour of the uterus in a single image, such as a coronal view. It is a noninvasive, reproducible, reliable method of differentiating the septate from the bicornuate uteri [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26633/abstract/19,51,62-64\">",
"     19,51,62-64",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h2\">",
"     Magnetic resonance imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Advantages of MRI are that it can provide excellent delineation of both internal and external uterine contours without exposure to ionizing radiation or an invasive procedure. MR imaging has been shown to be both sensitive and specific and is clearly less invasive than laparoscopy, which was considered the gold standard for diagnosis of anomalies [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26633/abstract/54\">",
"     54",
"    </a>",
"    ]. In the past, laparoscopy was essential in assigning the proper classification of a uterine anomaly, especially in distinguishing the indented fundus of a bicornuate uterus from the smooth or flat fundus of a septate uterus.",
"   </p>",
"   <p>",
"    However, MRI can determine the contour of the fundus, as well as measure the intercornual diameter (greater than four centimeters suggests a",
"    <span class=\"nowrap\">",
"     bicornuate/didelphys",
"    </span>",
"    uterus and less than two centimeters suggests a septate uterus; measurements of 2 to 4 cm are indeterminate), distinguish between the myometrial septum of a bicornuate uterus and the fibrous septum of a septate uterus, and visualize the extent of the septum in both anomalies [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26633/abstract/65\">",
"     65",
"    </a>",
"    ]. MR imaging may also be helpful in detecting a uterine horn and visualizing an endometrial stripe. Use of contrast agents for MRI has not been studied or shown to be of benefit for imaging of the uterus.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The incidence of congenital uterine anomalies is difficult to determine since many women with such anomalies are not diagnosed, especially if they are asymptomatic. Uterine anomalies occur in 2 to 4 percent of infertile women and fertile women with normal reproductive outcomes. The incidence is higher, however, among women with recurrent first trimester miscarriage or late first trimester-second trimester",
"      <span class=\"nowrap\">",
"       miscarriage/preterm",
"      </span>",
"      delivery.",
"     </li>",
"     <li>",
"      The underlying etiology of congenital m&uuml;llerian defects is not well understood. The karyotype of women with these anomalies is usually normal.",
"     </li>",
"     <li>",
"      Signs and symptoms suggestive of a uterine anomaly include dysmenorrhea, menstrual abnormalities (amenorrhea, hypomenorrhea), hematocolpos, and recurrent miscarriage or preterm delivery. The ability to achieve a clinical pregnancy is not typically impaired.",
"     </li>",
"     <li>",
"      Either two dimensional ultrasonography or hysterosalpingography is an acceptable first-line screening tool. The advantage of ultrasonography is that it can also be used to assess the adnexae and kidneys, while hysterosalpingography provides information about fallopian tube patency. Saline infusion sonohysterography and hysterosalpingography both delineate the uterine cavity well.",
"     </li>",
"     <li>",
"      Where available, magnetic resonance imaging",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      three dimensional ultrasonography are the best noninvasive means of diagnosing uterine anomalies. These two modalities have not been evaluated in comparative studies.",
"     </li>",
"     <li>",
"      Women with uterine anomalies should be evaluated by ultrasonography for coexistent renal abnormalities.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/1\">",
"      The American Fertility Society classifications of adnexal adhesions, distal tubal occlusion, tubal occlusion secondary to tubal ligation, tubal pregnancies, m&uuml;llerian anomalies and intrauterine adhesions. Fertil Steril 1988; 49:944.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/2\">",
"      Aci&eacute;n P, Aci&eacute;n M, S&aacute;nchez-Ferrer M. Complex malformations of the female genital tract. New types and revision of classification. Hum Reprod 2004; 19:2377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/3\">",
"      Sim&oacute;n C, Martinez L, Pardo F, et al. M&uuml;llerian defects in women with normal reproductive outcome. Fertil Steril 1991; 56:1192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/4\">",
"      Cooper JM, Houck RM, Rigberg HS. The incidence of intrauterine abnormalities found at hysteroscopy in patients undergoing elective hysteroscopic sterilization. J Reprod Med 1983; 28:659.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/5\">",
"      Aci&eacute;n P. Incidence of M&uuml;llerian defects in fertile and infertile women. Hum Reprod 1997; 12:1372.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/6\">",
"      Ashton D, Amin HK, Richart RM, Neuwirth RS. The incidence of asymptomatic uterine anomalies in women undergoing transcervical tubal sterilization. Obstet Gynecol 1988; 72:28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/7\">",
"      Raga F, Bauset C, Remohi J, et al. Reproductive impact of congenital M&uuml;llerian anomalies. Hum Reprod 1997; 12:2277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/8\">",
"      Jurkovic D, Gruboeck K, Tailor A, Nicolaides KH. Ultrasound screening for congenital uterine anomalies. Br J Obstet Gynaecol 1997; 104:1320.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/9\">",
"      Grimbizis GF, Camus M, Tarlatzis BC, et al. Clinical implications of uterine malformations and hysteroscopic treatment results. Hum Reprod Update 2001; 7:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/10\">",
"      Heinonen PK. Complete septate uterus with longitudinal vaginal septum. Fertil Steril 2006; 85:700.",
"     </a>",
"    </li>",
"    <li>",
"     Speroff, L, Glass, RH, Kase, NG. The uterus. In: Clinical Gynecologic Endocrinology and Infertility, Lippincott Williams &amp; Wilkins, Philadelphia 1999. p.148.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/12\">",
"      Fedele L, Bianchi S. Hysteroscopic metroplasty for septate uterus. Obstet Gynecol Clin North Am 1995; 22:473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/13\">",
"      Jayasinghe Y, Rane A, Stalewski H, Grover S. The presentation and early diagnosis of the rudimentary uterine horn. Obstet Gynecol 2005; 105:1456.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/14\">",
"      Reichman D, Laufer MR, Robinson BK. Pregnancy outcomes in unicornuate uteri: a review. Fertil Steril 2009; 91:1886.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/15\">",
"      Ombelet W, Verswijvel G, de Jonge E. Ectopic ovary and unicornuate uterus. N Engl J Med 2003; 348:667.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/16\">",
"      Dabirashrafi H, Mohammad K, Moghadami-Tabrizi N. Ovarian malposition in women with uterine anomalies. Obstet Gynecol 1994; 83:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/17\">",
"      Fedele L, Bianchi S, Agnoli B, et al. Urinary tract anomalies associated with unicornuate uterus. J Urol 1996; 155:847.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/18\">",
"      Fedele L, Zamberletti D, Vercellini P, et al. Reproductive performance of women with unicornuate uterus. Fertil Steril 1987; 47:416.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/19\">",
"      Troiano RN, McCarthy SM. Mullerian duct anomalies: imaging and clinical issues. Radiology 2004; 233:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/20\">",
"      Vercellini P, Daguati R, Somigliana E, et al. Asymmetric lateral distribution of obstructed hemivagina and renal agenesis in women with uterus didelphys: institutional case series and a systematic literature review. Fertil Steril 2007; 87:719.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/21\">",
"      Smith NA, Laufer MR. Obstructed hemivagina and ipsilateral renal anomaly (OHVIRA) syndrome: management and follow-up. Fertil Steril 2007; 87:918.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/22\">",
"      Stassart JP, Nagel TC, Prem KA, Phipps WR. Uterus didelphys, obstructed hemivagina, and ipsilateral renal agenesis: the University of Minnesota experience. Fertil Steril 1992; 57:756.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/23\">",
"      Lin PC, Bhatnagar KP, Nettleton GS, Nakajima ST. Female genital anomalies affecting reproduction. Fertil Steril 2002; 78:899.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/24\">",
"      Oppelt P, von Have M, Paulsen M, et al. Female genital malformations and their associated abnormalities. Fertil Steril 2007; 87:335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/25\">",
"      Thompson DP, Lynn HB. Genital anomalies associated with solitary kidney. Mayo Clin Proc 1966; 41:538.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/26\">",
"      Noumoff, JS, Heyer, S, Farber, M. The malignant potential of congenital anomalies of the paramesonephric ducts. Sem Reprod Med 1986; 4:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/27\">",
"      Marcus S, al-Shawaf T, Brinsden P. The obstetric outcome of in vitro fertilization and embryo transfer in women with congenital uterine malformation. Am J Obstet Gynecol 1996; 175:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/28\">",
"      Guirgis RR, Shrivastav P. Gamete intrafallopian transfer (GIFT) in women with bicornuate uteri. J In Vitro Fert Embryo Transf 1990; 7:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/29\">",
"      Andrews MC, Jones HW Jr. Impaired reproductive performance of the unicornuate uterus: intrauterine growth retardation, infertility, and recurrent abortion in five cases. Am J Obstet Gynecol 1982; 144:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/30\">",
"      Ben-Rafael Z, Seidman DS, Recabi K, et al. Uterine anomalies. A retrospective, matched-control study. J Reprod Med 1991; 36:723.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/31\">",
"      Ludmir J, Samuels P, Brooks S, Mennuti MT. Pregnancy outcome of patients with uncorrected uterine anomalies managed in a high-risk obstetric setting. Obstet Gynecol 1990; 75:906.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/32\">",
"      Heinonen PK. Gestational hypertension and preeclampsia associated with unilateral renal agenesis in women with uterine malformations. Eur J Obstet Gynecol Reprod Biol 2004; 114:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/33\">",
"      Green LK, Harris RE. Uterine anomalies. Frequency of diagnosis and associated obstetric complications. Obstet Gynecol 1976; 47:427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/34\">",
"      Harger JH, Archer DF, Marchese SG, et al. Etiology of recurrent pregnancy losses and outcome of subsequent pregnancies. Obstet Gynecol 1983; 62:574.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/35\">",
"      Jewelewicz, R, Husarni, N, Wallach, EE. When uterine factors cause infertility. Contemp Obstet Gynecol 1980; 16:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/36\">",
"      Daly DC, Maier D, Soto-Albors C. Hysteroscopic metroplasty: six years' experience. Obstet Gynecol 1989; 73:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/37\">",
"      Johansen K. Pregnancy in a rudimentary horn. Two case reports. Obstet Gynecol 1969; 34:805.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/38\">",
"      O'LEARY JL, O'LEARY JA. RUDIMENTARY HORN PREGNANCY. Obstet Gynecol 1963; 22:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/39\">",
"      Samuels TA, Awonuga A. Second-trimester rudimentary uterine horn pregnancy: rupture after labor induction with misoprostol. Obstet Gynecol 2005; 106:1160.",
"     </a>",
"    </li>",
"    <li>",
"     Tulandi, T. Laparoscopic excision of a rudimentary uterine horn. In: Nezhat's Operative Gynecologic Laparoscopy and Hysteroscopy, 3rd ed, Nezhat, C, Nezhat, F, Nezhat, C (Eds), Cambridge University Press, New York 2008. p.363.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/41\">",
"      Daskalakis G, Pilalis A, Lykeridou K, Antsaklis A. Rupture of noncommunicating rudimentary uterine horn pregnancy. Obstet Gynecol 2002; 100:1108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/42\">",
"      Contreras KR, Rothenberg JM, Kominiarek MA, Raff GJ. Hand-assisted laparoscopic management of a midtrimester rudimentary horn pregnancy with placenta increta: a case report and literature review. J Minim Invasive Gynecol 2008; 15:644.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/43\">",
"      Henriet E, Roman H, Zanati J, et al. Pregnant noncommunicating rudimentary uterine horn with placenta percreta. JSLS 2008; 12:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/44\">",
"      Mazouni C, Girard G, Deter R, et al. Diagnosis of Mullerian anomalies in adults: evaluation of practice. Fertil Steril 2008; 89:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/45\">",
"      Pui MH. Imaging diagnosis of congenital uterine malformation. Comput Med Imaging Graph 2004; 28:425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/46\">",
"      Shatzkes DR, Haller JO, Velcek FT. Imaging of uterovaginal anomalies in the pediatric patient. Urol Radiol 1991; 13:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/47\">",
"      Valdes C, Malini S, Malinak LR. Ultrasound evaluation of female genital tract anomalies: a review of 64 cases. Am J Obstet Gynecol 1984; 149:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/48\">",
"      Scanlan KA, Pozniak MA, Fagerholm M, Shapiro S. Value of transperineal sonography in the assessment of vaginal atresia. AJR Am J Roentgenol 1990; 154:545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/49\">",
"      Nussbaum, Blask, AR, Sanders, RC, Gearhart JP. Obstructed uterovaginal anomalies: demonstration with sonography. Part I: neonates and infants. Pediatr Radiol 1991; 179:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/50\">",
"      Blask AR, Sanders RC, Rock JA. Obstructed uterovaginal anomalies: demonstration with sonography. Part II. Teenagers. Radiology 1991; 179:84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/51\">",
"      Raga F, Bonilla-Musoles F, Blanes J, Osborne NG. Congenital M&uuml;llerian anomalies: diagnostic accuracy of three-dimensional ultrasound. Fertil Steril 1996; 65:523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/52\">",
"      Markham SM, Parmley TH, Murphy AA, et al. Cervical agenesis combined with vaginal agenesis diagnosed by magnetic resonance imaging. Fertil Steril 1987; 48:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/53\">",
"      Fedele L, Dorta M, Brioschi D, et al. Magnetic resonance imaging in Mayer-Rokitansky-K&uuml;ster-Hauser syndrome. Obstet Gynecol 1990; 76:593.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/54\">",
"      Pellerito JS, McCarthy SM, Doyle MB, et al. Diagnosis of uterine anomalies: relative accuracy of MR imaging, endovaginal sonography, and hysterosalpingography. Radiology 1992; 183:795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/55\">",
"      Bakri YN, al-Sugair A, Hugosson C. Bicornuate nonfused rudimentary uterine horns with functioning endometria and complete cervical-vaginal agenesis: magnetic resonance diagnosis. Fertil Steril 1992; 58:620.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/56\">",
"      Economy KE, Barnewolt C, Laufer MR. A comparison of MRI and laparoscopy in detecting pelvic structures in cases of vaginal agenesis. J Pediatr Adolesc Gynecol 2002; 15:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/57\">",
"      Soares SR, Barbosa dos Reis MM, Camargos AF. Diagnostic accuracy of sonohysterography, transvaginal sonography, and hysterosalpingography in patients with uterine cavity diseases. Fertil Steril 2000; 73:406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/58\">",
"      Alborzi S, Dehbashi S, Parsanezhad ME. Differential diagnosis of septate and bicornuate uterus by sonohysterography eliminates the need for laparoscopy. Fertil Steril 2002; 78:176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/59\">",
"      Markham SM, Waterhouse TB. Structural anomalies of the reproductive tract. Curr Opin Obstet Gynecol 1992; 4:867.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/60\">",
"      Letterie GS, Haggerty M, Lindee G. A comparison of pelvic ultrasound and magnetic resonance imaging as diagnostic studies for m&uuml;llerian tract abnormalities. Int J Fertil Menopausal Stud 1995; 40:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/61\">",
"      Baramki TA. Hysterosalpingography. Fertil Steril 2005; 83:1595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/62\">",
"      Wu MH, Hsu CC, Huang KE. Detection of congenital m&uuml;llerian duct anomalies using three-dimensional ultrasound. J Clin Ultrasound 1997; 25:487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/63\">",
"      Jurkovic D, Geipel A, Gruboeck K, et al. Three-dimensional ultrasound for the assessment of uterine anatomy and detection of congenital anomalies: a comparison with hysterosalpingography and two-dimensional sonography. Ultrasound Obstet Gynecol 1995; 5:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26633/abstract/64\">",
"      Bermejo C, Mart&iacute;nez Ten P, Cantarero R, et al. Three-dimensional ultrasound in the diagnosis of M&uuml;llerian duct anomalies and concordance with magnetic resonance imaging. Ultrasound Obstet Gynecol 2010; 35:593.",
"     </a>",
"    </li>",
"    <li>",
"     Leung, JWT, Hricak, H. Role of magnetic resonance imaging in the evaluation of gynecologic disease. In: Ultrasonography in Obstetrics and Gynecology, 4th ed, Callen PW (Ed), WB Saunders, Philadelphia 2000. p. 940.",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5418 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-217.117.136.88-D8E73D39BC-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_0_26633=[""].join("\n");
var outline_f26_0_26633=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H32\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLASSIFICATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      INCIDENCE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Overview",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Frequency of specific anomalies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      DEVELOPMENTAL DEFECTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Agenesis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Lateral fusion defects",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Septate/arcuate uterus",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Unicornuate uterus",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Bicornuate uterus",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Uterine didelphys",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Vertical fusion defects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Diethylstilbestrol induced defects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Associated renal anomalies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Signs and symptoms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Fertility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      OBSTETRICAL COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Overview",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Recurrent pregnancy loss",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Preterm delivery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Malpresentation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Uterine rupture",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Overview",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Hysterosalpingogram",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Ultrasonography",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      - Three-dimensional ultrasound",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      Magnetic resonance imaging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/5418\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/5418|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?40/11/41137\" title=\"diagnostic image 1\">",
"      Arcuate uterus HSG",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/5418|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?33/40/34439\" title=\"figure 1\">",
"      Mullerian anomalies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?15/44/16079\" title=\"figure 2\">",
"      Partial septate uterus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?8/40/8847\" title=\"figure 3\">",
"      Complete bicornuate uterus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?22/14/22767\" title=\"figure 4A\">",
"      Septate uterus and cervix",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?28/33/29215\" title=\"figure 4B\">",
"      Septate uterus and vag septum",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?13/57/14239\" title=\"figure 5\">",
"      Arcuate uterus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?43/40/44686\" title=\"figure 6\">",
"      Unicornuate uterus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?21/23/21887\" title=\"figure 7A\">",
"      Unicornuate uter and xtra horn",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?21/58/22447\" title=\"figure 7B\">",
"      Unicornuate uter and fuse horn",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?25/28/26063\" title=\"figure 7C\">",
"      Unicornuate uter and xtra hornB",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?22/32/23055\" title=\"figure 7D\">",
"      Unicornuate uter and xtra hornC",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?12/54/13167\" title=\"figure 7E\">",
"      Unicornuate uter and xtra hornD",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?1/45/1759\" title=\"figure 8\">",
"      Partial bicornuate uterus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?16/61/17375\" title=\"figure 9A\">",
"      Uterus didelphys normal vagina",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?22/11/22719\" title=\"figure 9B\">",
"      Uterus didelphys and vag sept",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?36/62/37871\" title=\"figure 10\">",
"      Uterus didelphys and hemivagina",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?37/8/38030\" title=\"figure 11\">",
"      Uterus didelphys bicollis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?11/6/11375\" title=\"figure 12A\">",
"      T shaped uterus 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?12/21/12639\" title=\"figure 12B\">",
"      T shaped uterus 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?16/12/16591\" title=\"figure 12C\">",
"      T shaped uterus 3",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/5418|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?23/63/24562\" title=\"picture 1A\">",
"      Didelphus uterus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?17/54/18275\" title=\"picture 1B\">",
"      Double cervix in situ",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?6/30/6624\" title=\"picture 1C\">",
"      Uterus bicollis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/5418|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?2/32/2572\" title=\"table 1\">",
"      Types of Mullerian anomalies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?1/23/1404\" title=\"table 2\">",
"      Types genital tract anomalies",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/22/4457?source=related_link\">",
"      Cervical insufficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/32/23048?source=related_link\">",
"      Congenital cervical anomalies and benign cervical lesions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/6/8298?source=related_link\">",
"      Definition and etiology of recurrent pregnancy loss",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/11/12473?source=related_link\">",
"      Diagnosis and management of congenital anomalies of the vagina",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/15/3322?source=related_link\">",
"      Outcome and follow-up of diethylstilbestrol (DES) exposed individuals",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/48/19210?source=related_link\">",
"      Pathogenesis, clinical features, and diagnosis of endometriosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/58/16296?source=related_link\">",
"      Prenatal diagnosis of renal agenesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/25/31125?source=related_link\">",
"      Primary dysmenorrhea in adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/52/28487?source=related_link\">",
"      Renal ectopic and fusion anomalies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/3/35898?source=related_link\">",
"      Risk factors for preterm labor and delivery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/55/40823?source=related_link\">",
"      Saline infusion sonohysterography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/21/29014?source=related_link\">",
"      Surgical management of congenital uterine anomalies",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f26_0_26634="Differential diagnosis of chest pain in adults";
var content_f26_0_26634=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Differential diagnosis of chest pain in adults",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/0/26634/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/0/26634/contributors\">",
"     James L Meisel, MD, FACP",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/0/26634/contributors\">",
"     Daniel Cottrell, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/0/26634/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/0/26634/contributors\">",
"     Mark D Aronson, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/0/26634/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/0/26634/contributors\">",
"     Fenny H Lin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?26/0/26634/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 7, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of patients presenting with chest pain is extensive, ranging from benign musculoskeletal etiologies to life-threatening cardiac disease. Many of the diseases that cause chest pain are reviewed in detail elsewhere. This topic will discuss the differential diagnosis of chest pain in an approximate order of prevalence seen in primary care practice. Within each subsection, diseases that may pose an immediate threat to life are emphasized, including the following six entities: acute coronary syndrome, aortic dissection, effort rupture of the esophagus, perforating peptic ulcer, pulmonary embolus, and tension pneumothorax. In the primary care setting, reports of the etiology of chest pain are consistent, including musculoskeletal (36 to 49 percent), cardiac (15 to 18 percent), gastrointestinal (8 to 19 percent), pulmonary (5 to 10 percent), and psychiatric (8 to 11 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/1-4\">",
"     1-4",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    The office and emergency department evaluation of the patient with chest pain are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/15/34042?source=see_link\">",
"     \"Diagnostic approach to chest pain in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/39/20090?source=see_link\">",
"     \"Evaluation of chest pain in the emergency department\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CHEST WALL PAIN",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chest wall causes of pain are among the most common etiologies of chest pain seen by primary care clinicians, accounting for 36 percent of episodes in one report (",
"    <a class=\"graphic graphic_table graphicRef87061 \" href=\"UTD.htm?38/32/39437\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/1-4\">",
"     1-4",
"    </a>",
"    ]. Musculoskeletal causes of chest pain are typically not life-threatening. However, it is important to note that chest wall tenderness may present concomitantly with myocardial ischemia; the latter should be considered first in any patient at risk by age, history, or associated symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/1\">",
"     1",
"    </a>",
"    ]. Causes of true chest wall pain may be musculoskeletal or related to the skin and sensory nerves.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Musculoskeletal pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;Demographic features, characteristics of the chest pain, and associated symptoms may favor the diagnosis of musculoskeletal chest pain or suggest other causes of chest discomfort (",
"    <a class=\"graphic graphic_table graphicRef55901 \" href=\"UTD.htm?40/49/41755\">",
"     table 2",
"    </a>",
"    ). As an example, the patient may describe a history of repetitive or unaccustomed activity involving the upper trunk or arms, consistent with a musculoskeletal pain etiology. Certain characteristics of the chest pain or associated symptoms, such as dyspnea, may suggest a non-musculoskeletal origin. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/7/9335?source=see_link\">",
"     \"Clinical evaluation of musculoskeletal chest pain\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Musculoskeletal chest pain is often insidious and persistent, lasting for hours to weeks. It is frequently sharp and localized to a specific area (such as the xiphoid, lower rib tips, or midsternum), but may be diffuse and poorly localized. The pain may be positional or exacerbated by deep breathing, turning, or arm movement; positional or pleuritic components are also noted in a variety of visceral processes, particularly those involving the pleura and pericardium.",
"   </p>",
"   <p>",
"    The proportion of patients with chest pain having a musculoskeletal source varies with the clinical setting. Musculoskeletal pain is more common in ambulatory patients presenting to their primary care clinician than in patients presenting to an emergency department [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/5\">",
"     5",
"    </a>",
"    ]. It also occurs more frequently among women than men. One study examined the incidence of musculoskeletal chest pain in 122 consecutive patients presenting to an emergency department with chest pain [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/6\">",
"     6",
"    </a>",
"    ]. Of 36 patients diagnosed with costochondritis, 69 percent were women. By comparison, amongst those patients with final diagnosis other than costochondritis, women represented only 31 percent.",
"   </p>",
"   <p>",
"    The differential diagnosis of musculoskeletal chest pain can be divided into three categories (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/9/2201?source=see_link\">",
"     \"Major causes of musculoskeletal chest pain\"",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Isolated musculoskeletal chest pain syndromes (costosternal, posterior chest wall syndromes)",
"     </li>",
"     <li>",
"      Rheumatic diseases",
"     </li>",
"     <li>",
"      Non-rheumatic systemic diseases",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Isolated musculoskeletal chest pain syndromes",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are a number of chest wall syndromes with chest pain associated with musculoskeletal inflammation (",
"    <a class=\"graphic graphic_table graphicRef79217 \" href=\"UTD.htm?41/37/42587\">",
"     table 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      \"Costochondritis\" is one of the more common presentations of musculoskeletal chest pain. It is a diffuse pain syndrome, in which multiple areas of tenderness are found that reproduce the described pain. The upper costal cartilages at the costochondral or costosternal junctions are most frequently involved. The areas of tenderness are not accompanied by heat, erythema, or localized swelling. &ldquo;Tietze syndrome&rdquo; is a similar condition but more localized, usually involving costosternal, sternoclavicular, or costochondral joints of the second and third ribs. Tietze syndrome typically is characterized by localized swelling; septic arthritis should be considered in the differential diagnosis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/9/2201?source=see_link&amp;anchor=H11#H11\">",
"       \"Major causes of musculoskeletal chest pain\", section on 'Tietze's syndrome'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Chest wall pain occurring after coronary artery bypass surgery may be a result of incisional discomfort, of internal mammary artery grafting, or related to sternal wires [",
"      <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Costovertebral joint dysfunction syndrome is an uncommon condition that causes posterior chest wall pain and may mimic a pulmonary embolism.",
"     </li>",
"     <li>",
"      Thoracic disk herniation is another unusual cause of posterior chest pain; the pain is sometimes dermatomal and \"band-like,\" and retrosternal or retrogastric pain has also been described [",
"      <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/7,8\">",
"       7,8",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Other isolated chest wall pain syndromes include sternalis syndrome, xiphoidalgia, and spontaneous sternoclavicular subluxation.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Rheumatic diseases",
"    </span>",
"    &nbsp;&mdash;&nbsp;Involvement of thoracic joints in rheumatic diseases can be associated with musculoskeletal chest wall pain (",
"    <a class=\"graphic graphic_table graphicRef73531 \" href=\"UTD.htm?12/57/13211\">",
"     table 4",
"    </a>",
"    ). Examples include rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and fibromyalgia. Less common rheumatic causes of chest pain include systemic lupus erythematosus, SAPHO syndrome (synovitis, acne, pustulosis, hyperostosis, and osteitis), or relapsing polychondritis. These conditions are described in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/9/2201?source=see_link\">",
"     \"Major causes of musculoskeletal chest pain\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Non-rheumatic systemic diseases",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of systemic disorders with bony involvement can lead to chest wall pain (",
"    <a class=\"graphic graphic_table graphicRef73531 \" href=\"UTD.htm?12/57/13211\">",
"     table 4",
"    </a>",
"    ). Examples include stress fractures due to coughing [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/9\">",
"     9",
"    </a>",
"    ], neoplasms including pathologic fractures [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/10\">",
"     10",
"    </a>",
"    ], infections such as septic arthritis and osteomyelitis, and sickle cell anemia. In acute chest syndrome, a complication of sickle cell anemia, chest pain is traditionally attributed to microocclusion and pulmonary infarction; newer evidence suggests bone infarction may also occur [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Skin and sensory nerves",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chest pain may be the presenting symptom of herpes zoster (shingles); it may precede the characteristic rash and, rarely, zoster may occur without a rash [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/12\">",
"     12",
"    </a>",
"    ]. Dysesthesia is usually present in the affected dermatome. Postherpetic and postradiation neuralgia are other unusual causes of chest pain. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/6/21608?source=see_link\">",
"     \"Postherpetic neuralgia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     CARDIOVASCULAR CAUSES OF CHEST PAIN",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H697452766\">",
"    <span class=\"h2\">",
"     Ischemic chest pain syndromes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Myocardial ischemia is classically thought to present as &ldquo;typical angina.&rdquo; This is defined as substernal discomfort precipitated by exertion, typically radiating to the shoulder, jaw, or inner aspect of the arm, and relieved by rest or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/24/11656?source=see_link\">",
"     nitroglycerin",
"    </a>",
"    in less than 10 minutes (",
"    <a class=\"graphic graphic_table graphicRef59572 \" href=\"UTD.htm?14/52/15179\">",
"     table 5",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/13\">",
"     13",
"    </a>",
"    ]. Angina-like chest pain due to myocardial ischemia may result from any condition that causes increased oxygen demand",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    decreased oxygen (or blood) supply to the heart. For example, oxygen supply-demand mismatch may result from coronary artery spasm, coronary artery embolus, anemia, arrhythmia, hypertensive crisis or left ventricular hypertrophy and strain. The most commonly encountered cause of myocardial ischemia and thus cardiac chest pain is atherosclerosis of coronary arteries, coronary artery disease (CAD).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Coronary artery disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ischemic chest pain due to coronary artery disease (CAD) encompasses a spectrum of presentations including stable angina pectoris, unstable angina, non-ST elevation myocardial infarction, and ST elevation myocardial infarction. Patients classically complain of chest heaviness, pressure, tightness or burning, but may vigorously deny &ldquo;pain.&rdquo; Other descriptions such as provocation with physical or emotional stress or cold, relief with rest, and radiation to the neck, jaw, and shoulder are common. Ischemic pain usually lasts more than 2 but less than 20 minutes, unless a myocardial infarction is occurring. Associated symptoms may include dyspnea, nausea and vomiting, diaphoresis, presyncope, or palpitations. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/53/28505?source=see_link\">",
"     \"Classification of unstable angina and non-ST elevation myocardial infarction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/50/15144?source=see_link\">",
"     \"Pathophysiology and clinical presentation of ischemic chest pain\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    This classical description of pain due to CAD is most frequently seen in middle-aged men with risk factors for atherosclerosis; women, patients with diabetes, and older adults often do not present with classical symptoms. As an example, one study of 94 patients found that 32 percent, especially women over age 65, presented with \"atypical\" symptoms; abdominal pain was most common, occurring in one-third of these patients, while paroxysmal dyspnea was the presenting symptom in 17 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/14\">",
"     14",
"    </a>",
"    ]. Such presentations do not necessarily suggest a better prognosis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/15\">",
"     15",
"    </a>",
"    ]. Even older women diagnosed with \"nonspecific chest pain\" may be at increased risk of cardiac morbidity [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/16\">",
"     16",
"    </a>",
"    ]. The term \"atypical chest pain&rdquo; (as opposed to &ldquo;atypical angina&rdquo; referenced in the cardiology literature) should be avoided in general medicine and emergency settings; it increases the risk of misdiagnosing women, older adults, patients with long-standing diabetes, and those with a myocardial infarction who present with symptoms such as dyspnea or postprandial epigastric pain. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/9/41113?source=see_link\">",
"     \"Clinical features and diagnosis of coronary heart disease in women\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H697452846\">",
"    <span class=\"h3\">",
"     Other ischemic chest pain conditions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Numerous conditions may lead to demand ischemia and infarction, including coronary vasospasm, tachyarrhythmias, hypotension, hypertensive crisis, and valvular heart disease. Because of their relation to myocardial ischemia, many of these conditions may cause angina-like chest pain. Certain hyperadrenergic states, including cocaine or amphetamine intoxication or pheochromocytoma, may cause chest pain through ischemic or other mechanisms. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H697452914\">",
"    <span class=\"h3\">",
"     Coronary vasospasm",
"    </span>",
"    &nbsp;&mdash;&nbsp;One interesting group of patients presents with variant angina, in which coronary vasospasm may result in classical anginal pain. It may be precipitated by hyperventilation and, occasionally, by exercise. Vasospastic angina may be associated with life-threatening arrhythmias. Patients are typically less than 60 years old and, other than cigarette or cocaine use, do not necessarily have traditional cardiovascular risk factors. The rest ECG may reveal transient ST segment elevation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/39/3706?source=see_link\">",
"     \"Variant angina\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other uncommon causes of chest pain due to coronary artery pathology include congenital anatomic anomalies of the coronary arteries that may cause chest pain or even sudden cardiac death when coronary blood flow is impaired, as well as spontaneous coronary artery dissection,- a rare but often deadly cause of chest pain and myocardial infarction that mainly affects otherwise healthy, young females [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/17\">",
"     17",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/56/14218?source=see_link\">",
"     \"Congenital and pediatric coronary artery abnormalities\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H697453026\">",
"    <span class=\"h3\">",
"     Cardiac syndrome X",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cardiac syndrome X is a syndrome of angina-like, non-gastrointestinal chest pain associated with normal coronary arteries; it is most commonly seen in premenopausal women [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/18\">",
"     18",
"    </a>",
"    ]. The pain is typical of angina in approximately one-half of patients and may be precipitated by exertion, although it also occurs at rest. The pain also often has characteristics atypical for epicardial CAD; it is more severe, prolonged, and is variably relieved with nitrates [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/19,20\">",
"     19,20",
"    </a>",
"    ]. An association with an underlying panic disorder has been described [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/20\">",
"     20",
"    </a>",
"    ]. ST segment depression may be seen on treadmill exercise testing.",
"   </p>",
"   <p>",
"    The diagnosis is one of exclusion, generally made if coronary angiography does not demonstrate evidence of CAD. In referral populations of women with chest pain (eg, hospitalization, undergoing coronary angiography), myocardial ischemia",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    coronary microvascular dysfunction are present in 20 to 50 percent of patients with normal coronary arteries (",
"    <a class=\"graphic graphic_table graphicRef74465 \" href=\"UTD.htm?20/15/20733\">",
"     table 6",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/15\">",
"     15",
"    </a>",
"    ]. Some patients with cardiac syndrome X may have altered sensory awareness to cardiac events, the so-called \"sensitive heart\" [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/42/5802?source=see_link\">",
"     \"Cardiac syndrome X: Angina pectoris with normal coronary arteries\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Valvular heart disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Significant valvular abnormalities, particularly of the aortic or mitral valves, may present with anginal chest pain.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Aortic stenosis should be considered whenever a patient presents with progressive angina, dyspnea, or syncope. A detailed physical examination of the heart should be performed to exclude \"weak and delayed\" arterial pulses, a sustained apical impulse, and characteristic auscultatory findings (",
"      <a class=\"graphic graphic_movie graphicRef56063 \" href=\"UTD.htm?20/22/20832\">",
"       movie 1",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/37/26202?source=see_link\">",
"       \"Auscultation of cardiac murmurs\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/56/22410?source=see_link\">",
"       \"Auscultation of heart sounds\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      The ECG may reveal left ventricular hypertrophy. The cause of chest pain in these patients may be left ventricular hypertrophy causing coronary ischemia through various mechanisms including demand ischemia. Many patients with aortic stenosis also have concurrent coronary atherosclerosis. It is important to obtain an echocardiogram in patients with suspected aortic stenosis early in the evaluation since exercise stress testing may be contraindicated. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/12/21706?source=see_link\">",
"       \"Clinical features and evaluation of aortic stenosis in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Patients with mitral stenosis infrequently experience chest pain. The pain often resembles angina and, although it is most commonly the result of pulmonary hypertension and right ventricular hypertrophy, may be due to underlying coronary artery disease or a coronary artery embolism [",
"      <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/23\">",
"       23",
"      </a>",
"      ]. An atrial tachyarrhythmia with left atrial and pulmonary vascular distension is another cause of intermittent chest pain in mitral stenosis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/18/13610?source=see_link\">",
"       \"Pathophysiology, clinical features, and evaluation of mitral stenosis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/47/19193?source=see_link\">",
"       \"Overview of pulmonary hypertension in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Valvular pulmonic stenosis is a relatively common congenital defect, but a rare cause of chest pain in primary care practice. Pulmonic stenosis occurring later in life is associated with the carcinoid syndrome. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/63/9206?source=see_link\">",
"       \"Clinical features of the carcinoid syndrome\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/62/39910?source=see_link\">",
"       \"Clinical manifestations and diagnosis of pulmonic stenosis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H697453258\">",
"    <span class=\"h2\">",
"     Nonischemic cardiac chest pain syndromes",
"    </span>",
"    &nbsp;&mdash;&nbsp;These conditions may cause chest pain through inflammation of the pericardium; inflammation of or injury to the myocardium without predisposing ischemic insult; or aortic injury.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Pericarditis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The major clinical manifestations of acute pericarditis are chest pain that is pleuritic in quality, a pericardial friction rub, and widespread ST segment elevation on the electrocardiogram [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/24\">",
"     24",
"    </a>",
"    ]. At least two of these features, with or without an accompanying pericardial effusion, are usually present. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/47/37625?source=see_link\">",
"     \"Clinical presentation and diagnostic evaluation of acute pericarditis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The chest pain of acute pericarditis is typically of fairly sudden onset and occurs over the anterior chest. It is usually sharp and exacerbated by inspiration. However, dull, oppressive pain, difficult to distinguish from that of myocardial infarction, can also occur. The pain may decrease in intensity when the patient sits up and can radiate, especially to the trapezius ridge.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Myocarditis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Myocarditis may present with both cardiac and systemic symptoms. When chest pain occurs, it is usually associated with concomitant pericarditis although evidence of infarction may be seen. Systemic symptoms include fever, myalgias, and muscle tenderness. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/16/26889?source=see_link\">",
"     \"Clinical manifestations and diagnosis of myocarditis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H697453628\">",
"    <span class=\"h3\">",
"     Acute aortic syndromes",
"    </span>",
"    &nbsp;&mdash;&nbsp;This term encompasses the related entities of acute aortic dissection, intramural aortic hematoma, and penetrating aortic ulcer. Because it can be imminently life threatening, acute aortic syndrome is an important vascular cause of chest pain, and its diagnosis often requires a high index of suspicion [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/25\">",
"     25",
"    </a>",
"    ]. In the classic presentation of aortic dissection, sometimes referred to as &ldquo;aortic chest pain,&rdquo; pain typically is cataclysmic in onset and described as intense, acute, searing, tearing, throbbing, or migratory, and may radiate to the anterior chest, jaw, back, or abdomen depending on which segment of aorta is involved [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/26\">",
"     26",
"    </a>",
"    ]. It is most common in men older than age 60. Hypertension is the most important risk factor; other risk factors include smoking and atherosclerosis. Less common associations include Marfan's syndrome, congenital bicuspid and unicommissural aortic valves, aortic coarctation, and, rarely, preexisting aortic aneurysm (due to vasculitic conditions such as giant cell arteritis, Takayasu arteritis, and others) and pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]. Cocaine use may precipitate aortic dissection [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Aortic dissection should be considered in any patient who presents with a catastrophic illness associated with hypertension, an aortic murmur, and unexplained physical findings of vascular origin. The presentation may be subtle, however; in one series, one-third of cases were initially misdiagnosed [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Symptoms associated with aortic dissection may be related to impaired blood flow to an organ or limb induced by the original dissection or by propagation of the dissection proximally or distally. Even in the absence of chest pain, findings that should prompt consideration of aortic dissection include, in approximately decreasing order of incidence:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Abnormal aortic contour or widened mediastinum on chest radiograph, seen in most patients (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef59322 \" href=\"UTD.htm?15/27/15806\">",
"       image 1",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Congestive heart failure, which may be due to acute aortic insufficiency (",
"      <a class=\"graphic graphic_movie graphicRef76340 \" href=\"UTD.htm?39/27/40368\">",
"       movie 2",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Neurologic deficits, including paraplegia, stroke, or decreased consciousness (due to spinal cord ischemia, dissection into the carotid arteries, or diminished carotid blood flow, respectively)",
"     </li>",
"     <li>",
"      Syncope, cardiac tamponade, and sudden death due to rupture of the aorta into the pericardial space",
"     </li>",
"     <li>",
"      Shock, hemothorax, and exsanguination, which may result if the dissection extends through the adventitia, with hemorrhage into the pleural space",
"     </li>",
"     <li>",
"      Acute lower extremity ischemia due to dissection into the iliac vessels",
"     </li>",
"     <li>",
"      Infrequently reported sequelae such as myocardial ischemia due to coronary occlusion or dissection, signs of mesenteric or renal ischemia, Horner syndrome due to compression of the superior cervical sympathetic ganglion, vocal cord paralysis due to compression of the left recurrent laryngeal nerve, and other rare physical findings",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/19/25914?source=see_link\">",
"     \"Clinical manifestations and diagnosis of aortic dissection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H697453853\">",
"    <span class=\"h1\">",
"     CHEST PAIN DUE TO HYPERADRENERGIC STATES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Catecholamines (eg, epinephrine and norepinephrine) have various physiological actions in peripheral circulation, including stimulation of heart rate and vasoconstriction. Catecholamine excess, or hyperadrenergic states, may be seen in conditions such as cocaine and amphetamine intoxication and pheochromocytoma. Such conditions may cause chest pain via demand ischemia (due to either increased demand or decreased delivery of oxygen), myocardial infarction, and other mechanisms including acute aortic syndromes. Other clinical manifestations may include tachycardia, hypertension, and evidence of vasospasm. Stress-induced cardiomyopathy may mimic myocardial infarction. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/30/23018?source=see_link&amp;anchor=H16#H16\">",
"     \"Cocaine: Acute intoxication\", section on 'Chest pain'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5953147\">",
"    <span class=\"h2\">",
"     Stress-induced cardiomyopathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Emotional stress can precipitate severe, reversible left ventricular dysfunction in patients without coronary heart disease, related to exaggerated sympathetic stimulation. Patients most commonly present with acute substernal chest pain. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/1/30745?source=see_link\">",
"     \"Stress-induced (takotsubo) cardiomyopathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H697453862\">",
"    <span class=\"h2\">",
"     Cocaine intoxication",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute cocaine use may cause arterial vasoconstriction and heightened thrombogenesis. It causes tachycardia, hypertension, increased myocardial demand for oxygen, and increased vascular shearing forces.",
"   </p>",
"   <p>",
"    The differential diagnosis of chest pain in patients who have used cocaine is similar to that in the general population except that the likelihood of the patient having a serious event is increased [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/30\">",
"     30",
"    </a>",
"    ], including increased risk of acute coronary syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/31\">",
"     31",
"    </a>",
"    ]. In one series approximately 6 percent of patients with cocaine-associated chest pain experienced an acute coronary syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/32\">",
"     32",
"    </a>",
"    ]. Rarely, cocaine intoxication may also cause aortic dissection. Other known complications of cocaine intoxication include myocarditis, pneumothorax, pulmonary hypertension, acute pulmonary syndrome, and bronchospasm. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H697453915\">",
"    <span class=\"h2\">",
"     Methamphetamine intoxication",
"    </span>",
"    &nbsp;&mdash;&nbsp;Methamphetamine intoxication may mimic cocaine intoxication and cause similar cardiac complications. In one study of patients presenting to the emergency department with chest pain after methamphetamine use, 25 percent of patients suffered acute coronary syndromes, and 8 percent had other cardiac complications such as tachyarrhythmias [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Pheochromocytoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pheochromocytoma is a rare disease that may present with chest pain due to demand ischemia and myocardial infarction. It should be considered particularly in patients who lack other coronary risk factors; have other symptoms suggestive of pheochromocytoma (eg, severe or paroxysmal hypertension, headache, palpitations, or generalized sweating), or whose symptoms are paroxysmal or worsen after the administration of beta adrenergic blockage; or who appear to be experiencing demand ischemia [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/34\">",
"     34",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/14/23786?source=see_link\">",
"     \"Clinical presentation and diagnosis of pheochromocytoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     GASTROINTESTINAL CAUSES OF CHEST PAIN",
"    </span>",
"    &nbsp;&mdash;&nbsp;The heart and esophagus share some common neurologic innervation. Thus, it may be difficult to distinguish between chest pain due to myocardial ischemia and pain originating from the esophagus based upon the history alone. Esophageal disease may cause symptoms thought \"classical\" for myocardial ischemia, including a sensation of chest pressure, provocation with exercise or emotion, palliation by rest or nitrates, or a crescendo pattern [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/35\">",
"     35",
"    </a>",
"    ]. In one study of 28 patients referred to a cardiology clinic for chest pain, 36 percent ultimately had a diagnosis of reflux esophagitis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/36\">",
"     36",
"    </a>",
"    ]. After a history was taken independently by a cardiologist and a gastroenterologist, an accurate diagnosis was made in only 40 and 30 percent of patients with myocardial disease and reflux esophagitis, respectively.",
"   </p>",
"   <p>",
"    Myocardial ischemia should be ruled out before any patient at risk for CAD, presenting with anginal-quality chest pain, is given a gastrointestinal diagnosis. Neither the clinical history nor the response of new chest pain to a \"GI cocktail\" (eg, viscous",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/34/35360?source=see_link\">",
"     lidocaine",
"    </a>",
"    and antacid) reliably differentiates the diagnoses, which often coexist [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/37\">",
"     37",
"    </a>",
"    ]. There are, however, several clues that suggest an esophageal etiology (",
"    <a class=\"graphic graphic_table graphicRef50553 \" href=\"UTD.htm?8/55/9083\">",
"     table 7",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Gastrointestinal causes of chest pain are primarily due to esophageal disorders, and the most common gastrointestinal cause of chest pain is gastroesophageal reflux disease (GERD). However, other gastrointestinal pathologies may result in pain referred to the thoracic region. Peptic ulcer disease can cause pain referred to the chest; notably, perforating peptic ulcer may be imminently life-threatening. Rupture of the esophagus is another imminently life-threatening gastrointestinal cause of chest pain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Gastroesophageal reflux disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chest pain due to gastroesophageal reflux disease (GERD) can mimic angina pectoris and may be described as squeezing or burning, located substernally and radiating to the back, neck, jaw or arms, lasting anywhere from minutes to hours, and resolving either spontaneously or with antacids. It may occur after meals, awaken patients from sleep, and be exacerbated by emotional stress. The preponderance of patients with reflux-induced chest pain also have a history of typical reflux symptoms (ie, dyspepsia, regurgitation, acid taste). After cardiac disease has been ruled out, a trial of high-dose acid suppression may assist in the diagnosis of GERD [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/38-40\">",
"     38-40",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/41/22168?source=see_link\">",
"     \"Clinical manifestations and diagnosis of gastroesophageal reflux in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/56/15240?source=see_link\">",
"     \"Chest pain of esophageal origin\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Eosinophilic esophagitis may mimic GERD in its presentation, with patients complaining of heartburn, dysphagia, or chest pain; however, symptoms associated with eosinophilic esophagitis may be resistant to antacid therapy. Diagnosis is usually made via endoscopic biopsy after treatment with proton-pump inhibitors fail to improve symptoms, or esophageal pH monitoring excludes GERD as the diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/41\">",
"     41",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/45/32474?source=see_link\">",
"     \"Pathogenesis, clinical manifestations, and diagnosis of eosinophilic esophagitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Esophageal hypersensitivity",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are considerable experimental data to indicate that some patients with chest pain have a lower threshold for esophageal pain than normal subjects. Studies utilizing intraesophageal balloon distension have shown that many patients with unexplained chest pain experience their pain at a lower volume of balloon inflation than that found in appropriate control subjects [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/42,43\">",
"     42,43",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/56/15240?source=see_link&amp;anchor=H3#H3\">",
"     \"Chest pain of esophageal origin\", section on 'Esophageal hypersensitivity'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    This mechanism of increased pain sensitivity may be similar to that experienced by patients with cardiac syndrome X [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/25/19864?source=see_link\">",
"     \"Cardiac syndrome X: Angina pectoris with normal coronary arteries: Pathogenesis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Abnormal motility patterns and achalasia",
"    </span>",
"    &nbsp;&mdash;&nbsp;The relatively uncommon diagnosis of a motility disorder or esophageal spasm should be entertained if chest pain is associated with dysphagia, and a",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/17/12564?source=see_link\">",
"     barium",
"    </a>",
"    swallow study does not reveal an anatomic abnormality of the esophagus. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/50/13096?source=see_link\">",
"     \"Diffuse esophageal spasm, nutcracker esophagus, and hypertensive lower esophageal sphincter\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Esophageal rupture, perforation, and foreign bodies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Spontaneous perforation of the esophagus most commonly results from a sudden increase in intraesophageal pressure combined with negative intrathoracic pressure caused by straining or vomiting (effort rupture of the esophagus or Boerhaave's syndrome) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/44\">",
"     44",
"    </a>",
"    ]. Odynophagia, tachypnea, dyspnea, cyanosis, fever, and shock develop rapidly thereafter [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/15,44\">",
"     15,44",
"    </a>",
"    ]. Other causes of perforation include caustic ingestion, pill esophagitis, Barrett's ulcer [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/45\">",
"     45",
"    </a>",
"    ], infectious ulcers in patients with AIDS, and iatrogenic injury (typically from passing an instrument or tube through the esophagus or following dilation of esophageal strictures). A patient with a foreign body impacted in the esophagus may present with chest pain. Esophageal foreign bodies are most commonly seen in children; adult patients are often prisoners, edentulous, or have intellectual disability, psychiatric illness, or alcohol dependency [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/46\">",
"     46",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/58/29606?source=see_link\">",
"     \"Boerhaave's syndrome: Effort rupture of the esophagus\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/57/10137?source=see_link\">",
"     \"Complications of endoscopic esophageal stricture dilation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/54/21353?source=see_link\">",
"     \"Ingested foreign bodies and food impactions in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Other causes of esophagitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Medications can induce esophageal abnormalities via both systemic and local actions. The types of medication causing direct esophageal injury can be roughly divided into antibiotics (most commonly tetracyclines and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/21/33104?source=see_link\">",
"     clindamycin",
"    </a>",
"    ), antiinflammatory agents (especially",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    ), and others including bisphosphonates,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/57/34711?source=see_link\">",
"     potassium chloride",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/48/777?source=see_link\">",
"     quinidine",
"    </a>",
"    preparations, and iron compounds in the United States; emepronium, alprenolol, and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/17/41234?source=see_link\">",
"     pinaverium",
"    </a>",
"    are common etiologies in other countries. The typical patient with medication-induced esophagitis does not have a history of prior esophageal disease. Patients will often present with the sudden onset of odynophagia and retrosternal pain; the pain may be so severe that swallowing saliva is difficult. Patients often relate (after careful questioning) the onset of symptoms to the swallowing of a pill without water, commonly at bedtime [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/47\">",
"     47",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/13/37078?source=see_link\">",
"     \"Medication-induced esophagitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Esophagitis may also be due to infectious causes, including esophageal candidiasis or CMV esophagitis, particularly in immunocompromised hosts due to AIDS or stem-cell transplant patients. Radiation injury may also induce esophagitis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/17/29972?source=see_link\">",
"     \"Clinical manifestations of oropharyngeal and esophageal candidiasis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/62/22504?source=see_link\">",
"     \"AIDS-related cytomegalovirus gastrointestinal disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/42/20137?source=see_link\">",
"     \"Gastrointestinal toxicity of radiation therapy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Other gastrointestinal causes of chest pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other gastrointestinal causes of chest pain include hiatus hernia, which can cause reflux symptoms. Less commonly, paraesophageal hiatus hernia can lead to symptoms due to life-threatening gastric volvulus. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/22/7527?source=see_link\">",
"     \"Hiatus hernia\"",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p>",
"    The possibility of radiating or referred visceral pain due to cholecystitis or biliary colic [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/48\">",
"     48",
"    </a>",
"    ], peptic ulcer disease, pancreatitis, kidney stones, and even appendicitis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/49\">",
"     49",
"    </a>",
"    ] should be considered in any patient with unexplained chest pain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     PULMONARY CAUSES OF CHEST PAIN",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pulmonary causes of chest pain may be related to the pulmonary vessels, lung parenchyma, airways, or pleural tissue. Pulmonary embolus and tension pneumothorax are two pulmonary causes of chest pain that may be imminently life threatening.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Pulmonary vasculature",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chest pain caused by abnormalities of the pulmonary vessels may be due to an acute problem such as a pulmonary embolism or a chronic condition such as pulmonary hypertension.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h3\">",
"     Acute pulmonary embolism",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of acute pulmonary embolism (PE) often requires a high index of suspicion, especially since it is an uncommon cause of chest pain in the primary care setting [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/1,2,50\">",
"     1,2,50",
"    </a>",
"    ]. It should be considered in any patient who presents with chest pain that is usually but not necessarily pleuritic in nature or dyspnea that is not fully explained by the clinical evaluation, chest radiograph, or electrocardiogram [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/51-53\">",
"     51-53",
"    </a>",
"    ]. Individual symptoms and signs are not helpful diagnostically because their frequency is similar among patients with and without PE [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/54\">",
"     54",
"    </a>",
"    ]. The Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED) study found that the most common symptoms of pulmonary embolism were dyspnea (73 percent), pleuritic chest pain (66 percent), cough (37 percent), and hemoptysis (13 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/53\">",
"     53",
"    </a>",
"    ]. Ninety-seven percent of patients had pleuritic pain, dyspnea or tachypnea; 90 percent had dyspnea, tachypnea, or signs of deep venous thrombosis; 84 percent had a chest x-ray abnormality; and 50 percent had nonspecific electrocardiographic abnormalities. Subsequent studies have corroborated these findings [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/55,56\">",
"     55,56",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/22/4456?source=see_link\">",
"     \"Overview of acute pulmonary embolism\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/57/6042?source=see_link\">",
"     \"Diagnosis of acute pulmonary embolism\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The PIOPED II study further elucidated that, if present, dyspnea may occur only on exertion. The onset of dyspnea is usually rapid. Orthopnea may occur. Occasionally, common symptoms may be absent or if present, mild, even with severe pulmonary embolism. A low-probability objective clinical assessment does not exclude the diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most patients with pulmonary embolism have identifiable risk factors including immobilization, surgery within the last three months, stroke, history of venous thromboembolism, or malignancy (",
"    <a class=\"graphic graphic_table graphicRef59759 \" href=\"UTD.htm?1/6/1132\">",
"     table 8",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/57\">",
"     57",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/48/43786?source=see_link\">",
"     \"Overview of the causes of venous thrombosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h3\">",
"     Pulmonary hypertension and cor pulmonale",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with secondary pulmonary hypertension often have symptoms that reflect the underlying etiology (eg, chronic obstructive pulmonary disease, pulmonary embolic disease, collagen vascular disease). There are, however, symptoms directly attributable to secondary pulmonary hypertension including dyspnea on exertion, fatigue, lethargy, chest pain, and syncope with exertion. Typical exertional angina has been reported in patients with mitral stenosis or congenital heart disease and cor pulmonale even in the presence of normal coronary arteries [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/23\">",
"     23",
"    </a>",
"    ]. The mechanism by which angina occurs is unclear; both pulmonary artery stretching and right ventricular ischemia have been proposed. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/47/19193?source=see_link\">",
"     \"Overview of pulmonary hypertension in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Idiopathic pulmonary arterial hypertension is a rare disease. Most patients present with exertional dyspnea, which is indicative of an inability to increase cardiac output with exercise. Exertional chest pain, syncope, and edema are indications of more severe pulmonary hypertension and impaired right heart function.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Lung parenchyma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Causes of chest pain related to the lung parenchyma include infection, cancer, or chronic diseases such as sarcoidosis, as well as diseases involving the bronchial airways such as asthma, emphysema, and COPD.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h3\">",
"     Pneumonia",
"    </span>",
"    &nbsp;&mdash;&nbsp;The patient with community acquired pneumonia (CAP) caused by pyogenic organisms classically presents with the sudden onset of rigors followed by fever, pleuritic chest pain, and cough productive of purulent sputum. Chest pain occurs in 30 percent of cases, chills in 40 to 50 percent, and rigors in 15 percent. Because of the rapid onset of symptoms, most individuals seek medical care within six days [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/58\">",
"     58",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/26/26026?source=see_link\">",
"     \"Diagnostic approach to community-acquired pneumonia in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h3\">",
"     Cancer",
"    </span>",
"    &nbsp;&mdash;&nbsp;Isolated chest pain is a relatively rare presentation of lung cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/1,2,50\">",
"     1,2,50",
"    </a>",
"    ]. The chest pain experienced by 25 to 50 percent of lung cancer patients is usually in association with cough, dyspnea, weight loss, or hemoptysis. Some patients have a dull, intermittent pain on the side of the tumor; severe or persistent pain often indicates chest wall or mediastinal invasion. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/57/16282?source=see_link\">",
"     \"Overview of the risk factors, pathology, and clinical manifestations of lung cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/24/31111?source=see_link\">",
"     \"Evaluation of mediastinal masses\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h3\">",
"     Sarcoidosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chest pain is a common manifestation of pulmonary sarcoidosis, although it rarely occurs in isolation; most commonly it is accompanied by cough and dyspnea. Granulomatous involvement of the ventricular septum and conduction system of the heart can lead to a variety of arrhythmias (including heart block) and sudden death; such involvement may be heralded by chest pain, palpitations, syncope, or dizziness. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/25/21914?source=see_link\">",
"     \"Clinical manifestations and diagnosis of sarcoidosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/19/17722?source=see_link\">",
"     \"Cardiac sarcoidosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H697454380\">",
"    <span class=\"h2\">",
"     Asthma and COPD",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diseases of the bronchial airways such as asthma and COPD may present with chest pain. These conditions are both characterized by some degree of airway inflammation and bronchospasm. &nbsp;",
"   </p>",
"   <p>",
"    Chest pain is common in asthma exacerbations, occurring in as many as 76 percent of patients in one study [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/59\">",
"     59",
"    </a>",
"    ]. Chest pain or tightness associated with asthma is commonly described along with respiratory complaints and may be a dull ache or sharp, stabbing pain in the sternal, parasternal, or subcostal areas, worsened by coughing, deep inspiration, or movement and improved by sitting upright. &nbsp;",
"   </p>",
"   <p>",
"    Clinicians should remember that asthma and COPD exacerbations often have triggers (such as pneumonia or pulmonary embolism) that may actually be the cause of chest pain. For example, a meta-analysis of patients with COPD exacerbations of unknown cause found that approximately 20 to 25 percent are associated with occult pulmonary embolism [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h2\">",
"     Pleura and pleural space",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pleuritic chest pain is caused by irritation of nerve endings of pain fibers in the costal pleura. It often has a stabbing quality that worsens with inspiration. Pain referred from the pleura may be felt in the thoracic wall in the areas of skin innervated by the intercostal nerves [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/61\">",
"     61",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The term &ldquo;pleuritic&rdquo; chest pain implies pain originating from any condition causing inflammation or disruption of pleural membranes. Clinicians should note that other etiologies of chest pain may worsen with deep breathing, such as pericarditis or musculoskeletal chest pain syndromes (",
"    <a class=\"graphic graphic_table graphicRef75028 \" href=\"UTD.htm?8/44/8907\">",
"     table 9",
"    </a>",
"    ). &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h3\">",
"     Pneumothorax",
"    </span>",
"    &nbsp;&mdash;&nbsp;A spontaneous pneumothorax (as well as acute pulmonary embolus) should be considered in any patient who complains of the sudden onset of pleuritic chest pain and respiratory distress (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef73277 \" href=\"UTD.htm?8/46/8928\">",
"     image 2",
"    </a>",
"    ). A primary spontaneous pneumothorax usually occurs without a precipitating event in a person (most commonly a young adult male smoker) with no clinical lung disease; recurrence is common [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/62\">",
"     62",
"    </a>",
"    ]. A secondary spontaneous pneumothorax occurs as a complication of underlying lung disease such as chronic obstructive pulmonary disease, pneumocystic pneumonia, or as an iatrogenic complication of certain procedures. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/3/10297?source=see_link\">",
"     \"Primary spontaneous pneumothorax in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/35/24121?source=see_link\">",
"     \"Secondary spontaneous pneumothorax in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A tension pneumothorax is rare, but potentially life-threatening unless treated emergently. It occurs when a tissue flap from the injured lung creates a one-way valve, progressively trapping air in the intrapleural space during inspiration. Respiratory failure occurs as the healthy lung is compressed. Physical findings include unilateral loss of breath sounds with hypertympany, shift of the trachea away from the injured side, and jugular venous distension. The diagnosis is based upon a characteristic history and examination; it should be emergently treated prior to a confirmatory chest radiograph. Decompression is accomplished by inserting a large-bore needle into the second intercostal space in the midclavicular line on the affected side [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/63\">",
"     63",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h3\">",
"     Pleuritis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pleuritis is an inflammation of the parietal and serous pleura of the lung. Viral pleurisy is a common cause of pleuritic chest pain in young adults (",
"    <a class=\"graphic graphic_table graphicRef75028 \" href=\"UTD.htm?8/44/8907\">",
"     table 9",
"    </a>",
"    ). Other causes include autoimmune diseases such as systemic lupus erythematosus or rheumatoid arthritis, and drugs that can cause a lupus-like syndrome including",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/34/36391?source=see_link\">",
"     procainamide",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/57/15254?source=see_link\">",
"     hydralazine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/21/40279?source=see_link\">",
"     isoniazid",
"    </a>",
"    , and others. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/32/28168?source=see_link\">",
"     \"Drug-induced lupus\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/21/26969?source=see_link\">",
"     \"Overview of lung disease associated with rheumatoid arthritis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/60/11210?source=see_link\">",
"     \"Pulmonary manifestations of systemic lupus erythematosus in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H35\">",
"    <span class=\"h3\">",
"     Pleural effusion",
"    </span>",
"    &nbsp;&mdash;&nbsp;A patient with a significant pleural effusion is more likely to present with dyspnea or vague chest discomfort than with typical \"pleuritic\" chest pain, except in the setting of pleuritis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/7/16505?source=see_link\">",
"     \"Diagnostic evaluation of a pleural effusion in adults: Initial testing\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H36\">",
"    <span class=\"h1\">",
"     MEDIASTINAL CAUSES OF CHEST PAIN",
"    </span>",
"    &nbsp;&mdash;&nbsp;Disease originating in the mediastinum is a rare cause of chest pain in primary care practice, but may be seen in other settings. Such pain may be associated with signs and symptoms of involvement of different mediastinal or surrounding structures [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/64\">",
"     64",
"    </a>",
"    ]. Mediastinitis may result from esophageal rupture such as in effort rupture of the esophagus (see above) or postoperatively as a complication of cardiac surgery. Spontaneous pneumomediastinum is a rare entity that commonly presents with chest pain [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/65\">",
"     65",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/24/31111?source=see_link\">",
"     \"Evaluation of mediastinal masses\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/48/1800?source=see_link\">",
"     \"Postoperative mediastinitis after cardiac surgery\"",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H37\">",
"    <span class=\"h1\">",
"     PSYCHOGENIC/PSYCHOSOMATIC CAUSES OF CHEST PAIN",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chest pain may be a presenting symptom of panic disorder, depression, and hypochondriasis, as well as cardiac, cancer, or other phobias (",
"    <a class=\"graphic graphic_table graphicRef73966 \" href=\"UTD.htm?37/9/38044\">",
"     table 10",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/66-68\">",
"     66-68",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/42/44713?source=see_link\">",
"     \"Panic disorder: Epidemiology, clinical manifestations, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Reviews of the literature have estimated that approximately one-third of patients presenting to the emergency department for chest pain have a psychiatric disorder, while approximately one-half of patients with noncardiac chest pain have various psychiatric diagnoses [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/69,70\">",
"     69,70",
"    </a>",
"    ]. Among patients with chest pain due to coronary artery disease (CAD), 20 to 30 percent also have a coexisting psychiatric disorder. Hyperventilation, which is associated with panic attacks, can also result in nonanginal chest pain and occasionally electrocardiographic changes, particularly nonspecific ST and T wave abnormalities [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/71,72\">",
"     71,72",
"    </a>",
"    ]. Amongst younger patients with chest pain, the rates of psychiatric syndromes may be even higher [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/73\">",
"     73",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Panic disorder is a particularly common cause of chest pain. One report of patients evaluated in one emergency department for chest pain found that 20 percent had panic disorder as the etiology [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/74\">",
"     74",
"    </a>",
"    ]. Given its prevalence and long-term negative impact on function [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/75\">",
"     75",
"    </a>",
"    ], panic disorder and other psychosocial pathology should be actively considered in evaluating the patient who complains of chest pain of uncertain etiology [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/76\">",
"     76",
"    </a>",
"    ]. Vigilance is necessary since patients with psychiatric disorders may develop organic disease [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/37,70\">",
"     37,70",
"    </a>",
"    ]. In addition, ischemia may occur during a panic attack in a patient with CAD [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/77\">",
"     77",
"    </a>",
"    ]. Thus organic disease must be reasonably excluded before ascribing chest pain to a nonorganic origin.",
"   </p>",
"   <p>",
"    Another psychological basis for chest pain is the Munchausen syndrome. This entity denotes a psychological disorder in which patients deliberately feign serious medical illness, inventing false symptoms and signs. In one literature review, 58 patients with cardiac Munchausen syndrome were identified [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/78\">",
"     78",
"    </a>",
"    ]. Of these, 54 (95 percent) were male; the mean age was 44 years (range, 23 to 71). The most common presenting symptom was retrosternal chest pain (50 patients); other presenting complaints were syncope, dyspnea, and back pain. Patients typically gave a history of prior cardiac disease and often reported having \"white collar\" jobs; on investigation, these historical data proved to be untrue. Acute myocardial infarction was the most common admitting diagnosis. All subjects had had numerous admissions and extensive cardiac testing, which were negative for cardiac disease but which the patients reported were positive. When confronted, most patients changed their history, became uncooperative, and refused psychiatric examination. The majority left hospitals against medical advice, and none reported for outpatient follow-up. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/21/7512?source=see_link\">",
"     \"Factitious disorder and Munchausen syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H38\">",
"    <span class=\"h1\">",
"     PAIN REFERRED TO THE CHEST",
"    </span>",
"    &nbsp;&mdash;&nbsp;Referred pain may occur when the same spinal cord segments supplying dermatomal areas of the chest wall also innervate the very sensitive parietal pleura or peritoneum. As an example, irritation of the mediastinal pleura or of the central diaphragm due to gallbladder or liver disease may result in neck and shoulder pain, while more peripheral diaphragmatic irritation may result in inferior chest pain [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/61\">",
"     61",
"    </a>",
"    ]. A herniated thoracic disc may cause \"band-like\" anterior chest pain [",
"    <a class=\"abstract\" href=\"UTD.htm?26/0/26634/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?20/34/21027?source=see_link\">",
"       \"Patient information: Chest pain (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?4/45/4819?source=see_link\">",
"       \"Patient information: Pleuritic chest pain (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?33/27/34225?source=see_link\">",
"       \"Patient information: Costochondritis (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?42/9/43157?source=see_link\">",
"       \"Patient information: Chest pain (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H40\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of chest pain is extensive, ranging from benign musculoskeletal etiologies to life-threatening cardiac disease (",
"    <a class=\"graphic graphic_table graphicRef87061 \" href=\"UTD.htm?38/32/39437\">",
"     table 1",
"    </a>",
"    ). &nbsp;",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Imminently life-threatening causes of chest pain include acute coronary syndrome, aortic dissection, tension pneumothorax, pulmonary embolism, esophageal rupture, and pain referred from a perforating peptic ulcer. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Chest wall pain is the most common cause of chest pain in ambulatory settings. It can be categorized as musculoskeletal pain or disorders of the skin and sensory nerves. Musculoskeletal pain can be caused by costochondritis, pain related to surgery, costovertebral joint dysfunction, rheumatologic disorders, and non-rheumatologic disorders. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Chest wall pain'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Cardiovascular causes of chest pain may be related to ischemic conditions including coronary artery disease or demand ischemia from conditions including coronary vasospasm, valvular disease, or others. Cardiac syndrome X is ischemic type chest pain that occurs in the absence of documented epicardial coronary artery disease. Nonischemic causes include pericarditis, myocarditis, and reversible left ventricular dysfunction due to emotional stress. Vascular causes include acute aortic syndromes. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Cardiovascular causes of chest pain'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Hyperadrenergic states such as cocaine or methamphetamine intoxication and pheochromocytoma may cause chest pain by various mechanisms, including demand ischemia, acute coronary syndrome, and aortic dissection. (See",
"      <a class=\"local\" href=\"#H697453853\">",
"       'Chest pain due to hyperadrenergic states'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Gastrointestinal causes of chest pain may include gastroesophageal reflux, esophageal hypersensitivity, abnormal motility, esophageal disease, and esophagitis from medication use, infection, or other causes. A perforating peptic ulcer may cause pain that is referred to the chest. It may be difficult to distinguish between chest pain due to myocardial ischemia and gastrointestinal causes based upon the history alone. Any patient at risk for CAD who presents with anginal-quality chest pain should have myocardial ischemia ruled out before being given a gastroenterologic diagnosis. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Gastrointestinal causes of chest pain'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Pulmonary causes of chest pain may be related to the pulmonary vessels, parenchyma, airways, or pleural tissue. (See",
"      <a class=\"local\" href=\"#H24\">",
"       'Pulmonary causes of chest pain'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Chest pain may be a presenting symptom of panic disorder, depression, and hypochondriasis, as well as cardiac, cancer, or other phobias. (See",
"      <a class=\"local\" href=\"#H37\">",
"       'Psychogenic/psychosomatic causes of chest pain'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Referred pain may occur when the same spinal cord segments supplying dermatomal areas of the chest wall also innervate other areas that are inflamed, including liver disease or a herniated thoracic disc. (See",
"      <a class=\"local\" href=\"#H38\">",
"       'Pain referred to the chest'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/1\">",
"      Klinkman MS, Stevens D, Gorenflo DW. Episodes of care for chest pain: a preliminary report from MIRNET. Michigan Research Network. J Fam Pract 1994; 38:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/2\">",
"      Svavarsd&oacute;ttir AE, J&oacute;nasson MR, Gudmundsson GH, Fjeldsted K. Chest pain in family practice. Diagnosis and long-term outcome in a community setting. Can Fam Physician 1996; 42:1122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/3\">",
"      Verdon F, Herzig L, Burnand B, et al. Chest pain in daily practice: occurrence, causes and management. Swiss Med Wkly 2008; 138:340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/4\">",
"      B&ouml;sner S, Becker A, Haasenritter J, et al. Chest pain in primary care: epidemiology and pre-work-up probabilities. Eur J Gen Pract 2009; 15:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/5\">",
"      Buntinx F, Knockaert D, Bruyninckx R, et al. Chest pain in general practice or in the hospital emergency department: is it the same? Fam Pract 2001; 18:586.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/6\">",
"      Disla E, Rhim HR, Reddy A, et al. Costochondritis. A prospective analysis in an emergency department setting. Arch Intern Med 1994; 154:2466.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/7\">",
"      Wise CM. Chest wall syndromes. Curr Opin Rheumatol 1994; 6:197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/8\">",
"      Brown CW, Deffer PA Jr, Akmakjian J, et al. The natural history of thoracic disc herniation. Spine (Phila Pa 1976) 1992; 17:S97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/9\">",
"      De Maeseneer M, De Mey J, Debaere C, et al. Rib fractures induced by coughing: an unusual cause of acute chest pain. Am J Emerg Med 2000; 18:194.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/10\">",
"      Harbick S, Frederick R, Ward M, Cummings AJ. Unusual cause of chest pain in a 60-year-old woman. Ann Emerg Med 2000; 35:382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/11\">",
"      Rucknagel DL, Kalinyak KA, Gelfand MJ. Rib infarcts and acute chest syndrome in sickle cell diseases. Lancet 1991; 337:831.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/12\">",
"      Gilden DH, Wright RR, Schneck SA, et al. Zoster sine herpete, a clinical variant. Ann Neurol 1994; 35:530.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/13\">",
"      National Heart, Lung, and Blood Institute Coronary Artery Surgery Study. A multicenter comparison of the effects of randomized medical and surgical treatment of mildly symptomatic patients with coronary artery disease, and a registry of consecutive patients undergoing coronary angiography. Circulation 1981; 63:I1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/14\">",
"      Lusiani L, Perrone A, Pesavento R, Conte G. Prevalence, clinical features, and acute course of atypical myocardial infarction. Angiology 1994; 45:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/15\">",
"      Johnson BD, Shaw LJ, Buchthal SD, et al. Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation 2004; 109:2993.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/16\">",
"      Robinson JG, Wallace R, Limacher M, et al. Elderly women diagnosed with nonspecific chest pain may be at increased cardiovascular risk. J Womens Health (Larchmt) 2006; 15:1151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/17\">",
"      Lodha A, Mirsakov N, Malik B, Shani J. Spontaneous coronary artery dissection: case report and review of literature. South Med J 2009; 102:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/18\">",
"      Phan A, Shufelt C, Merz CN. Persistent chest pain and no obstructive coronary artery disease. JAMA 2009; 301:1468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/19\">",
"      Rosen SD, Uren NG, Kaski JC, et al. Coronary vasodilator reserve, pain perception, and sex in patients with syndrome X. Circulation 1994; 90:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/20\">",
"      Kaski JC, Rosano GM, Collins P, et al. Cardiac syndrome X: clinical characteristics and left ventricular function. Long-term follow-up study. J Am Coll Cardiol 1995; 25:807.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/21\">",
"      Cannon RO 3rd, Camici PG, Epstein SE. Pathophysiological dilemma of syndrome X. Circulation 1992; 85:883.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/22\">",
"      B&ouml;rjesson M, Albertsson P, Dellborg M, et al. Esophageal dysfunction in syndrome X. Am J Cardiol 1998; 82:1187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/23\">",
"      STUCKEY D. Cardiac pain in association with mitral stenosis and congenital heart disease. Br Heart J 1955; 17:397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/24\">",
"      Lange RA, Hillis LD. Clinical practice. Acute pericarditis. N Engl J Med 2004; 351:2195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/25\">",
"      Hagan PG, Nienaber CA, Isselbacher EM, et al. The International Registry of Acute Aortic Dissection (IRAD): new insights into an old disease. JAMA 2000; 283:897.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/26\">",
"      Vilacosta I, Rom&aacute;n JA. Acute aortic syndrome. Heart 2001; 85:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/27\">",
"      DeSanctis RW, Doroghazi RM, Austen WG, Buckley MJ. Aortic dissection. N Engl J Med 1987; 317:1060.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/28\">",
"      Spittell PC, Spittell JA Jr, Joyce JW, et al. Clinical features and differential diagnosis of aortic dissection: experience with 236 cases (1980 through 1990). Mayo Clin Proc 1993; 68:642.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/29\">",
"      Nallamothu BK, Saint S, Kolias TJ, Eagle KA. Clinical problem-solving. Of nicks and time. N Engl J Med 2001; 345:359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/30\">",
"      Hollander JE, Henry TD. Evaluation and management of the patient who has cocaine-associated chest pain. Cardiol Clin 2006; 24:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/31\">",
"      Bamberg F, Schlett CL, Truong QA, et al. Presence and extent of coronary artery disease by cardiac computed tomography and risk for acute coronary syndrome in cocaine users among patients with chest pain. Am J Cardiol 2009; 103:620.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/32\">",
"      Hollander JE, Hoffman RS, Gennis P, et al. Prospective multicenter evaluation of cocaine-associated chest pain. Cocaine Associated Chest Pain (COCHPA) Study Group. Acad Emerg Med 1994; 1:330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/33\">",
"      Turnipseed SD, Richards JR, Kirk JD, et al. Frequency of acute coronary syndrome in patients presenting to the emergency department with chest pain after methamphetamine use. J Emerg Med 2003; 24:369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/34\">",
"      Thygesen K, Alpert JS, White HD, Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. J Am Coll Cardiol 2007; 50:2173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/35\">",
"      Davies HA, Jones DB, Rhodes J, Newcombe RG. Angina-like esophageal pain: differentiation from cardiac pain by history. J Clin Gastroenterol 1985; 7:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/36\">",
"      Voskuil JH, Cramer MJ, Breumelhof R, et al. Prevalence of esophageal disorders in patients with chest pain newly referred to the cardiologist. Chest 1996; 109:1210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/37\">",
"      Ros E, Armengol X, Grande L, et al. Chest pain at rest in patients with coronary artery disease. Myocardial ischemia, esophageal dysfunction, or panic disorder? Dig Dis Sci 1997; 42:1344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/38\">",
"      Fass R, Fennerty MB, Ofman JJ, et al. The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain. Gastroenterology 1998; 115:42.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/39\">",
"      Achem SR, Kolts BE, MacMath T, et al. Effects of omeprazole versus placebo in treatment of noncardiac chest pain and gastroesophageal reflux. Dig Dis Sci 1997; 42:2138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/40\">",
"      Castell DO, Katz PO. The acid suppression test for unexplained chest pain. Gastroenterology 1998; 115:222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/41\">",
"      Furuta GT, Liacouras CA, Collins MH, et al. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology 2007; 133:1342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/42\">",
"      Richter JE, Barish CF, Castell DO. Abnormal sensory perception in patients with esophageal chest pain. Gastroenterology 1986; 91:845.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/43\">",
"      Rao SS, Gregersen H, Hayek B, et al. Unexplained chest pain: the hypersensitive, hyperreactive, and poorly compliant esophagus. Ann Intern Med 1996; 124:950.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/44\">",
"      Pate JW, Walker WA, Cole FH Jr, et al. Spontaneous rupture of the esophagus: a 30-year experience. Ann Thorac Surg 1989; 47:689.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/45\">",
"      Guenther M, Wunderlich C, Madisch A, et al. Beans in the pericardium. Lancet 2009; 374:586.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/46\">",
"      Koyuncu N, Yilmaz S, Soysal S. An unusual cause of chest pain: foreign body in the oesophagus. Emerg Med J 2007; 24:e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/47\">",
"      Jaspersen D. Drug-induced oesophageal disorders: pathogenesis, incidence, prevention and management. Drug Saf 2000; 22:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/48\">",
"      Thomas LR, Baden L, Zaleznik DF. Clinical problem-solving. Chest pain with a surprising course. N Engl J Med 1999; 341:1134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/49\">",
"      Majeski J, Durst GG Jr. Geriatric acute perforated appendicitis: atypical symptoms lead to a difficult diagnosis. South Med J 1998; 91:669.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/50\">",
"      An exploratory report of chest pain in primary care. A report from ASPN. J Am Board Fam Pract 1990; 3:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/51\">",
"      Palla A, Petruzzelli S, Donnamaria V, Giuntini C. The role of suspicion in the diagnosis of pulmonary embolism. Chest 1995; 107:21S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/52\">",
"      Yu DR, Miller R, Bray PF. Clinical problem-solving. Through thick and thin. N Engl J Med 1998; 338:1684.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/53\">",
"      Stein PD, Terrin ML, Hales CA, et al. Clinical, laboratory, roentgenographic, and electrocardiographic findings in patients with acute pulmonary embolism and no pre-existing cardiac or pulmonary disease. Chest 1991; 100:598.",
"     </a>",
"    </li>",
"    <li>",
"     PIOPED II.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/55\">",
"      Stein PD, Beemath A, Matta F, et al. Clinical characteristics of patients with acute pulmonary embolism: data from PIOPED II. Am J Med 2007; 120:871.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/56\">",
"      Stein PD, Fowler SE, Goodman LR, et al. Multidetector computed tomography for acute pulmonary embolism. N Engl J Med 2006; 354:2317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/57\">",
"      Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). The PIOPED Investigators. JAMA 1990; 263:2753.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/58\">",
"      Marrie TJ. Community-acquired pneumonia. Clin Infect Dis 1994; 18:501.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/59\">",
"      Edmondstone WM. Chest pain and non-respiratory symptoms in acute asthma. Postgrad Med J 2000; 76:413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/60\">",
"      Rizkallah J, Man SF, Sin DD. Prevalence of pulmonary embolism in acute exacerbations of COPD: a systematic review and metaanalysis. Chest 2009; 135:786.",
"     </a>",
"    </li>",
"    <li>",
"     Moore KL. Clinically oriented anatomy, Williams and Wilkins, Baltimore 1985. p.146.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/62\">",
"      Sadikot RT, Greene T, Meadows K, Arnold AG. Recurrence of primary spontaneous pneumothorax. Thorax 1997; 52:805.",
"     </a>",
"    </li>",
"    <li>",
"     Advanced Trauma Life Support Course for Physicians. Committee on Trauma, American College of Surgeons, Chicago 1993. p.143.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/64\">",
"      Gaissert HA, Piyavisetpat N, Mark EJ. Case records of the Massachusetts General Hospital. Case 14-2009. A 36-year-old man with chest pain, dysphagia, and pleural and mediastinal calcifications. N Engl J Med 2009; 360:1886.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/65\">",
"      Caceres M, Ali SZ, Braud R, et al. Spontaneous pneumomediastinum: a comparative study and review of the literature. Ann Thorac Surg 2008; 86:962.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/66\">",
"      Alpha-1-antitrypsin deficiency. Usage of alpha-1-proteinase inhibitor concentrate in replacement therapy. A symposium. November 1, 1986, San Diego, California. Proceedings. Am J Med 1988; 84:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/67\">",
"      Eifert GH, Hodson SE, Tracey DR, et al. Heart-focused anxiety, illness beliefs, and behavioral impairment: comparing healthy heart-anxious patients with cardiac and surgical inpatients. J Behav Med 1996; 19:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/68\">",
"      Katon W. Panic disorder and somatization. Review of 55 cases. Am J Med 1984; 77:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/69\">",
"      Wulsin LR, Yingling K. Psychiatric aspects of chest pain in the emergency department. Med Clin North Am 1991; 75:1175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/70\">",
"      Fleet RP, Dupuis G, Marchand A, et al. Panic disorder, chest pain and coronary artery disease: literature review. Can J Cardiol 1994; 10:827.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/71\">",
"      Bass C, Chambers JB, Kiff P, et al. Panic anxiety and hyperventilation in patients with chest pain: a controlled study. Q J Med 1988; 69:949.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/72\">",
"      Evans DW, Lum LC. Hyperventilation: An important cause of pseudoangina. Lancet 1977; 1:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/73\">",
"      Lipsitz JD, Hsu DT, Apfel HD, et al. Psychiatric disorders in youth with medically unexplained chest pain versus innocent heart murmur. J Pediatr 2012; 160:320.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/74\">",
"      Worthington JJ 3rd, Pollack MH, Otto MW, et al. Panic disorder in emergency ward patients with chest pain. J Nerv Ment Dis 1997; 185:274.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/75\">",
"      Lantinga LJ, Sprafkin RP, McCroskery JH, et al. One-year psychosocial follow-up of patients with chest pain and angiographically normal coronary arteries. Am J Cardiol 1988; 62:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/76\">",
"      Lynch P, Galbraith KM. Panic in the emergency room. Can J Psychiatry 2003; 48:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/77\">",
"      Ben Freedman S, Tennant CC. Panic disorder and coronary artery spasm. Med J Aust 1998; 168:376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/0/26634/abstract/78\">",
"      Mehta NJ, Khan IA. Cardiac Munchausen syndrome. Chest 2002; 122:1649.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6834 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-61.234.146.186-FF084CEA57-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_0_26634=[""].join("\n");
var outline_f26_0_26634=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H40\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CHEST WALL PAIN",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Musculoskeletal pain",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Isolated musculoskeletal chest pain syndromes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Rheumatic diseases",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Non-rheumatic systemic diseases",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Skin and sensory nerves",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      CARDIOVASCULAR CAUSES OF CHEST PAIN",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H697452766\">",
"      Ischemic chest pain syndromes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Coronary artery disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H697452846\">",
"      - Other ischemic chest pain conditions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H697452914\">",
"      - Coronary vasospasm",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H697453026\">",
"      - Cardiac syndrome X",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Valvular heart disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H697453258\">",
"      Nonischemic cardiac chest pain syndromes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Pericarditis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Myocarditis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H697453628\">",
"      - Acute aortic syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H697453853\">",
"      CHEST PAIN DUE TO HYPERADRENERGIC STATES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5953147\">",
"      Stress-induced cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H697453862\">",
"      Cocaine intoxication",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H697453915\">",
"      Methamphetamine intoxication",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Pheochromocytoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      GASTROINTESTINAL CAUSES OF CHEST PAIN",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Gastroesophageal reflux disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Esophageal hypersensitivity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Abnormal motility patterns and achalasia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Esophageal rupture, perforation, and foreign bodies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Other causes of esophagitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Other gastrointestinal causes of chest pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      PULMONARY CAUSES OF CHEST PAIN",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Pulmonary vasculature",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      - Acute pulmonary embolism",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      - Pulmonary hypertension and cor pulmonale",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Lung parenchyma",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      - Pneumonia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      - Cancer",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      - Sarcoidosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H697454380\">",
"      Asthma and COPD",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      Pleura and pleural space",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      - Pneumothorax",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      - Pleuritis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H35\">",
"      - Pleural effusion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H36\">",
"      MEDIASTINAL CAUSES OF CHEST PAIN",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H37\">",
"      PSYCHOGENIC/PSYCHOSOMATIC CAUSES OF CHEST PAIN",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H38\">",
"      PAIN REFERRED TO THE CHEST",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H40\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PC/6834\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/6834|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?15/27/15806\" title=\"diagnostic image 1\">",
"      Aortic dissection PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?8/46/8928\" title=\"diagnostic image 2\">",
"      Pneumothorax PA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/6834|MOV\">",
"      <a href=\"#\" title=\"MOVIES\">",
"       MOVIES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?20/22/20832\" title=\"movie 1\">",
"      Phonocardiogram calcific AS at 2nd right intercostal space",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?39/27/40368\" title=\"movie 2\">",
"      AR as heard at the second right intercostal space",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/6834|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?38/32/39437\" title=\"table 1\">",
"      Differential diagnosis of chest pain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?40/49/41755\" title=\"table 2\">",
"      History in musculoskeletal CP",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?41/37/42587\" title=\"table 3\">",
"      Isolated chest pain syndromes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?12/57/13211\" title=\"table 4\">",
"      Systemic causes MS chest pain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?14/52/15179\" title=\"table 5\">",
"      Definitions angina CASS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?20/15/20733\" title=\"table 6\">",
"      Card synd X variant angina",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?8/55/9083\" title=\"table 7\">",
"      Features esophageal chest pain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?1/6/1132\" title=\"table 8\">",
"      Causes of venous thrombosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?8/44/8907\" title=\"table 9\">",
"      Causes of pleuritic chest pain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?37/9/38044\" title=\"table 10\">",
"      Dx criteria panic disorder",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/62/22504?source=related_link\">",
"      AIDS-related cytomegalovirus gastrointestinal disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/37/26202?source=related_link\">",
"      Auscultation of cardiac murmurs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/56/22410?source=related_link\">",
"      Auscultation of heart sounds",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/58/29606?source=related_link\">",
"      Boerhaave's syndrome: Effort rupture of the esophagus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/19/17722?source=related_link\">",
"      Cardiac sarcoidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/42/5802?source=related_link\">",
"      Cardiac syndrome X: Angina pectoris with normal coronary arteries",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/25/19864?source=related_link\">",
"      Cardiac syndrome X: Angina pectoris with normal coronary arteries: Pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/56/15240?source=related_link\">",
"      Chest pain of esophageal origin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/53/28505?source=related_link\">",
"      Classification of unstable angina and non-ST elevation myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/7/9335?source=related_link\">",
"      Clinical evaluation of musculoskeletal chest pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/9/41113?source=related_link\">",
"      Clinical features and diagnosis of coronary heart disease in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/12/21706?source=related_link\">",
"      Clinical features and evaluation of aortic stenosis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/63/9206?source=related_link\">",
"      Clinical features of the carcinoid syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/19/25914?source=related_link\">",
"      Clinical manifestations and diagnosis of aortic dissection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/41/22168?source=related_link\">",
"      Clinical manifestations and diagnosis of gastroesophageal reflux in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/16/26889?source=related_link\">",
"      Clinical manifestations and diagnosis of myocarditis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/62/39910?source=related_link\">",
"      Clinical manifestations and diagnosis of pulmonic stenosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/25/21914?source=related_link\">",
"      Clinical manifestations and diagnosis of sarcoidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/17/29972?source=related_link\">",
"      Clinical manifestations of oropharyngeal and esophageal candidiasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/14/23786?source=related_link\">",
"      Clinical presentation and diagnosis of pheochromocytoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/47/37625?source=related_link\">",
"      Clinical presentation and diagnostic evaluation of acute pericarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/30/23018?source=related_link\">",
"      Cocaine: Acute intoxication",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/57/10137?source=related_link\">",
"      Complications of endoscopic esophageal stricture dilation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/56/14218?source=related_link\">",
"      Congenital and pediatric coronary artery abnormalities",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/57/6042?source=related_link\">",
"      Diagnosis of acute pulmonary embolism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/15/34042?source=related_link\">",
"      Diagnostic approach to chest pain in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/26/26026?source=related_link\">",
"      Diagnostic approach to community-acquired pneumonia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/7/16505?source=related_link\">",
"      Diagnostic evaluation of a pleural effusion in adults: Initial testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/50/13096?source=related_link\">",
"      Diffuse esophageal spasm, nutcracker esophagus, and hypertensive lower esophageal sphincter",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/32/28168?source=related_link\">",
"      Drug-induced lupus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/39/20090?source=related_link\">",
"      Evaluation of chest pain in the emergency department",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/24/31111?source=related_link\">",
"      Evaluation of mediastinal masses",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/21/7512?source=related_link\">",
"      Factitious disorder and Munchausen syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/42/20137?source=related_link\">",
"      Gastrointestinal toxicity of radiation therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/22/7527?source=related_link\">",
"      Hiatus hernia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/54/21353?source=related_link\">",
"      Ingested foreign bodies and food impactions in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/9/2201?source=related_link\">",
"      Major causes of musculoskeletal chest pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/13/37078?source=related_link\">",
"      Medication-induced esophagitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/22/4456?source=related_link\">",
"      Overview of acute pulmonary embolism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/21/26969?source=related_link\">",
"      Overview of lung disease associated with rheumatoid arthritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/47/19193?source=related_link\">",
"      Overview of pulmonary hypertension in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/48/43786?source=related_link\">",
"      Overview of the causes of venous thrombosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/57/16282?source=related_link\">",
"      Overview of the risk factors, pathology, and clinical manifestations of lung cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/42/44713?source=related_link\">",
"      Panic disorder: Epidemiology, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/45/32474?source=related_link\">",
"      Pathogenesis, clinical manifestations, and diagnosis of eosinophilic esophagitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/50/15144?source=related_link\">",
"      Pathophysiology and clinical presentation of ischemic chest pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/18/13610?source=related_link\">",
"      Pathophysiology, clinical features, and evaluation of mitral stenosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?42/9/43157?source=related_link\">",
"      Patient information: Chest pain (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?20/34/21027?source=related_link\">",
"      Patient information: Chest pain (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?33/27/34225?source=related_link\">",
"      Patient information: Costochondritis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?4/45/4819?source=related_link\">",
"      Patient information: Pleuritic chest pain (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/6/21608?source=related_link\">",
"      Postherpetic neuralgia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/48/1800?source=related_link\">",
"      Postoperative mediastinitis after cardiac surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/3/10297?source=related_link\">",
"      Primary spontaneous pneumothorax in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/60/11210?source=related_link\">",
"      Pulmonary manifestations of systemic lupus erythematosus in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/35/24121?source=related_link\">",
"      Secondary spontaneous pneumothorax in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/1/30745?source=related_link\">",
"      Stress-induced (takotsubo) cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/39/3706?source=related_link\">",
"      Variant angina",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f26_0_26635="Terminology of preexcitation pathways";
var content_f26_0_26635=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F53343&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F53343&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Terminology and anatomic connections of preexcitation pathways",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Old terminology",
"       </td>",
"       <td class=\"subtitle1\">",
"        Proposed or commonly used terminology",
"       </td>",
"       <td class=\"subtitle1\">",
"        Anatomic connections",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Kent bundle*",
"       </td>",
"       <td>",
"        Accessory atrioventricular (AV) connection or AV bypass tract",
"       </td>",
"       <td>",
"        Atrium to ventricle",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        James fiber&bull;",
"       </td>",
"       <td>",
"        Atrionodal bypass tract",
"       </td>",
"       <td>",
"        Atrium to low AV node",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Atriofascicular bypass tract",
"       </td>",
"       <td>",
"        Atrium to bundle of His",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"4\">",
"        Mahaim fiber",
"       </td>",
"       <td>",
"        Atriofascicular bypass tract",
"       </td>",
"       <td>",
"        Atrium to bundle branch",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nodofascicular bypass tract",
"       </td>",
"       <td>",
"        AV node to bundle branch",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nodoventricular bypass tract",
"       </td>",
"       <td>",
"        AV node to ventricular tissue",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fasciculoventricular bypass tract",
"       </td>",
"       <td>",
"        Bundle branch to ventricular tissue",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * These bypass tracts result in delta waves and the Wolff-Parkinson-White syndrome.",
"     <br>",
"      &bull; These bypass tracts result in the Lown-Ganong-Levine syndrome and enhanced AV nodal conduction.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_0_26635=[""].join("\n");
var outline_f26_0_26635=null;
var title_f26_0_26636="Eosinophil associated diseases";
var content_f26_0_26636=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F76434&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F76434&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Eosinophil-associated diseases and disorders",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\" class=\"container\">",
"     <tbody>",
"      <tr>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Allergic diseases",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Atopic and related diseases",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Medication-related eosinophilias",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Infectious diseases",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Parasitic infections, mostly with Helminths",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Specific fungal infections",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Other infections (infrequent)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Hematologic and neoplastic disorders",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Hypereosinophilic syndrome",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Leukemia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Lymphomas",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Tumor-associated",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Mastocytosis",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Diseases with specific organ involvement",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Skin and subcutaneous diseases",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Pulmonary diseases",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Gastrointestinal diseases",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Neurologic diseases",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Rheumatologic diseases",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Cardiac diseases",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Renal diseases",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Immunologic reactions",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Specific immune deficiency diseases",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Transplant rejection",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Endocrine",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Hypoadrenalism",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_0_26636=[""].join("\n");
var outline_f26_0_26636=null;
var title_f26_0_26637="Quinolone MICs versus GNR II";
var content_f26_0_26637=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F75299&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F75299&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Activity of quinolones against selected gram-negative and other pathogens in vitro-II",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\" rowspan=\"2\">",
"       Organism",
"      </td>",
"      <td class=\"subtitle1\" colspan=\"6\">",
"       Representative MIC",
"       <sub>",
"        90",
"       </sub>",
"       (range), mcg/mL",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2\">",
"       Ciprofloxacin",
"      </td>",
"      <td class=\"subtitle2\">",
"       Norfloxacin",
"      </td>",
"      <td class=\"subtitle2\">",
"       Ofloxacin",
"      </td>",
"      <td class=\"subtitle2\">",
"       Levofloxacin",
"      </td>",
"      <td class=\"subtitle2\">",
"       Moxifloxacin",
"      </td>",
"      <td class=\"subtitle2\">",
"       Gemifloxacin",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Moraxella catarrhalis",
"      </td>",
"      <td>",
"       (0.03-0.25)",
"      </td>",
"      <td>",
"       0.4",
"      </td>",
"      <td>",
"       (0.06-0.5)",
"      </td>",
"      <td>",
"       0.06-0.12",
"      </td>",
"      <td>",
"       0.012-0.06",
"      </td>",
"      <td>",
"       &le;0.004-0.015",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Mycoplasma pneumoniae",
"      </td>",
"      <td>",
"       (1-8)",
"      </td>",
"      <td>",
"       12",
"      </td>",
"      <td>",
"       (0.78-2)",
"      </td>",
"      <td>",
"       -",
"      </td>",
"      <td>",
"       0.06-0.12",
"      </td>",
"      <td>",
"       0.25",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Neisseria gonorrheae",
"      </td>",
"      <td>",
"       0.01",
"      </td>",
"      <td>",
"       0.06",
"      </td>",
"      <td>",
"       0.06",
"      </td>",
"      <td>",
"       0.015-0.1",
"      </td>",
"      <td>",
"       0.015",
"      </td>",
"      <td>",
"       -",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Neisseria meningitidis",
"      </td>",
"      <td>",
"       (0.008-0.12)",
"      </td>",
"      <td>",
"       0.03",
"      </td>",
"      <td>",
"       (0.06-0.4)",
"      </td>",
"      <td>",
"       -",
"      </td>",
"      <td>",
"       0.015",
"      </td>",
"      <td>",
"       0.002",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Proteus mirabilis",
"      </td>",
"      <td>",
"       <p>",
"        0.06",
"       </p>",
"       <p>",
"        (0.03-0.39)",
"       </p>",
"      </td>",
"      <td>",
"       <p>",
"        0.1",
"       </p>",
"       <p>",
"        (0.12-0.5)",
"       </p>",
"      </td>",
"      <td>",
"       <p>",
"        0.5",
"       </p>",
"       <p>",
"        (0.12-1)",
"       </p>",
"      </td>",
"      <td>",
"       0.06-0.25",
"      </td>",
"      <td>",
"       0.25-2",
"      </td>",
"      <td>",
"       0.12-0.5",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Providencia rettgeri",
"      </td>",
"      <td>",
"       <p>",
"        1.0",
"       </p>",
"       <p>",
"        (0.03-2)",
"       </p>",
"      </td>",
"      <td>",
"       <p>",
"        2",
"       </p>",
"       <p>",
"        (0.25-3.1)",
"       </p>",
"      </td>",
"      <td>",
"       <p>",
"        1",
"       </p>",
"       <p>",
"        (0.5-8)",
"       </p>",
"      </td>",
"      <td>",
"       0.5-3.1",
"      </td>",
"      <td>",
"       -",
"      </td>",
"      <td>",
"       -",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Providencia stuartii",
"      </td>",
"      <td>",
"       <p>",
"        0.5",
"       </p>",
"       <p>",
"        (0.125-2)",
"       </p>",
"      </td>",
"      <td>",
"       <p>",
"        2",
"       </p>",
"       <p>",
"        (0.25-2)",
"       </p>",
"      </td>",
"      <td>",
"       <p>",
"        1",
"       </p>",
"       <p>",
"        (1-8)",
"       </p>",
"      </td>",
"      <td>",
"       0.25-1",
"      </td>",
"      <td>",
"       16",
"      </td>",
"      <td>",
"       0.25-16",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Pseudomonas aeruginosa",
"      </td>",
"      <td>",
"       <p>",
"        0.5",
"       </p>",
"       <p>",
"        (0.25-8)",
"       </p>",
"      </td>",
"      <td>",
"       <p>",
"        2",
"       </p>",
"       <p>",
"        (2-16)",
"       </p>",
"      </td>",
"      <td>",
"       <p>",
"        2",
"       </p>",
"       <p>",
"        (2 - &gt;50)",
"       </p>",
"      </td>",
"      <td>",
"       2-50",
"      </td>",
"      <td>",
"       8 - &ge;32",
"      </td>",
"      <td>",
"       4-8",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Salmonella spp",
"      </td>",
"      <td>",
"       0.06",
"      </td>",
"      <td>",
"       <p>",
"        0.06",
"       </p>",
"       <p>",
"        (0.06-0.25)",
"       </p>",
"      </td>",
"      <td>",
"       0.12-0.25",
"      </td>",
"      <td>",
"       0.12",
"      </td>",
"      <td>",
"       0.06",
"      </td>",
"      <td>",
"       0.015-0.125",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Serratia marcescens",
"      </td>",
"      <td>",
"       <p>",
"        0.25",
"       </p>",
"       <p>",
"        (0.06-12.5)",
"       </p>",
"      </td>",
"      <td>",
"       <p>",
"        1",
"       </p>",
"       <p>",
"        (0.25-50)",
"       </p>",
"      </td>",
"      <td>",
"       <p>",
"        1",
"       </p>",
"       <p>",
"        (0.5-25)",
"       </p>",
"      </td>",
"      <td>",
"       0.12-12.5",
"      </td>",
"      <td>",
"       2-4",
"      </td>",
"      <td>",
"       1-2",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Stenotrophomonas maltophilia",
"      </td>",
"      <td>",
"       <p>",
"        2",
"       </p>",
"       <p>",
"        (2-25)",
"       </p>",
"      </td>",
"      <td>",
"       <p>",
"        4",
"       </p>",
"       <p>",
"        (4 - &gt;64)",
"       </p>",
"      </td>",
"      <td>",
"       <p>",
"        3.1",
"       </p>",
"       <p>",
"        (3 - &gt;25)",
"       </p>",
"      </td>",
"      <td>",
"       2-25",
"      </td>",
"      <td>",
"       1-4",
"      </td>",
"      <td>",
"       4",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     MIC",
"     <sub>",
"      90",
"     </sub>",
"     : minimal inhibitory concentration for 90 percent of strains.",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Eliopoulos, GM, Eliopoulos, CT. Activity in vitro of the quinolones. In: Quinolone antimicrobial agents (2nd ed), Hooper, DC, Wolfson, JS (Eds), American Society for Microbiology, Washington, DC, 1993, p. 161, and Wolfson, JS, Hooper, DC, Clin Microbiol Rev 1989; 2:378. Perry, CM, Barman Balfour, JA, Lamb, HM. Drugs 1999; 58:683. Barman Balfour, JA, Wiseman, LR. Drugs 1999; 57:363. Blondeau, JM. J Antimicrob Chemother 1999; 43(SupplB):1.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_0_26637=[""].join("\n");
var outline_f26_0_26637=null;
var title_f26_0_26638="Impedance-pH monitoring and laparoscopic Nissen fundoplication";
var content_f26_0_26638=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F60423&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F60423&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 646px\">",
"   <div class=\"ttl\">",
"    Impedance-pH monitoring before and after laparoscopic Nissen fundoplication",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 626px; height: 304px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     Pre-OP: pre-operation; Post-OP: post-operation.",
"    </div>",
"    <div class=\"reference\">",
"     Data from: del Genio G, Tolone S, del Genio F, et al. Total fundoplication controls acid and nonacid reflux: Evaluation by pre- and postoperative 24-h pH-multichannel intraluminal impedance. Surg Endosc 2008; 22:2518.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_0_26638=[""].join("\n");
var outline_f26_0_26638=null;
var title_f26_0_26639="Hand arthritis in HH";
var content_f26_0_26639=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F78740&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F78740&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Hand arthritis in hemochromatosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 233px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCADpAbADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD581TUbhWC+Y3Tjms1tTuBwZGx9adq5/egc9O9ZZ5OBQBfbU5yP9a35006ncH/AJaH86z6SgDRbU5+AJW/Ok/tS56ea351n0UAaR1S5KgGZwB2zR/ac5b/AFjfnWbT05fnpQB0+m39wTxMwH1r2T4bq4ia6k/1gwoNeK6JHukXAyc19E+E7FYdHt9g4IDH3NNAbrXEjsCx7068vWMe0HGO1PMBfbgAVDcWTHGBk0xFI3MjR7C3HWtKymdFj6/LzVEWciEfKcGtSC3cDlTQBwvxOtHbUU1GLJhmUB/Zq8y1QSI6OjNzXu2sW4lhlt5U3RyDpXlGs6bsLxH+FuDSYHMSR3O0MHYZ96taRb3c1xGilmLtgD1rUit1MW0dK6vwXpoNw0xAJjGF9jRYZ1+jxjRvD6WaHLuN0jerHrTIp32HGR6Gkc7yRSpEQCNvBpiC3mYS9e+a0/MaQqSfcCs+GMgkY/GrGGUgqMgUAN8etJL4Ui25JjlXdjsOa8iujIZeuOK9f1P/AEjTZreTlZFwfrXlM8LiYg8YJFDAoxg7xnrXSeH1czRqucsQMVkiIYAxz612HgSwMuqxseVjG7/CkM9A8UlrP4W69CDgrp0pz/wA18Xy3T7z856+tfZvxAOPh54iH/UPm/8AQDXxZdTbyq7FXYNuQOv1oYDxePyNxrs9Ru5YtN06fzSPtMWT+n+NcBXXXTGXw7pAxyoYZ9s0gOv8LakNih5C2OD9K5rxVE9hqsmzPlS/vEOfXqKs6R5lvZO427c4+lN1WY6jbmGYDenKNjmgDmnu37mq0104UjdxSSqUdkbgjiqs2aAF+0yHjNI0z5xnp6VDS44zQBMLh/Wu0+HttLLdfbD91TtUnv61wles+CbNY9JtWJKoy7sepoA6i/u3jMUaMCoIY/Wob69M52A9uo/lU3kJcR4G3cD1zT4tHmlePyx97qfSmIzFjlmsTDj5N27cOua6jw6hs5baRgd0YDEqat2uiGK2RduWzjp1rbi0p1iXCYHrimB4z8edM2a5Frdnk294Ash/uuBj+WK8p8xu5r6p8QeH01XRbnTbqPdDIMg91YdDXy9qllJp2o3FpN9+Fyh/A0mMrb29aC7Z6mm0+FDJIqDucUgOx8CPFaR3N5MSZuETI+6D1Iqvrpf+1jgkgc81Yu1Sz0i3SAEvMoLVoW2kTXtss8SKSAAxbrQBzV3K/lqSDk9TV/QJCt8gfJQdq173w9cvEo2gFcZOK19K8LSGRcqw6ZbHFAHZ+BZPsjybMYlUpj0zXh3iy3ksPEWo28i7cTuRz2JJH6V7TZBrDd1DDgV5j8UVaXVYronO9dpx7UwOOEnvU1sDNOsY6scVUHWug8G2D32roFQsE5NIClqzbpgW6461nSgg/wBauasf3w9MVQZye9ADaWj60lABS0lFABTlOGzTaUdaAOn8NkvcIo6ZFfTfggF/DlsWAY7f5V8zeFk/0hTnpzXtvgzX59PgFsxVrcnIyOR6800B6JEjbzlcVoQ2DyYIUgetULDXLJYvOnCt6IDkmtAX1/fgFAlnCeijlsUxFmDSGaTcWGB2ptxBLGPlTNNhs3Y58+fP+/irL210ir9nuWP+y4zmgDGubYGEySDGK8q1i3ZrucEZy5Nep6pqjIj21/D5bY+8Ohrzq/IluGYDj1oA5tYMAjGMGu68Bw+ZDdoMeaMED1FcsYf33f1xW14fumsb1ZAcKeGoA6aS3C3BXGCKtQQNkrjdmpYpoblg5YBu5q9Hc28eBGhc+p6UAUhZtu5XkdKbPauh+71rTF65Pyov86V70Kv+kQHb6rzQBhTQ5BypCgZNeW6i225lwMrvJ/WvYNUaM6ZcSWsqk7eAeDXlF5bE7yRyeaGBXsF824UY4zXqfhexXTrUlhmWTr7D0rh/Clj52oxKy5A+Y/QV6PFhVAXtQBW8dsT4B8RqD10+b/0E18WyHc7EetfZ/jQE+BdeP/TjLj/vk18XkEEg9aTBCV32kaelzY2aEkmNASB2rg48eYu4ZGRmvZfB1jLf2Mb20R5UD7vWkMBpi/2fLGBxgEhRXJXyCO/ZQWXH3c+lez2uj3FnE3mRjeRySK898ZWTxu7SIhCjOcYIpsDgfEASK6SSI4LL831rBdtxq3qU7TOOu1emao0gCiiigAr2bwPuk8LWasoIUEg14zXU+FfF9zoqC3lQXFmCSEJwVz6H0oA9RsUc3WxFPzNjFexeG/DAFkj3eVYjOK8e8NePPDtiBqF3DvuM/u4w2Qp9xXomheLJPEUAurqRobUn93EnBYetMR2Y0u1DFPNjDDoMjIrQ/s+JoRGCOlYEd/AHQRw4jI/GrFvdzLK3lPxjjNMCS80p4lYgAxntXyx8bPDp0vxK99bkNaXPoPuN3Br6ZvrW9vraUw6lcWtx1zG3B9iPSvGfiNpt7fWE1pfvGZlyVlxwT2pMDwSrujJBLqlrHdPsheQKzk4C5PU+1VZUaKRkcYZTg0ykM9e8YaI+mraxyIxijTajgZyOOa1PD9uZ7bEKHlQeOAfeud8N+M47vRo7PXbjcYF8tS3JZe3Nel+E9V0WxtUa2hFy7fdBbC/jTAt2Hh+5uRnA6DjGa6mz8HXYh3OQcjoKS01uZ0EoRII89FGavT63qcCLLakkHn51yDTEc5qXhS4RmDKevBx1ryH4yaQdPs9PfbhWdkI98V9D2fjC+mZY7nSoph/eR8Efhj+teOftF6jZ30NglsWSVHLPEVIxkfr+FJgeCdDjHNekfD+AaZYS3U2RNMRtHoB0rh9KsZb7UIooV3MTnFekXSSwWSopHnqOuOBSGeZ6r/rR9KoGr+q/64fSqBGKAEooooAKKKKACnJjeM9M02nJ94UAdX4dzvTyxkk16VpSkAf5xXCeDYcsGIHSvS9OgzgkU0B1vg+xFzeb5OVQbgPU13cBIB46VjeDLIxwBsfMRzXRvH5YYA8daYhnnPtO3II9KsWcrNN83IArOLlW3DgGrMEoRwScg+lAFbxVHHNpsrOoLLyDXml1H8xIFer61bC5sG2Hkjp615leRmMsCOQcEUAYwjKyHPerNsCRimyN8wOMVYtV3kY6scUAbGjRM5DSE7M4A9a6iKBRghax9MiAZFHGOK6YBUjWgCnEjCUADGTWpJbq0fI5x0qpA6vIe2D3rQY/Lz1oA4jxXGsbDZlWxzjvXIzBWB4Fdv4phLyM3tXFyJg9aANvwYUFzNGRh2T5W9MV0yI4cAetcZpbNbzLKh5FdhY36yEbYWdvbpQBL4thLeC9aUr96ykGP+A18ST/AOuf/eNfcXiF3l8KasGi25tZBjOe1fD90MXMo9HP86TBDEyGGOTnivfvhxZ6pLbRXGoavJaW0a/8e8EaqHyO7HJrwBSVYEdQc17R4S1l7nTocOBhQCvahDPVBfOkbFmM69Mt1xXBeI3jvrmQum2MDoe9b2l3gMWXPFYPjwR2qJMjcyKQFFMR474kgRJnaLhQxGKwa39eKhTuJy3Qe9YFSMKKKKACiiigB8WfNTb97IxX094XhiGn201vGUQxAbD2r5y8PQh9Tgd8bUYNz619KeD8z6Yj7flQYOKaEzo9NiEk4LsflGfpWvI0QUFXAI6mueaUJEXRiCOg9aqrdmWVckt680wO00yaOVGjJO45rzb4swfYLBJJFJG4gH19K7PTb3y7mN8ZA4ORTfiZaW2raJJDOm5HXKsOqn1FAHxxqpzfytjGTmqdaviOwm07UXgnVs5JViPvD1rKqRiqCSAOpr2H4d2iQ2MPmHfnnJ7GvKdOt2mlGBwO9ev/AA9jk2iKQEx/wnHFNAeo2qsYUCJujrpNNYSwssgwAPlB7Vj2LrHDGhUnB7VpIzrOoIAUimIsWyLDdhlUYA3fWvKPiutnqscqToF+YmNu6mvY7aMNBcM2NyrxXkXjLSDL5rHluQCeQKAOB+EGkw3fiW7tXkjF0Iv3IY8Ngndj9K7DUNJube+x5JLq3PGRXmFhJPpeuR3duzJPby7gV68HmvpnwhrGhatcWV7eOPKbDMjevcY70kB8hauMTKfUVQrU1pB5qgelZdIYlFOYYx702gBc8UlFFABTo/vim1JDy4FAHofgxC0We3TNepaBEGmQPyo5NeceCgq2q9Mk816Z4cBMrM/3QvFNCZ6p4Yh32zsoxgYBqzcoc7RnFJo8ixaNF5XVucim3FwEHP4mmBA6KoHzDHf2oZNoG3p61UmnaRjgACpbWf8AhflaAL8DM1tICa4PxMqi4BUAE9a9DslXynx0rzzxCc6pKvYGgDBlhJ24q5pyYkJPbpQy7VyaW0fcXx1oA6fSUMkw2kEd613lMakZ4rL0N8WjFfvDqankkbIzz7UAWIpQH3dzWiHLLmsdJkzyCCKv28ynABoAoa4itljnGMVw9/bmOXP8J6V3epOrhsYxXI6qSXVcdKAItOhEkig9O9dzZQpGiqgAHtXJ6TEzOgA+8a7ZFWMKo7UAR68m7w7qQ/6dn/lXwvdnN1MfVz/OvuvVyG0S/A7wOP0r4Tuhi6mH+2f50mCIq9C+H+77Azj5gGxj0rz2vTfgoxu7+705iCrgOq4796QztYpWjWNT8oyKg8Yb7uaOIgBVXKn1qfU2+zXixEAFHIIqLULlLmdTIvG0AYpiPKPGln5F3GFIx5e79a5mu/8Aihboy2d1CDgZjb+YrgKQwooooAKKKKANDSS32hFTglutfVXw5tXh8LWhmwd67gfUV8taEyx3sMjLuVWBKnvX1dYzK/hqzubGQG3KgLgdOKaEJrMkMasUIGDk+lZOk3luhfKDDHAJ9aztWmkMj7gWU/pWQC8aK7MBGD680wO5vJXjjR48kHglauazLJLoluHJUPnmsvSdZt5LZbeYLj+9mtLxBeQTaVFDbY3Iw4oA+b/inciTVbeAcmFD+p6fpXEV13xQUDxfcheyrn61yoTgdyakZ1/hq0i/cb9o3AZB7mvdvAnh9pIg2MW5GcivE9Ktt4skOM7QzAHpivffCOqCDRCIxtPcdqaEac2nzW0mVJaMH5SKfBueZS7EHNZ194lmjgKBEOeKt6fdfbrVQgAkHORTA6Wyl3W8yPjaV6jrXC+JIIyGIbgjiupgRrezcysPMbjr2riNZuj5rLwSCRzQB5Zr+jvb6qJAMxTn5T7+lerfCXQooLqEnYs5YMJJPmEfpgVxt2/2jU7S2kG4R7pcen+c17J8JrdJtShYAjawORSA+QNcj2zgH+7WI4w1dR4hTc4KjkLzXNzLikMhooooAKKKKACprYfvQahqW3J81cUAejeEtwQH2r0rQJyu3PQjBFec+F8i1AHJrutMlO0YHzDtTQHr/gu5E9u9qx46qKtXcTiVlce3NcBo2pPaXEU0ZIKkE4PavT7t1miSYchlzxTEYLR4OBSgAcdDVkx7snoKhZDv5oA1NLbKgZ4xXDeIY8azcfWu50xcMuO9cn4sgMeru394A0Ac9OSE6VVt38ly3XIxVuccc1RfIbpQB2fheWK5hlRD+8A+YVJJlJCK57wpcm21uIEnbJ8h989K67UrcCYnseaAKXAGW60qz7E4HIqtJuD7RzRMSkQNADw7Skk/dA5rlrm4WW4c54zgV1AONNnkHHynmuFViHJ9TQB23hvYEeU4JVeB6VqrOSck5Fcx4TuQ121sT99TitwIUYrk5BoA0LuUSabdLnrEw/Svh294vJ/+ujfzr7YYMbWcA9UP8q+J73/j8uP+ujfzpMEQV2fwhvPsnj3TvmIWUtG3uME/0rjK0/DN19i8RaZcb9gjuIyzeg3DP6ZpDPoH4iWAttXeZF+WUB81y0SyPlh0Uda7v4kXCPbWso5WSMGvOm1OKNzEOMimBV8R2TX+gXca/NJGPMUepFeUV63e3y28W5Ocjp615lq8IivHZBiOQllHp7UgKNFFFABRRRQBZspvKkGTgZzX0f8ABrxPpus2kvh/c0c4i3rvHBI4OPfkV8z1u+DNbl0DxHYX8bbVilUuevyZw36ZoA981mG5tLmeK54APB9awb2N5EyikcZ9q9E8WwrfW8d3EA0cwDE/UZFYCW/7nYV5HGfWqEc5YmcBcZO3rXTWP71B79QeoqnaWwWTAXGDyK6XS9NWWddoxmgD51+KkHk+MLjOcMitXMKNuCO3NenfHDSvJ8VwEAfNDycemP8AGvPZbYoucjFSM1bXxELNQywh2ON2a95+H1xba94We9tASApVo+6sPWvmSRScivYP2aNYMGvX2kSn9zdR71H+0P8A61NAbGs3EsbHnGDUOh+JbmzvCgcBR6966TxfoZSW6GeVJK8da810zykuJDcMBKCV256UCPTZPEkl0pAbqO3eo7W2a9md2Hy7c1yFnON0Wxtwzg4r0fTtlv4evbnAAVCQfwpgecaDMl14u1FyQUQCJPwzX0t8NbCHT9Mgu5QoaZsBvQZr5D8GazFY6o814rMrncWA619Y+Dr+PXfA/wBo09lZIpMKOu3vzSA+R/F2lyaVqLQSj5cfK3qK4q9jKsT0BOa+i/GPh6PxBpx2AC7jBMbf0rwTVrOW0nkguEZZEJDBuxoYzBoqWRMZwKipAFKaSigAqxZgmYYGar1d04YmU+/WgD0vw4ALZeBk8V19kwjKmuP8Os8kKjHfiu306BVxv5IpgalupPOMV6X4Suhd6OIHP7yL5fw7V57ARxxxXS+F737Leqp/1chwaYjqHxv2/pUckRHIIOau3sA3hh0boaiQdjQBJYHa6isTxrCRexvjhkxW5Adsi46Zqr41h3WMUo/hOPzoA88uBjp1qg/LYPWtO4QEVRZADzQAtqxinjlU/MhDCvR5iJ7KGZTkEA15uh7V3egzfaNEQDqny/lQBUvFCncKoOxkIFak3zBgRWYgIlH1oAsXA26JcA/3TXERjpmu71MbNDuG/wBmuHjHFAF7RZPs+s2j9Bvwa7q9i/ebl79a8+tzi7hI6hhXpRw8YJHUUAUQpMMgPdT/ACr4jvv+P24/66N/OvuZY8I+R2PFfDF5/wAfc/8Avt/OkwRDRRRSGfQ3iK9/tDwno90DhJbcEfTFeY3shKAryQcGu70Zhe/DvSwTuSOHy8emK5VLKaRpURUUdMkdabAyLmSZ7cZyTiseaD7RCyZG9eRXX/2YfLZC3zAZIxXLyQmO8G3IOeRSA588daStjxFpwtJY5oTuhlXOfRu4rJKkDnigBtFKQR1pKAFAycVctrUycHvVSMFnAUZNdRo8KllEq4k7A0AfQnwzvn1vwVb28+fPtk8ssepx3NX2swrbSvzDiuT+Fd4un6zFA5xBcDYc9j2Nesalp4FwWA+XqKoRy0emqrl1HzHqMV0Phy32zhXAxmmpEozxzWhooAugDQB5L+0LpKrq9hcjIDQHP1z/APWrw+82gFQPxr6m+O+nibRbOYKCVdkJ9iK+YNQgKyMjDODikxmMVDZx0rV8D6i+ieL9KvoyAI51D54+UnB/QmqgjChh0PpUBQkZXgg5pAfX/i6BLi3t7tQNkijn6ivn7xdYvY6rMYflRznP86948NT/ANvfDbS7oj94YVYj+6cdK4DxzpwnshJgBhx0qmI5Xw4oZYgM7V9a9Kuzs8CX3PWM1xHh6FQQGGAMDNd94hiFv8P9Rb+7EcH8KEB86W2WZQp5r6R/ZV1XzJtZ0O5YlZAtxGD64wQPwBr5y04fvlHavYf2e7l7P4n2CrkRzo8bD1OOP51IzqJXEZyjAkVw/jTQ7XW8lgIrofdkA6+xrcurhlkCgk1UuUYnzDyRVCPENX0i40+6eG4Taw5B7MPUViSKVOec17rf2lrrMRtrpMH+Fu6n2rzDxN4eudKuSky5jP3XA4IqRnKUvGOvPpUkkZU1GQR1oAStXSgpIBHzdqi07TJbzBHyr2z3rs/DPhxoJxNKocDpxQB0nhmzaO2jOwqxGTmuwtLeQkHgCqGmw4wMYOK6S0wVxVCJbOELwTmtWDgAgc9qqwpggmtFFXAIoA7bSZftumRk/fUYP1FRyLtbpVPwpPsmaFujcj61r30YBOBQBUjOOtWNaiN1o0oA525FVFPJzWpD+8tGU9CMUAeWzL7VnzqSelbWoxeTdSx+jGsyYUAUGyGFdd4KmPlzxH1yK5R0ycVu+En235TP3loA3L1SshI6d6z1GJ/r0rXvkyWrN2fvQRnFAD9dGPD1xgfw/wBa4RG4rv8AXUz4en/3f615+VwvFAEkDESo3oRXp1qwktY2HQjNeXxAhvWvSdCbzdKh9lxQBZwecnsa+FL8Yvrgf9NG/nX3cw5OfQ/yr4V1VdmqXi/3ZnH/AI8aTBFSlNJRSGezeGJ2TwppcCY2mPcR65rU+wfMpB4+nSsXwPC13o1kCcKF2LzXqWjaJ56gMGYgelMR59qFgQpwp3NxkVxmtaRcQTPLNGfLxw3Q19Mf8I0ixDy4AGx1NcR4z8IXs9uX8hjGB2xRYDzXwposWuaRepNgqvCqeucdRXC32mSQXc1vIMNE5Q/UV65pETaJYXaxpsmIJG4cBq5SPRLi+lee5kzPI5ZuOpoGcLc2u5F2rtwME1Te3dQTg8V32oaI8MmCp2duKo3GmFGVSpKvSAxNCthJlgNzV22mWqvGsjxjzBVfS9AFp+8BPJzgV0FtFtZcDFAGhpD+VNG6/KyEMPYivoPTZ11TRYLkcsyc/XvXz0N0bhgOe9ev/CvUhPp01oxO5DuAPoaYjVuE2fnUdmxju0I7nmruogFiuMEGqcHyzKAOfWmBa+JFoL7whccZKASflXyx4isjHM8oAKY5+tfYN5CLnQ5Ym5DRkV8z+JtPw1xAwwQxBNIDy9wQwZuh4prRgNkDrV66iwxUfwnFQbeMnr2pDPo74AXJuvA0lnIcmGRgM+h6D9KTxBbKwuYivAPArE/Z9naOS/t8/K2GArs9ftgt6+R8rZzVIRwelWIDOMEHOcV1fjpPL+F13jqY8fzqpp9qBM4A6Z5rc8f2vmfDK7Cg/wCrzQB8xWI2yk+lej/CO4kXxvp8kbFZFJCkdc153EjRS/Nx2PFd14AnFl4o0ufpsmRi3tmpGdncQfOylfmxkComt2xh811mq2KC5LRcn0FU2sy68gZqhHE3UQSbeBnniriWltrFs1nfKrKwwM9QfauhOhu+ZJE2qOR71lvZyLdMVXbigDxvxh4Tn0S7MbjdAxPlyDv7H3rl1tHadYyOpr2jx7A9/wDZIVbhSdwPauf07wyv2yMsTxzgikMr6NpqxxxZX5sCu00i1AQZSoYtM+zyDOCPaugsYFCD1oQizaW6Efd5q9DbDPy8UtvHheBxV1FUEY4pgMSNh0NWVJUDPalwCc5pjHPyg4PrQBf066MN1HIDjB5rurgCWFXXnIrzyNFPXtXd6NKLjSk5yVGDQBTC/Mc1pWJ6rxVKQYJqxZP849TSA47xVbmLVpOOHAYVz0qZzXceN4OIJh/uk1x5GR9aYGZIhBBrQ8PsU1KM+pxUckeR0ptixjvoj/tigDubpN3T0rN2gHmth/mhBHpWXL94/WgCTVE83RJ1H9yvOGHzYr0yf5tNmX/YNebOPmPXrQAsa9DXoXhvjS48+leexnJxXoPhjH9lpnmgC+R1+hr4Z19duuagPSd//QjX3U68HHpXw34pXZ4k1NfS4f8AnSYIyqKKKQz3D4OxjUtHgiyFaBmBPoM8Zr2qx1e2tYUihhae4HHyjrXzR8IbnW59XGlaHGHMx3SE9EXjLE+lfVeiWVro8axhllvSB5k2O/oPQU0Iiuhr2oRMsFvHar/embGfpjNZMvg+dw011qkhl/upnb/OuvN6JAQDyKpTXGTjOc0wPKNQ8N3izuXbzrfdn5RyPcinNokduFMYJx1BHNd3NL5Ild8AZwBWTf3UU0OVAEi/rQBwerWYkgdtoCj1rm7vTXl2MDtCfrXa61cK6LFHjk5bFZoiBQ5FIDMggYRAYz7Um0p94d60Y0IOBUFzGd2TQMaDlgOK7D4dXYs/EUI3YSUFD9a42MHt0rU092t7qGRSQVYH9aBHuerRKPnxzWVHgPx97tW1ORdafFMnKuob8xWHnbLntTA6fTP3lmVPJrwnxxZGPXr1CMfMSK9y0SXcuOnFeafFG0EevtIFG2RAfr60gPB9Y0wwyu6j5G5PsazJLRmG1ByOa77VbZXjfisDyEU8Lk/yoGdR8DJ3t/EzROcB0xzXs2vQeZITjGO9eN/Dtfs/iexIGMtg/lXvWrxgwbgoJoQjjtORUmdT16c10Hia3Mvw/voyAf3RrFRAL8bv4hXX3UaXPg+7iB/5ZsDTA+TL20zc4BByM1veG4GW4t853BgRmq0sWLnODW1pC+XMjkfdOcUhnrsjCW4ygB3HrWrpunrJKCyA1yHhDWIr+1UhsNjBBPIr0TS7iKzt/MkOT2FMRLqWmW9vbCW6YKB2FcXcC4vJHXSdOXy1JBkfoa9AWwbUCLnU8hOqQe3q3+FPkjhjTbGqqOwHagDxHUPDl+1yZLuP/vntUUen+XMOPbJHSvTtVjHLdx2rkL6UPcKhXAB5BoAybiBRCvABB/OprSPBAxUd4CJFGCV7VZs+RQBowxArn0qdYwTgCkgOFFWBtFAEe3ap4qBsHnuKtEjBzUJAxjFADouPyrqfCM3zSQk8HkVyobb24rV8PXHkahGegPBoA6u7h+dqrwZVgCOa0LnkZqkchg3pSATxBb/atKkAGWUbhXnxQ5I4r1BcSwspGQRXnmowG2vJYyOjEj6UwM9k4OKqhCk6n/aq/jOeagkQ5z6GgDtIPmskJ9KozR8nHertkf8AQoz6ioZcE+lABGubKQHB4NecTKBK64/iNel2wHksOted3o23UwPUOePxoAgiQbxXoHhhf+JYv1NcIi85rvPC5xpw9iaANLaTke1fD3jVPL8W6uvpcv8Azr7jHMh9K+JfiOnl+OtcX0unpMDm6KKKQz3H4L38WmaVss1SO5n+aWc/ebn7ufQV69Dfnh+WY9SK+YPh7rCWGpKly4EfRQTx717nYausxX7OcLjI56imhHdWt+reYSwGR8ualtN00m7dnPUGuSaVlUNnG7tWnpV4UA3FueKYG7rFsskJVcE5zXD66rWYK92OAfavSLaMT24J6jv7VynxKsfs+nW06rkFyCfTigDgXBJzjgUj525FS8GEE+lRg5GB2pARoCXzSzrlM9qfuw+cCkn5TNAFLbtYEVdgk5Gaqt0qa2PIJGaAPcvBdwLzw5b7jkqu0/hUV9bhHLLxg5rI+F10Gs57Yk7lOfwrpdSQgn0pgLpLbZkJ6GsD4rWW+1trtR9wlCfatezbZKvP0q54ts/7Q8NXMa8sE3D6jmgDwK6jBVuOTXNyQbLhl6ZNdTdKykjPPcVk3kQBEhX2pAWvDB8rWrJ/SQV7/fKWs0YcgjrXzrpT+VqNuwOAJF/nX0UCJNOjHbaCKAORvYWtr1XP3W6V1NkQ+hXIPGUYn8qxtRjEsY9RWzpIL6RcKefkI/SmB87NGHZs9QavWUXlsGzn2qhchor2ZDxhyMfjWrYDzMHnJFIDmfDWpy29yrwuQV7djX0P8OzLqVguoagAqrxCnrj+KvlbSLoQ3wBPBxX0j4R1rz9NgWEgJGoCqPShAeiTTtk88VWmnU9Dms8XXmoN3GaY0nJGcCmBJc2wuI2O7BAzXJ6lp+ZCyg5/nXXWtwgbA5bpTDagyglQUY9PSgDzW9VluSh9KsWYxx7dK1/Gmmmw1CN9pEci5Bx3rKhUbgaAL8B4qc5+lRwD5RU5TuM0AMAyPal24/GnL1qXaKAKkg+bAqe2ykqMOxzTCuWJFTRjHtQB3sLCW0RvUA1Vk4NL4fkE1gqk5K8GpZ0wxpAJDJtYelYHiq32zRzgfK3BrbQdM+tGqWn2zTnQcsBkfWgDz4gZzTXXPbk1Zkjw5BGDUew9D+FMDp9KG6wTPXFQz9T9ataMoNigPpTJUDFhnpQA60GYiMV5/rcfl6pOCP4s16FYghMVxvimEJqj8feGaAMiPGOa7fwxxp341xEYweeld34dXGmCgDSXnmvir4prt+IniBfS7avtSJhnAr4w+Lgx8S/EY/6fHpMDkKKKKQxQSCCDgivVPhvqr3iojviSFgH+h6fyryqtPw9q02i6rDeQjcEPzxk4Dr3BoA+pI0ElishQsB3rQ0mFZo2CttYcil8JzWet+HoL3Tn8y1njGU7oe4NXtOt/skhjbO4561Qjd0B2EQDjLA4q74s0kaz4elt4+JBh0+o7VQ01wjNtbv0roLacEbSfwoA8BuoWt3aFwVdTg1RDfvV54zXdfE/SjZaql5GuILkdewYda4In5qQEw+Z88Yp8qllwPzqskyjj8Kuj7vNAFXyWAYkg0Q7lI9Klk5U4pkOT17UAdz8Nrkx60EPAdSK9Pv0yoOM1494TmEGsWshOAGFe0zjdCGHPFMDCVSsgZex6VvWZE1qY27jFYrcSN7Vo6ZKMjntQB454g0s2OsXUBXAVzgnuK53UYgIWBHTpXrXxO08K1vfIOHGxz79q8yvEBGPWgDnrddtxEc/xD+dfRlim/QoWPJMY/lXgAgUSA4719D6MA/h2HH/PIfypAc/JGSwXHGa6DSrfFnIvqvSs4hSuAuW3da6bTowbc4HO2mB8va7H5Ou3sTcFZm/nWhoo3OBzwOKsePLMW3iu+OOC2cfWpvBxDaxZJtyHlUfWkB4PPMYrtTnnFeq/DTxMkaiGRsOMAD1FePam5E6gDgDNS6VqL20yujYKnIpDPr7T78zEZ6HpW5KmYw5614z8OvF1vdbILuURuOhY8E17ZaQ/aLReTyMg1QiCOPJVk6jrWtYkSEbh0qraQtEWD8+hqaNir8HkUgNLxFosWtaTsI/eJyjehry2Sze1unhlBDocYr13Trn5drHrWP4v8PG8Vb6wAMy/fUfxCgDhLdfX8at7cjjpUSfKTngjqDTt/PB4pgJgBulSNgJk03IOc05sbaAIMjPHSlU9KacZIpBxjmgDqfCswEkkeccZFbd2MjpXJaBMI9Si54YY612Ewz1NICgrZ/CrVrICCKpM/lt0zT1kCnINAGD4isvIuvNQfu3OfoaysV2VzClzausnJP6Vyslu0NwYznGeKYG9pqbbFM+lRXK4OR1NW7IAxqgHQVBcr1PvQAlkCjAt3rA8ZW4Esco/iGK3YST9Kq6/ELnTmGPnT5hQBwyIM4rttJ/dadGOh21yUERedVA5JxXWR5Ee0YIHAoAtwNkge9fG3xd/5KZ4j/6/Hr7HhIwMdc18b/Fv/kpXiP8A6/HpMDkaKKKQwooooA9U+BXjc+H9cXSr6QjTb5guT/yzfsfoen5V9I6rDIrxyLjA5Br4cVirBlJBByCK+rvgt4xi8W+HUsLyQHU7RdjqW+Z0A4cD26fhTQju9NYMS2Mbv0q0935bjBxjvVC6ie0T5uD6juKgkO5M7vpTA6K/tLbxFoz2s/Ujhu6nsa8K13TrjSL6S0u0KyK2N3Zh6ivVrG+azmRt3A6jPUVa8X6FbeK9HS4tCv2tBmN/X/ZNAHhjMBJjIxV+NyUwe1U7+0msrp7e5jaOWM4ZTUsDfKOaQErnDU+IjJJ61EzfPlgcU9AD0oA1tNk2zK3cEGvdNNnFzpcMgP3kBrwa12rjB5r2LwXOZ/DsLZyVyv60wH3jCOfPamRXQjYbaTV2VQcEEmsJbra+HbpQB12rW6a1oU1seXK5T/eHSvENQVre6eOVCrIcFT2NeuaXe4cDPB6H1rl/iBoolnN/br9774Hc+tAHAbMuGUZJPSvetAJGgwn0jGR+FeI2EBluokxnLAYr27TwYtCUKSCeB9KAM+3ZvPZAOpyK6rSn3RMpxuxXKDdHOzZ79a2NPuSkqE9GPOKAPJvilZBdfkbB/eKGrL8GxD/hJdJDlUX7QgJY4AGe9dx8W7ZSY7mJSccE47Vzvwus2u/FVrJdIDZQfvJWYcewx3oA+W9Vx5oHOcc1nRttYEVo6wV8wYznHSsxmJAHYVIzoNH1BoZFYHBB9etfQ/wo+IPkLDY6nJ5lm2FVmPMf/wBavluGQowIzXV+GtSMU8eWIGeaAPuO7gVoxNbENGwDcc5FQKgdgTxXnnwk8cq0cWl6lIGhfiJ2P3fY+1en3do8B3R/NGT+VMRGgKHrxntWhaX3lMVPKelY/mksRkDFP8znp1oAd4l8OR30ZvdNAE2Msg6N/wDXrhGDRyMjqVZTggjGDXo+n3zQSbSfkPUGo9e0GDV4muLVgtxjqOjfWgDzvOMA1IpyOvFPvrK5s5DHcRMuO/Y1AhwMHimAPgUxeevalYk/hQq8c0AW9OYJewEdQwru52G32rgbBC17Cp/vCu2upAAQPSgChLxIT/DUkaeYm7I4qB2O7B5qWA44PHpSAnUgD61UuLUSSbscjkVYU5YfWriR8g9QaAM+wUhXJ61HKnfNXymwvgcGoJFFMCpEuD+NR3KbSc9CMVcUDHSmzjepGKAOQS2MWpOAOO1bVuuBgmo54f8AS1ParSrhuRzQA6FVDcHvXxv8XePiX4j/AOvx6+yI1Od3vXxz8XwR8TPEOe90T+gpMDjqKKKQwooooAK6DwL4in8L+JbPU7ZsGJvnXsyHqD/nsK5+igD7vFxb+IvDsN/YEPHJGJE2nP1H1rnppyiMm7Poa8o/Zx8dCxvX8PalKBb3B3W7MeEfuPof8a9p8R6asL+dFwW529qpCOdS4IAVzz2roPD+ptbPt3fuyeVrkpmDFtp5HOPQ1PDMY0DBuaAOv8Z+HbDXbcTcR3AHEijn8a8nv9GvdLdhPGWjB4kXkGvRbPV/MiEbt0461UvLolyr4ZD60Aeau+T1pyseoNdLrOiW9ypmtf3b9So6GuZiieGZopQQynpSA0rZ8Dn8a9W+Hs4Xw6xz0kNeSDr8tejeHpDZeFIBnDOxb9aYGxqcyOWbnIJrAVibk54JOBnoKLueR2PqR0PeoUkLSAPigDoUj8iRY2IJwCCOlWrs+fbFWyRWVbyghcnJFa9kVkyOvtQByVlpvla08hGExn2zXpCnZp1uD0IzWJJY5aUbcEDitiNjNZQKRyBjFAFWb6dRVnTkOMkcr0p0kA2rng1atYkUggnFIDJ8S2qXumurDcV7VR+HlibeW3VUAzN8x9ea6C8iRw2OPWpNCtCqWskYxmUDj60wPz91jAn54OBWYTmtXWUzMOecVlsAOAakYNgcAnFWLOcxOOcYqsRiigD1nwnqQeNDkhl9DX0v8NPF6araR6bfyA3CriNj/GB2+tfF/h3UGhnUbiMV654X1YxSRSwuQykMrA8g0wPpnUbMxN5qqdp9O1VBICAe9O8EeJLfxDYiC4YC8VQCp/i96s6rZfZ3IUY9PegRmySYfJOOeKv2l+9ucgnB7VlOpJwfvCm+ZhSAcmmB0N3NFcxFmUNnsRXMXljbSMSq7CfSrMNwcYyakkQSLnODQBz9xp7xAsnzL+tQwp8vSuot49zYIziob3TCoMsS/KeSPSgDP0WDdqCk9E5rdugS3HaqOggJM47mt0Wpc89fakBjOmDn1pyr8ufSr9xZMBwKrrCVJzQAxAAwq/Awx7Gq8UQJxg5FWYY9pwelACMNxIqCWEhc1pJHnk0y4jBUCgDIUepphcKfmPFW3tiM1Umix97FAFK9Cq6lTySMUjEbx70zUI2UAoCcHrT7UCVkzxTAsWyZYA9K+PPjjF5XxO1sf3pd1falvbqGOTXxz+0NEIfilqYH8QVvzzSYHmtFFFIYUUUUAFFFFAE1rcSWtxHNCxWRCCCOoNfWHwt8YJ408HfZbqQNqloArZ6sMcNXyTXSeAPEs/hfxJbX0LHys7JlzwyHrQgPoi/jNreFmXBJximxusm4L2q3qhh1K2hu7aQMsqiRWzwc1gxSm3uRwwXOD7GqEXVd1lByQua10ZbiDrjFZqxhlY5+XNXLKJll+QEhuKAJ4UcyBB0qnr+hmRRcRDEqDkDuK6C3ttnL9c1pxxBsbhu9aAPLraIvOkS5LOQK9JvYdlrbWyH5UXBI+lVB4fRNUS5tQSN24qe30rqvsQkI4HA9OaAOReFmhwc59e9Q20KsBuOWrtLrSFMeQOT3Fc3cWbwXhUqcj260ALbJtTgEk1paa5EvWo7aBmUHaTV+GwKnPKg0AdAojmgD7fnA5qSysmZGYdz0p+k2/AyQexroba2SODaMHuKQHPSQFGB25IqwkREe4gbTWxPZbxmMZ71XktG2YGSemKAMiVYnjcJjIFaOhqFtYyxACsGqo1hIm5kX8am0hx54gkI4O3bQB+d+tNukU8ZI7VkNnPNaurn5x9Ky8Ek45pDEJJ69qSiigB8TmNwynBFdx4X1baEV347YrhKuafdG3mUjtQB9E+FtalglimhkKyocgg17/wCGddh8S6WFkKrexj5h6+9fIXhjXEJXewBr1TwvrrWV5FcW0u1gc49R6UxHruowNBMdwqkoB6d62bPUbfWtMS4TBJ4YehqjNAUf5cAdqYFJkJU4GD39qmgdgNrAkjoasFd6n+90q3bW4jhBcAselADLaNgu5hhjWhCpK888dDTYYy2SwrSsbYlfu8nikBlW+nJ9q3xrtOe1bkduFXJzmrlpZhJecZAp8se1/agZmTQ5zxxWfJbAMWbj1ro1g3cnoaa9spOAO3U0XAxEtgQCuKcYCG6VfaBlOGwaRoymBzk+tAiuka45GKrzR72OOEHU1LJ5jkjcAgPOOppJmygRRgCgDMmQFuJG2+lVmhXJ5Jq7PHz71F5fBoAyruP5DjsafZRKxGRkir0kG4YJ61JFbbEHFABbBVZsDJr49/aZXb8Vrz3t4j+hr7Ft4wsjA+tfHv7T2P8Aha90B2toR+hoA8mooopDCiiigAooooAKKKKAPa/hP4j+0aGmnXRJa2JVHJ7dQPy4rsLsB33qcqe9fPfhnV30bU0nGTESBIo7j/GvcfDV/DqCKBIGhk+ZWHvTQje0gtOWDnGDgg11tqqJEIoFG7H3vesO0sDDKMcqT2rq7GBBtyMKOtMB9tauyfOwL98Ctqx0tnjyFO48Vd0z7LHHvcAtV/UdYW1sD9hh8y6f5Y1A6k0AR2WmeUCJAM1aFqhIYDkcVP4csrpLMPqkvmXch3EDovtS3kohn24FIA+zqYyD0rC1q0+VJEXBzjdjtXSQukg9eOlWPs6yRbGAIPagDktPt1eMYwfwrQSzIzhcrUxtRBcMVyRmtCINtxGw57EUAQ2MYX5SvPqK2QoVdvrWf86lQIskngg8VfT9380py3akMsJtiQANzVS5lcggSonvimtKuSc5Y9BVK4Qy8YPXtQBBeeWFyZJZWPcnA/Sm+FbNZLi4nZcYbg55p0tq2VVTx6VtaNZi0tz/AHnOTTEfmlq4DPGAMEDmszaT0rX1b/Xj/dFZ1IZAY2ABIwD0pNpq5P8A6mH/AHDUK/dNAEIU07aRg0q9DUtAFzSrowSLk969K8N6xuwpbnrXlcf+sX611/h3/WJQB9D+ANfW2lMTyYSTsTxmvTVdJwORgjIx3r568PfeWvc9F/49rf6CqEasFuyvnGRV1IiwGQTipLf+tXLfo1ICWw05n2s5AX0rVYw2cLNkfKM02z/1S/Sqt1/H/vD+dIZY0xZnDT3I2s/3U9BVyVN3an96KAI1j9TTtgzTqO9AETQqaha3JbtVug0AZM9ltfK1BPbEY9K2Zvumql39xfrQBiPbnP4002zcEDNaMn8VH/LIfWmIzhanzDuFTSWzbRgcVcboKlb/AFY+tAGZ9jKvxXxT+006v8WdQ2KRsijQ/UZzX3QPvivhj9pP/kres/8AAf5mgDyiiiikMKKKKACiiigAooooAK6Hwj4gm0S7DYMkB+8mf5VgL/WpoepoA+pvDGt2erWlvc2swMcgxhjyp7g118dtceR5i8xg9Qe1fP8A8Jf9VJ/11X+VfRei/wDIPk+lUIdp0gmukhEvHU+tdVatGs+UAUIMZPWuD0T/AJD7fSu2h++31oYHQ2N6PORAMgjimata+bhxwao6b/x/RfjW5df6g0gKOmQnbgjpxWzbxHJz6VR037p+tbMP3aQzOe23bm2jNQxQMrcZH1rUP3qjb76/WgAa2BjXsRioriEyAhTk9eKvn7tQx/eegCha2TAEmrQgC4OOasp/q6U9vrQBU+xq04c9u1XQMDA6UlLQB//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Serial radiographs, five years apart, of the metacarpophalangeal joints in a patient with hereditary hemochromatosis. The second film shows loss of joint space at the metacarpophalangeal articulations, cyst formation, and a hook-like osteophyte on the radial aspect of the metacarpal head of the middle finger.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of John S Axford, BSc, MD, FRCP.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_0_26639=[""].join("\n");
var outline_f26_0_26639=null;
